col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


805 Results       Page 1

 [1] 
MDPI AG: International Journal of Molecular Sciences
  original article Date Title Authors   All Authors
1 [GO] 2023―Mar―22 Lymphocyte-to-C-Reactive Protein (LCR) Ratio Is Not Accurate to Predict Severity and Mortality in Patients with COVID-19 Admitted to the ED Laure Abensur Vuillaume, François Lefebvre, Axel Benhamed, Amandine Schnee, Mathieu Hoffmann, Fernanda Godoy Falcao, et al. (+4)
2 [GO] 2023―Mar―22 mRNA Vaccines against SARS-CoV-2: Advantages and Caveats Miriam Echaide, Luisa Chocarro de Erauso, Ana Bocanegra, Ester Blanco, Grazyna Kochan, David Escors
3 [GO] 2023―Mar―21 Extracellular Vesicles of COVID-19 Patients Reflect Inflammation, Thrombogenicity, and Disease Severity Anat Aharon, Ayelet Dangot, Fadi Kinaani, Mor Zavaro, Lian Bannon, Tali Bar-lev, et al. (+3)
4 [GO] 2023―Mar―20 Direct Application of 3-Maleimido-PROXYL for Proving Hypoalbuminemia in Cases of SARS-CoV-2 Infection: The Potential Diagnostic Method of Determining Albumin Instability and Oxidized Protein Level in Severe COVID-19 Ekaterina Georgieva, Vasil Atanasov, Rositsa Kostandieva, Vanya Tsoneva, Mitko Mitev, Georgi Arabadzhiev, et al. (+3)
5 [GO] 2023―Mar―20 Interaction of SARS-CoV-2 Nucleocapsid Protein and Human RNA Helicases DDX1 and DDX3X Modulates Their Activities on Double-Stranded RNA Camilla Lodola, Massimiliano Secchi, Virginia Sinigiani, Antonella De Palma, Rossana Rossi, Davide Perico, et al. (+2)
6 [GO] 2023―Mar―17 Immunology of Multisystem Inflammatory Syndrome after COVID-19 in Children: A Review of the Current Evidence Filippos Filippatos, Elizabeth-Barbara Tatsi, Athanasios Michos
7 [GO] 2023―Mar―17 Erythrocytes Functionality in SARS-CoV-2 Infection: Potential Link with Alzheimer’s Disease Elena Kosenko, Lyudmila Tikhonova, Gubidat Alilova, Carmina Montoliu
8 [GO] 2023―Mar―16 The APSANTICO Study: A Prospective Observational Study to Evaluate Antiphospholipid Antibody Profiles in Patients with Thromboembolic Antiphospholipid Syndrome (APS) after COVID-19 Infection and/or Vaccination Olivia Ott, Eva Herrmann, Annabel Schulz, Edelgard Lindhoff-Last
9 [GO] 2023―Mar―16 Molecular Analysis of SARS-CoV-2 Spike Protein-Induced Endothelial Cell Permeability and vWF Secretion Yuexi Guo, Venkateswarlu Kanamarlapudi
10 [GO] 2023―Mar―15 Dopamine Transmission Imbalance in Neuroinflammation: Perspectives on Long-Term COVID-19 Maria Mancini, Silvia Natoli, Fabrizio Gardoni, Monica Di Luca, Antonio Pisani
11 [GO] 2023―Mar―15 The SARS-CoV-2 Virus and the Cholinergic System: Spike Protein Interaction with Human Nicotinic Acetylcholine Receptors and the Nicotinic Agonist Varenicline Eric C. Carlson, Marian Macsai, Sonia Bertrand, Daniel Bertrand, Jeffrey Nau
12 [GO] 2023―Mar―14 Secretory Phospholipase A2 and Interleukin-6 Levels as Predictive Markers of the Severity and Outcome of Patients with COVID-19 Infections Stanislav Urazov, Alexandr Chernov, Oleg Popov, Natalya Klenkova, Natalya Sushentseva, Irina Polkovnikova, et al. (+5)
13 [GO] 2023―Mar―14 A Simultaneous Extraction/Derivatization Strategy for Quantitation of Vitamin D in Dried Blood Spots Using LC-MS/MS: Application to Biomarker Study in Subjects Tested for SARS-CoV-2 Yashpal S. Chhonker, Nusrat Ahmed, Christine M. Johnston, Ruanne V. Barnabas, Daryl J. Murry
14 [GO] 2023―Mar―14 Interaction of Laurusides 1 and 2 with the 3C-like Protease (Mpro) from Wild-Type and Omicron Variant of SARS-CoV-2: A Molecular Dynamics Study Ida Autiero, Giovanni N. Roviello
15 [GO] 2023―Mar―13 COVID-19-Induced Myocarditis: Pathophysiological Roles of ACE2 and Toll-like Receptors Patrizia Pannucci, Sophie R. Jefferson, Jonathan Hampshire, Samantha L. Cooper, Stephen J. Hill, Jeanette Woolard
16 [GO] 2023―Mar―13 Importance, Applications and Features of Assays Measuring SARS-CoV-2 Neutralizing Antibodies Pia Gattinger, Anna Ohradanova-Repic, Rudolf Valenta
17 [GO] 2023―Mar―10 SARS-CoV-2 Spike Protein and Neutralizing Anti-Spike Protein Antibodies Modulate Blood Platelet Function Boguslawa Luzak, Marcin Rozalski, Tomasz Przygodzki, Magdalena Boncler, Dagmara Wojkowska, Marcin Kosmalski, Cezary Watala
18 [GO] 2023―Mar―08 Hematological Parameters and Procalcitonin as Discriminants between Bacterial Pneumonia-Induced Sepsis and Viral Sepsis Secondary to COVID-19: A Retrospective Single-Center Analysis Emanuel Moisa, Madalina Dutu, Dan Corneci, Ioana Marina Grintescu, Silvius Negoita
19 [GO] 2023―Mar―08 Dissection of Antibody Responses of Gam-COVID-Vac-Vaccinated Subjects Suggests Involvement of Epitopes Outside RBD in SARS-CoV-2 Neutralization Maria Byazrova, Pia Gattinger, Ekaterina Astakhova, Gerhard Hofer, Musa Khaitov, Alexander Filatov, Rudolf Valenta
20 [GO] 2023―Mar―08 In Silico Binding of 2-Aminocyclobutanones to SARS-CoV-2 Nsp13 Helicase and Demonstration of Antiviral Activity Thahani S. Habeeb Mohammad, Yash Gupta, Cory T. Reidl, Vlad Nicolaescu, Haley Gula, Ravi Durvasula, et al. (+2)
21 [GO] 2023―Mar―06 Autophagy in Inflammatory Response against SARS-CoV-2 Roxana Resnik, Fabiana Lopez Mingorance, Francisco Rivera, Florencia Mitchell, Claudio D. Gonzalez, Maria I. Vaccaro
22 [GO] 2023―Mar―06 New Insights into the Identification of Metabolites and Cytokines Predictive of Outcome for Patients with Severe SARS-CoV-2 Infection Showed Similarity with Cancer Susan Costantini, Gabriele Madonna, Elena Di Gennaro, Francesca Capone, Palmina Bagnara, Mariaelena Capone, et al. (+9)
23 [GO] 2023―Mar―06 Effect of SARS-CoV-2 mRNA-Vaccine on the Induction of Myocarditis in Different Murine Animal Models Vanessa A. Zirkenbach, Rebecca M. Ignatz, Renate Öttl, Zeynep Cehreli, Vera Stroikova, Mansur Kaya, et al. (+4)
24 [GO] 2023―Mar―03 COVID-19 and Cancer Diseases-The Potential of Coriolus versicolor Mushroom to Combat Global Health Challenges Tomasz Jędrzejewski, Małgorzata Pawlikowska, Justyna Sobocińska, Sylwia Wrotek
25 [GO] 2023―Mar―03 Classification of COVID-19 Patients into Clinically Relevant Subsets by a Novel Machine Learning Pipeline Using Transcriptomic Features Andrea R. Daamen, Prathyusha Bachali, Amrie C. Grammer, Peter E. Lipsky
26 [GO] 2023―Mar―02 Exploration of the Shared Molecular Mechanisms between COVID-19 and Neurodegenerative Diseases through Bioinformatic Analysis Yingchao Shi, Wenhao Liu, Yang Yang, Yali Ci, Lei Shi
27 [GO] 2023―Mar―02 A Particular Focus on the Prevalence of α- and β-Thalassemia in Western Sicilian Population from Trapani Province in the COVID-19 Era Rossella Daidone, Antonella Carollo, Maria Patrizia Perricone, Renato Messina, Carmela Rita Balistreri
28 [GO] 2023―Mar―02 SARS-CoV-2 S Mutations: A Lesson from the Viral World to Understand How Human Furin Works Leonardo Cassari, Angela Pavan, Giulia Zoia, Monica Chinellato, Elena Zeni, Alessandro Grinzato, et al. (+4)
29 [GO] 2023―Mar―02 Comparison of SARS-CoV-2 Detection in Nasopharyngeal Swab and Saliva Samples from Patients Infected with Omicron Variant Licia Bordi, Giuseppe Sberna, Eleonora Lalle, Lavinia Fabeni, Valentina Mazzotta, Simone Lanini, et al. (+7)
30 [GO] 2023―Mar―01 Monitoring of SARS-CoV-2 Infection in Ragusa Area: Next Generation Sequencing and Serological Analysis Maria Denaro, Elisa Ferro, Giuseppe Barrano, Salvatore Meli, Mariangela Busacca, Damiano Corallo, et al. (+11)
31 [GO] 2023―Mar―01 SARS-CoV-2 Lysate Stimulation Impairs the Release of Platelet-like Particles and Megakaryopoiesis in the MEG-01 Cell Line Valentina Lopardo, Francesco Montella, Roberta Maria Esposito, Carla Zannella, Silvana Mirella Aliberti, Mario Capunzo, et al. (+3)
32 [GO] 2023―Feb―28 A Novel Ambroxol-Derived Tetrahydroquinazoline with a Potency against SARS-CoV-2 Proteins Alena I. Krysantieva, Julia K. Voronina, Damir A. Safin
33 [GO] 2023―Feb―27 COVID-19 Biogenesis and Intracellular Transport Alexander A. Mironov, Maksim A. Savin, Galina V. Beznoussenko
34 [GO] 2023―Feb―27 Plasma Apolipoprotein Concentrations Are Highly Altered in Severe Intensive Care Unit COVID-19 Patients: Preliminary Results from the LIPICOR Cohort Study Floran Begue, Kévin Chemello, Bryan Veeren, Brice Lortat-Jacob, Alexy Tran-Dinh, Nathalie Zappella, et al. (+8)
35 [GO] 2023―Feb―27 Discovery and Optimization of Neutralizing SARS-CoV-2 Antibodies Using ALTHEA Gold Plus Libraries™ Omar U. Guzmán-Bringas, Keyla M. Gómez-Castellano, Edith González-González, Juana Salinas-Trujano, Said Vázquez-Leyva, Luis Vallejo-Castillo, et al. (+2)
36 [GO] 2023―Feb―27 SARS-CoV-2 Transplacental Transmission: A Rare Occurrence? An Overview of the Protective Role of the Placenta Yin Ping Wong, Geok Chin Tan, T. Yee Khong
37 [GO] 2023―Feb―24 Treatment of Acute Respiratory Distress Syndrome Caused by COVID-19 with Human Umbilical Cord Mesenchymal Stem Cells Tetiana Bukreieva, Hanna Svitina, Viktoriia Nikulina, Alyona Vega, Oleksii Chybisov, Iuliia Shablii, et al. (+5)
38 [GO] 2023―Feb―23 Virus-like Particles of Nodavirus Displaying the Receptor Binding Domain of SARS-CoV-2 Spike Protein: A Potential VLP-Based COVID-19 Vaccine Kiven Kumar, Wen Siang Tan, Siti Suri Arshad, Kok Lian Ho
39 [GO] 2023―Feb―23 Identifying Drug Candidates for COVID-19 with Large-Scale Drug Screening Yifei Wu, Scott D. Pegan, David Crich, Lei Lou, Lauren Nicole Mullininx, Edward B. Starling, et al. (+4)
40 [GO] 2023―Feb―23 Lessons Learnt from COVID-19: Computational Strategies for Facing Present and Future Pandemics Matteo Pavan, Stefano Moro
41 [GO] 2023―Feb―23 Can T Cells Abort SARS-CoV-2 and Other Viral Infections? Leo Swadling, Mala K. Maini
42 [GO] 2023―Feb―23 Anti-Spike Antibodies Present in the Milk of SARS-CoV-2 Vaccinated Mothers Are Complement-Activating Chiara Agostinis, Miriam Toffoli, Andrea Balduit, Alessandro Mangogna, Hadida Yasmin, Chiara Ragazzon, et al. (+9)
43 [GO] 2023―Feb―22 Pathways of Coagulopathy and Inflammatory Response in SARS-CoV-2 Infection among Type 2 Diabetic Patients Orsolya-Zsuzsa Akácsos-Szász, Sándor Pál, Kinga-Ilona Nyulas, Enikő Nemes-Nagy, Ana-Maria Fárr, Lóránd Dénes, et al. (+4)
44 [GO] 2023―Feb―21 Identification of and Mechanistic Insights into SARS-CoV-2 Main Protease Non-Covalent Inhibitors: An In-Silico Study Jian-Xin Shen, Wen-Wen Du, Yuan-Ling Xia, Zhi-Bi Zhang, Ze-Fen Yu, Yun-Xin Fu, Shu-Qun Liu
45 [GO] 2023―Feb―20 Chemosensory Ability and Sensitivity in Health and Disease: Epigenetic Regulation and COVID-19 Naina Bhatia-Dey, Antonei B. Csoka, Thomas Heinbockel
46 [GO] 2023―Feb―20 α1-Adrenergic Receptors: Insights into Potential Therapeutic Opportunities for COVID-19, Heart Failure, and Alzheimer’s Disease Dianne M. Perez
47 [GO] 2023―Feb―20 Potent Therapeutic Strategies for COVID-19 with Single-Domain Antibody Immunoliposomes Neutralizing SARS-CoV-2 and Lip/cGAMP Enhancing Protective Immunity Yajun Zhou, Xing Lu, Xiaoqing Wang, Tianlei Ying, Xiangshi Tan
48 [GO] 2023―Feb―20 Identifying SARS-CoV-2 Drugs Binding to the Spike Fatty Acid Binding Pocket Using In Silico Docking and Molecular Dynamics Sakshi Piplani, Puneet Singh, Nikolai Petrovsky, David A. Winkler
49 [GO] 2023―Feb―17 The Comparison of Retinal Microvascular Findings in Acute COVID-19 and 1-Year after Hospital Discharge Assessed with Multimodal Imaging-A Prospective Longitudinal Cohort Study Kristina Jevnikar, Andrej Meglič, Luka Lapajne, Mateja Logar, Nataša Vidovič Valentinčič, Mojca Globočnik Petrovič, Polona Jaki Mekjavić
50 [GO] 2023―Feb―16 Cell Type-Specific Anti-Viral Effects of Novel SARS-CoV-2 Main Protease Inhibitors Nina Geiger, Viktoria Diesendorf, Valeria Roll, Eva-Maria König, Helena Obernolte, Katherina Sewald, et al. (+5)
51 [GO] 2023―Feb―16 Analysis of Bacteriophage Behavior of a Human RNA Virus, SARS-CoV-2, through the Integrated Approach of Immunofluorescence Microscopy, Proteomics and D-Amino Acid Quantification Carlo Brogna, Vincenzo Costanzo, Barbara Brogna, Domenico Rocco Bisaccia, Giancarlo Brogna, Marino Giuliano, et al. (+5)
52 [GO] 2023―Feb―14 Distinct Conformations of SARS-CoV-2 Omicron Spike Protein and Its Interaction with ACE2 and Antibody Myeongsang Lee, Marian Major, Huixiao Hong
53 [GO] 2023―Feb―13 Plasma N-Cleaved Galectin-9 Is a Surrogate Marker for Determining the Severity of COVID-19 and Monitoring the Therapeutic Effects of Tocilizumab Hiroko Iwasaki-Hozumi, Yosuke Maeda, Toshiro Niki, Haorile Chagan-Yasutan, Gaowa Bai, Takashi Matsuba, et al. (+3)
54 [GO] 2023―Feb―10 The Prognostic Value of Pentraxin-3 in COVID-19 Patients: A Systematic Review and Meta-Analysis of Mortality Incidence Anna Paola Capra, Alessio Ardizzone, Giuseppe Pantò, Irene Paterniti, Michela Campolo, Lelio Crupi, et al. (+2)
55 [GO] 2023―Feb―10 Recognition of Differentially Expressed Molecular Signatures and Pathways Associated with COVID-19 Poor Prognosis in Glioblastoma Patients Faisal A. Alzahrani, Mohd Faheem Khan, Varish Ahmad
56 [GO] 2023―Feb―10 Plasma Proteomic Variables Related to COVID-19 Severity: An Untargeted nLC-MS/MS Investigation Lisa Pagani, Clizia Chinello, Giulia Risca, Giulia Capitoli, Lucrezia Criscuolo, Andrea Lombardi, et al. (+11)
57 [GO] 2023―Feb―10 Accurate Detection of SARS-CoV-2 by Next-Generation Sequencing in Low Viral Load Specimens Marius Ilié, Jonathan Benzaquen, Véronique Hofman, Elodie Long-Mira, Sandra Lassalle, Jacques Boutros, et al. (+15)
58 [GO] 2023―Feb―09 Induced Pluripotent Stem Cell-Derived Organoids: Their Implication in COVID-19 Modeling Mária Csöbönyeiová, Martin Klein, Marcela Kuniaková, Ivan Varga, Ľuboš Danišovič
59 [GO] 2023―Feb―08 Apalutamide Prevents SARS-CoV-2 Infection in Lung Epithelial Cells and in Human Nasal Epithelial Cells Amene Majidipur, Margot Morin-Dewaele, Jeanne Gaspar Lopes, Francois Berry, Julien Fouchet, Sophie Bartier, et al. (+14)
60 [GO] 2023―Feb―08 Endogenous miRNA-Based Innate-Immunity against SARS-CoV-2 Invasion of the Brain Walter J. Lukiw, Aileen I. Pogue
61 [GO] 2023―Feb―08 Nucleoside Analogs That Inhibit SARS-CoV-2 Replication by Blocking Interaction of Virus Polymerase with RNA Elena Matyugina, Ivan Petushkov, Sergei Surzhikov, Vasily Kezin, Anna Maslova, Olga Ivanova, et al. (+6)
62 [GO] 2023―Feb―07 Monocytic HLA-DR Expression in Immune Responses of Acute Pancreatitis and COVID-19 Shiyu Liu, Wenjuan Luo, Peter Szatmary, Xiaoying Zhang, Jing-Wen Lin, Lu Chen, et al. (+6)
63 [GO] 2023―Feb―07 Trained Immunity, BCG and SARS-CoV-2 General Outline and Possible Management in COVID-19 Paweł Zapolnik, Wojciech Kmiecik, Artur Mazur, Hanna Czajka
64 [GO] 2023―Feb―07 Identify the Virus-like Models for COVID-19 as Bio-Threats: Combining Phage Display, Spectral Detection and Algorithms Analysis Yuting Wu, Zhiwei Liu, Sihan Mao, Bing Liu, Zhaoyang Tong
65 [GO] 2023―Feb―07 A Protein Co-Conservation Network Model Characterizes Mutation Effects on SARS-CoV-2 Spike Protein Lianjie Zeng, Yitan Lu, Wenying Yan, Yang Yang
66 [GO] 2023―Feb―07 Identification of SARS-CoV-2 Main Protease (Mpro) Cleavage Sites Using Two-Dimensional Electrophoresis and In Silico Cleavage Site Prediction Noémi Miltner, Gergő Kalló, Éva Csősz, Márió Miczi, Tibor Nagy, Mohamed Mahdi, et al. (+2)
67 [GO] 2023―Feb―06 The Search of Association of HLA Class I and Class II Alleles with COVID-19 Mortality in the Russian Cohort Valery Cheranev, Irina Bulusheva, Valery Vechorko, Dmitriy Korostin, Denis Rebrikov
68 [GO] 2023―Feb―06 Unveiling the Potentiality of Shikonin Derivatives Inhibiting SARS-CoV-2 Main Protease by Molecular Dynamic Simulation Studies Raju Das, Sarmin Ummey Habiba, Raju Dash, Yohan Seo, Joohan Woo
69 [GO] 2023―Feb―06 SARS-CoV-2 Spike Protein Activates Human Lung Macrophages Francesco Palestra, Remo Poto, Renato Ciardi, Giorgia Opromolla, Agnese Secondo, Valentina Tedeschi, et al. (+9)
70 [GO] 2023―Feb―03 From Co-Infections to Autoimmune Disease via Hyperactivated Innate Immunity: COVID-19 Autoimmune Coagulopathies, Autoimmune Myocarditis and Multisystem Inflammatory Syndrome in Children Robert Root-Bernstein
71 [GO] 2023―Feb―03 Occupational Skin Dermatitis among Healthcare Workers Associated with the COVID-19 Pandemic: A Review of the Literature Yu Sawada
72 [GO] 2023―Feb―03 The Role of Cyclodextrins in COVID-19 Therapy-A Literature Review Beatriz Almeida, Cátia Domingues, Filipa Mascarenhas-Melo, Inês Silva, Ivana Jarak, Francisco Veiga, Ana Figueiras
73 [GO] 2023―Feb―03 Detection of SARS-CoV-2-Specific Antibodies in Human Breast Milk and Their Neutralizing Capacity after COVID-19 Vaccination: A Systematic Review Vicky Nicolaidou, Rafaela Georgiou, Maria Christofidou, Kyriacos Felekkis, Myrtani Pieri, Christos Papaneophytou
74 [GO] 2023―Feb―03 Periodontitis and COVID-19: Immunological Characteristics, Related Pathways, and Association Manlin Qi, Wenyue Sun, Kun Wang, Wen Li, Jinying Lin, Jing Gong, Lin Wang
75 [GO] 2023―Feb―02 Evaluation of In Vitro Distribution and Plasma Protein Binding of Selected Antiviral Drugs (Favipiravir, Molnupiravir and Imatinib) against SARS-CoV-2 Orsolya Dömötör, Éva A. Enyedy
76 [GO] 2023―Feb―01 Transient Changes in the Plasma of Astrocytic and Neuronal Injury Biomarkers in COVID-19 Patients without Neurological Syndromes Matthew P. Lennol, Nicholas J. Ashton, Oscar Moreno-Pérez, María-Salud García-Ayllón, Jose-Manuel Ramos-Rincon, Mariano Andrés, et al. (+7)
77 [GO] 2023―Jan―31 Transcriptional Insights of Oxidative Stress and Extracellular Traps in Lung Tissues of Fatal COVID-19 Cases Aref Hosseini, Darko Stojkov, Timothée Fettrelet, Rostyslav Bilyy, Shida Yousefi, Hans-Uwe Simon
78 [GO] 2023―Jan―30 Pathway and Network Analyses Identify Growth Factor Signaling and MMP9 as Potential Mediators of Mitochondrial Dysfunction in Severe COVID-19 Ya Wang, Klaus Schughart, Tiana Maria Pelaia, Tracy Chew, Karan Kim, Thomas Karvunidis, et al. (+12)
79 [GO] 2023―Jan―30 Microvascular Thrombosis as a Critical Factor in Severe COVID-19 Patricia P. Wadowski, Benjamin Panzer, Alicja Józkowicz, Christoph W. Kopp, Thomas Gremmel, Simon Panzer, Renate Koppensteiner
80 [GO] 2023―Jan―30 Peripheral Blood Genes Crosstalk between COVID-19 and Sepsis Changyin Fang, Yongping Ma
81 [GO] 2023―Jan―30 Role of Sex and Age in Fatal Outcomes of COVID-19: Women and Older Centenarians Are More Resilient Calogero Caruso, Gabriella Marcon, Giulia Accardi, Anna Aiello, Anna Calabrò, Mattia Emanuela Ligotti, et al. (+3)
82 [GO] 2023―Jan―30 Revealing the Molecular Interactions between Human ACE2 and the Receptor Binding Domain of the SARS-CoV-2 Wild-Type, Alpha and Delta Variants Cécilia Hognon, Emmanuelle Bignon, Antonio Monari, Marco Marazzi, Cristina Garcia-Iriepa
83 [GO] 2023―Jan―30 SARS-CoV-2: Advances in Serological Methods and the Understanding of Antibody Escape Daniele Focosi, Fabrizio Maggi
84 [GO] 2023―Jan―30 Modulation of NBAS-Related Functions in the Early Response to SARS-CoV-2 Infection Valentina Granata, Isabel Pagani, Emanuela Morenghi, Maria Lucia Schiavone, Alessandra Lezzi, Silvia Ghezzi, et al. (+3)
85 [GO] 2023―Jan―26 Alterations in Circulating miRNA Levels after Infection with SARS-CoV-2 Could Contribute to the Development of Cardiovascular Diseases: What We Know So Far Myrtani Pieri, Panayiotis Vayianos, Vicky Nicolaidou, Kyriacos Felekkis, Christos Papaneophytou
86 [GO] 2023―Jan―26 Comparative Analysis of Library Preparation Approaches for SARS-CoV-2 Genome Sequencing on the Illumina MiSeq Platform Anna Gladkikh, Ekaterina Klyuchnikova, Polina Pavlova, Valeriya Sbarzaglia, Nadezhda Tsyganova, Margarita Popova, et al. (+6)
87 [GO] 2023―Jan―25 SARS-CoV-2 as an Oncolytic Virus Following Reactivation of the Immune System: A Review Joao P. Bounassar-Filho, Laura Boeckler-Troncoso, Jocelyne Cajigas-Gonzalez, Maria G. Zavala-Cerna
88 [GO] 2023―Jan―24 Convergent Evolution in SARS-CoV-2 Spike Creates a Variant Soup from Which New COVID-19 Waves Emerge Daniele Focosi, Rodrigo Quiroga, Scott McConnell, Marc C. Johnson, Arturo Casadevall
89 [GO] 2023―Jan―19 T-Cell Immunity in COVID-19-Recovered Individuals and Individuals Vaccinated with the Combined Vector Vaccine Gam-COVID-Vac Sergey Petrovich Krechetov, Valentina Valentinovna Vtorushina, Evgenia Vladimirovna Inviyaeva, Elena Aleksandrovna Gorodnova, Svetlana Vladimirovna Kolesnik, Dmitry Anatolievich Kudlay, et al. (+4)
90 [GO] 2023―Jan―19 Extracellular Vesicles: New Players in the Mechanisms of Sepsis- and COVID-19-Related Thromboinflammation Martina Schiavello, Barbara Vizio, Ornella Bosco, Emanuele Pivetta, Filippo Mariano, Giuseppe Montrucchio, Enrico Lupia
91 [GO] 2023―Jan―19 Convergent Evolution Dynamics of SARS-CoV-2 and HIV Surface Envelope Glycoproteins Driven by Host Cell Surface Receptors and Lipid Rafts: Lessons for the Future Jacques Fantini, Henri Chahinian, Nouara Yahi
92 [GO] 2023―Jan―19 Coordinated Loss and Acquisition of NK Cell Surface Markers Accompanied by Generalized Cytokine Dysregulation in COVID-19 Maria O. Ustiuzhanina, Julia D. Vavilova, Anna A. Boyko, Maria A. Streltsova, Sofya A. Kust, Leonid M. Kanevskiy, et al. (+11)
93 [GO] 2023―Jan―19 In Silico and In Vitro Inhibition of SARS-CoV-2 PLpro with Gramicidin D Sara Protić, Nevena Kaličanin, Milan Sencanski, Olivera Prodanović, Jelena Milicevic, Vladimir Perovic, et al. (+3)
94 [GO] 2023―Jan―16 COVID-19 Plasma Extracellular Vesicles Increase the Density of Lipid Rafts in Human Small Airway Epithelial Cells Sara Darwish, Lauren P. Liu, Tanya O. Robinson, Spurthi Tarugu, Anna H. Owings, Sarah C. Glover, Abdel A. Alli
95 [GO] 2023―Jan―16 Can Baseline IL-6 Levels Predict Long COVID in Subjects Hospitalized for SARS-CoV-2 Disease? Lydia Giannitrapani, Luigi Mirarchi, Simona Amodeo, Anna Licata, Maurizio Soresi, Francesco Cavaleri, et al. (+6)
96 [GO] 2023―Jan―16 Hemodialysis-Associated Immune Dysregulation in SARS-CoV-2-Infected End-Stage Renal Disease Patients Cecilia González-Cuadrado, Paula Jara Caro-Espada, Marta Chivite-Lacaba, Alberto Utrero-Rico, Claudia Lozano-Yuste, Elena Gutierrez-Solis, et al. (+6)
97 [GO] 2023―Jan―13 The Breadth of Bacteriophages Contributing to the Development of the Phage-Based Vaccines for COVID-19: An Ideal Platform to Design the Multiplex Vaccine Ihtisham Ul Haq, Katarzyna Krukiewicz, Galal Yahya, Mehboob Ul Haq, Sajida Maryam, Rasha A. Mosbah, et al. (+2)
98 [GO] 2023―Jan―13 DNA Oligonucleotides as Antivirals and Vaccine Constituents against SARS Coronaviruses: A Prospective Tool for Immune System Tuning Volodymyr V. Oberemok, Oksana A. Andreeva, Edie E. Alieva
99 [GO] 2023―Jan―11 T Cell Receptor Sequences Amplified during Severe COVID-19 and Multisystem Inflammatory Syndrome in Children Mimic SARS-CoV-2, Its Bacterial Co-Infections and Host Autoantigens Robert Root-Bernstein, Elizabeth Churchill, Shelby Oliverio
100 [GO] 2023―Jan―11 Urokinase System in Pathogenesis of Pulmonary Fibrosis: A Hidden Threat of COVID-19 Anna A. Shmakova, Vladimir S. Popov, Iliya P. Romanov, Nikita R. Khabibullin, Nailya R. Sabitova, Anna A. Karpukhina, et al. (+7)
101 [GO] 2023―Jan―11 Integrated Data Analysis Uncovers New COVID-19 Related Genes and Potential Drug Re-Purposing Candidates Alexandros Xenos, Noël Malod-Dognin, Carme Zambrana, Nataša Pržulj
102 [GO] 2023―Jan―10 Susceptibility of Fat Tissue to SARS-CoV-2 Infection in Female hACE2 Mouse Model Hariprasad Thangavel, Dhanya Dhanyalayam, Kezia Lizardo, Neelam Oswal, Enriko Dolgov, David S. Perlin, Jyothi F. Nagajyothi
103 [GO] 2023―Jan―09 Zymosan Particle-Induced Hemodynamic, Cytokine and Blood Cell Changes in Pigs: An Innate Immune Stimulation Model with Relevance to Cytokine Storm Syndrome and Severe COVID-19 Gábor Kökény, Tamás Bakos, Bálint András Barta, Georgina Viktória Nagy, Tamás Mészáros, Gergely T. Kozma, et al. (+4)
104 [GO] 2023―Jan―09 COVID-19 Heart Lesions in Children: Clinical, Diagnostic and Immunological Changes Elena Vasichkina, Daria Alekseeva, Igor Kudryavtsev, Anzhela Glushkova, Anastasia Y. Starshinova, Anna Malkova, et al. (+2)
105 [GO] 2023―Jan―09 Severe COVID-19-A Review of Suggested Mechanisms Based on the Role of Extracellular Matrix Stiffness Garry Kerch
106 [GO] 2023―Jan―09 Adiponectin, Leptin, and Resistin Are Dysregulated in Patients Infected by SARS-CoV-2 Fabio Perrotta, Filippo Scialò, Marta Mallardo, Giuseppe Signoriello, Vito D’Agnano, Andrea Bianco, et al. (+2)
107 [GO] 2023―Jan―09 Structural and Functional RNA Motifs of SARS-CoV-2 and Influenza A Virus as a Target of Viral Inhibitors Izabela Szczesniak, Agnieszka Baliga-Gil, Aleksandra Jarmolowicz, Marta Soszynska-Jozwiak, Elzbieta Kierzek
108 [GO] 2023―Jan―06 COVID-19: Has the Liver Been Spared? Nicolò Brandi, Daniele Spinelli, Alessandro Granito, Francesco Tovoli, Fabio Piscaglia, Rita Golfieri, Matteo Renzulli
109 [GO] 2023―Jan―04 Gas6/TAM Axis Involvement in Modulating Inflammation and Fibrosis in COVID-19 Patients Manuela Rizzi, Stelvio Tonello, Davide D’Onghia, Pier Paolo Sainaghi
110 [GO] 2023―Jan―04 Immunogenicity and Safety of the BNT162b2 COVID-19 Vaccine in Patients with Cystic Fibrosis with or without Lung Transplantation Francesca Lucca, Valentino Bezzerri, Elisa Danese, Debora Olioso, Denise Peserico, Christian Boni, et al. (+7)
111 [GO] 2023―Jan―04 Genome-Wide mRNA and Long Non-Coding RNA Analysis of Porcine Trophoblast Cells Infected with Porcine Reproductive and Respiratory Syndrome Virus Associated with Reproductive Failure Xinming Zhang, Xianhui Liu, Jiawei Peng, Sunyangzi Song, Ge Xu, Ningjia Yang, et al. (+9)
112 [GO] 2023―Jan―02 Nanoparticles in Clinical Trials: Analysis of Clinical Trials, FDA Approvals and Use for COVID-19 Vaccines Eugenia D. Namiot, Aleksandr V. Sokolov, Vladimir N. Chubarev, Vadim V. Tarasov, Helgi B. Schiöth
113 [GO] 2023―Jan―02 The Ethanol Extract of Evodiae Fructus and Its Ingredient, Rutaecarpine, Inhibit Infection of SARS-CoV-2 and Inflammatory Responses Shengying Lin, Xiaoyang Wang, Hongsheng Guo, Niyu Dai, Roy Wai-Lun Tang, Hung Chun Lee, et al. (+5)
114 [GO] 2023―Jan―02 Modelling the Transitioning of SARS-CoV-2 nsp3 and nsp4 Lumenal Regions towards a More Stable State on Complex Formation Nele Klatte, Denis C. Shields, Clement Agoni
115 [GO] 2023―Jan―02 Electrochemical Biosensor for the Determination of Specific Antibodies against SARS-CoV-2 Spike Protein Sarunas Zukauskas, Alma Rucinskiene, Vilma Ratautaite, Almira Ramanaviciene, Greta Pilvenyte, Mikhael Bechelany, Arunas Ramanavicius
116 [GO] 2022―Dec―29 HIF-1α-Dependent Metabolic Reprogramming, Oxidative Stress, and Bioenergetic Dysfunction in SARS-CoV-2-Infected Hamsters Sirsendu Jana, Michael R. Heaven, Charles B. Stauft, Tony T. Wang, Matthew C. Williams, Felice D’Agnillo, Abdu I. Alayash
117 [GO] 2022―Dec―28 High-Affinity Antibodies Designing of SARS-CoV-2 Based on Molecular Dynamics Simulations Zihui Tian, Hongtao Liu, Shuangyan Zhou, Zengyan Xie, Shuai Yuan
118 [GO] 2022―Dec―27 COVID-19 Mimics Pulmonary Dysfunction in Muscular Dystrophy as a Post-Acute Syndrome in Patients Suresh C. Tyagi, Sathnur Pushpakumar, Utpal Sen, Sri Prakash L. Mokshagundam, Dinesh K. Kalra, Mohamed A. Saad, Mahavir Singh
119 [GO] 2022―Dec―27 Impact on the Clinical Evolution of Patients with COVID-19 Pneumonia and the Participation of the NFE2L2/KEAP1 Polymorphisms in Regulating SARS-CoV-2 Infection María Elena Soto, Giovanny Fuentevilla-Álvarez, Adrián Palacios-Chavarría, Rafael Ricardo Valdez Vázquez, Héctor Herrera-Bello, Lidia Moreno-Castañeda, et al. (+8)
120 [GO] 2022―Dec―27 Coronavirus-Specific Antibody and T Cell Responses Developed after Sputnik V Vaccination in Patients with Chronic Lymphocytic Leukemia Alexey A. Komissarov, Maria Kislova, Ivan A. Molodtsov, Andrei A. Petrenko, Elena Dmitrieva, Maria Okuneva, et al. (+8)
121 [GO] 2022―Dec―23 Longitudinal Analysis of Antiphospholipid Antibody Dynamics after Infection with SARS-CoV-2 or Vaccination with BNT162b2 Manca Ogrič, Polona Žigon, Snezna Sodin-Semrl, Mirjana Zlatković-Švenda, Marija Zdravković, Milica Ovuka, et al. (+5)
122 [GO] 2022―Dec―21 TRPC3-Nox2 Protein Complex Formation Increases the Risk of SARS-CoV-2 Spike Protein-Induced Cardiomyocyte Dysfunction through ACE2 Upregulation Yuri Kato, Kazuhiro Nishiyama, Jae Man Lee, Yuko Ibuki, Yumiko Imai, Takamasa Noda, et al. (+4)
123 [GO] 2022―Dec―20 Iron Dyshomeostasis in COVID-19: Biomarkers Reveal a Functional Link to 5-Lipoxygenase Activation Beatrice Dufrusine, Silvia Valentinuzzi, Sandra Bibbò, Verena Damiani, Paola Lanuti, Damiana Pieragostino, et al. (+13)
124 [GO] 2022―Dec―20 Past COVID-19: The Impact on IVF Outcomes Based on Follicular Fluid Lipid Profile Natalia Lomova, Natalia Dolgushina, Alisa Tokareva, Vitaly Chagovets, Natalia Starodubtseva, Ilya Kulikov, et al. (+2)
125 [GO] 2022―Dec―20 Direct Inhibition of SARS-CoV-2 Spike Protein by Peracetic Acid Yuichiro Yamamoto, Yoshio Nakano, Mana Murae, Yoshimi Shimizu, Shota Sakai, Motohiko Ogawa, et al. (+8)
126 [GO] 2022―Dec―19 The Association of PLAUR Genotype and Soluble suPAR Serum Level with COVID-19-Related Lung Damage Severity Ludmila A. Nekrasova, Anna A. Shmakova, Larisa M. Samokhodskaya, Karina I. Kirillova, Simona S. Stoyanova, Elena A. Mershina, et al. (+4)
127 [GO] 2022―Dec―19 Detection of the Omicron SARS-CoV-2 Lineage and Its BA.1 Variant with Multiplex RT-qPCR Nikita D. Yolshin, Andrey B. Komissarov, Kirill V. Varchenko, Tamila D. Musaeva, Artem V. Fadeev, Dmitry A. Lioznov
128 [GO] 2022―Dec―16 Identification of Darunavir Derivatives for Inhibition of SARS-CoV-2 3CLpro Ling Ma, Yongli Xie, Mei Zhu, Dongrong Yi, Jianyuan Zhao, Saisai Guo, et al. (+5)
129 [GO] 2022―Dec―14 SARS-CoV-2 Spike Protein Mutation at Cysteine-488 Impairs Its Golgi Localization and Intracellular S1/S2 Processing Yuichiro Yamamoto, Tetsuya Inoue, Miyu Inoue, Mana Murae, Masayoshi Fukasawa, Mika K. Kaneko, et al. (+2)
130 [GO] 2022―Dec―13 Dysbiosis: An Indicator of COVID-19 Severity in Critically Ill Patients Silvia Cuenca, Zaida Soler, Gerard Serrano-Gómez, Zixuan Xie, Jordi Barquinero, Joaquim Roca, et al. (+2)
131 [GO] 2022―Dec―12 Shrunken Pore Syndrome Is Frequently Occurring in Severe COVID-19 Anders O. Larsson, Michael Hultström, Robert Frithiof, Miklos Lipcsey, Mats B. Eriksson
132 [GO] 2022―Dec―12 High-Yield Production of Chimeric Hepatitis E Virus-Like Particles Bearing the M2e Influenza Epitope and Receptor Binding Domain of SARS-CoV-2 in Plants Using Viral Vectors Eugenia S. Mardanova, Roman Y. Kotlyarov, Maya D. Stuchinskaya, Lyudmila I. Nikolaeva, Gergana Zahmanova, Nikolai V. Ravin
133 [GO] 2022―Dec―12 Integrated Analysis of Bulk RNA-Seq and Single-Cell RNA-Seq Unravels the Influences of SARS-CoV-2 Infections to Cancer Patients Yu Chen, Yujia Qin, Yuanyuan Fu, Zitong Gao, Youping Deng
134 [GO] 2022―Dec―12 Quasispecies Analysis of SARS-CoV-2 of 15 Different Lineages during the First Year of the Pandemic Prompts Scratching under the Surface of Consensus Genome Sequences Wahiba Bader, Jeremy Delerce, Sarah Aherfi, Bernard La Scola, Philippe Colson
135 [GO] 2022―Dec―12 An Escherichia coli Expressed Multi-Disulfide Bonded SARS-CoV-2 RBD Shows Native-like Biophysical Properties and Elicits Neutralizing Antisera in a Mouse Model Subbaian Brindha, Takahiro Yoshizue, Rawiwan Wongnak, Hitoshi Takemae, Mami Oba, Tetsuya Mizutani, Yutaka Kuroda
136 [GO] 2022―Dec―09 Inflammation in COVID-19 and the Effects of Non-Pharmacological Interventions during the Pandemic: A Review Vicente Javier Clemente-Suárez, Álvaro Bustamante-Sanchez, José Francisco Tornero-Aguilera, Pablo Ruisoto, Juan Mielgo-Ayuso
137 [GO] 2022―Dec―09 Dapsone Lowers Neutrophil to Lymphocyte Ratio and Mortality in COVID-19 Patients Admitted to the ICU Badar Kanwar, Asif Khattak, Richard E. Kast
138 [GO] 2022―Dec―08 Exploring Highly Conserved Regions of SARS-CoV-2 Spike S2 Subunit as Targets for Fusion Inhibition Using Chimeric Proteins Daniel Polo-Megías, Mario Cano-Muñoz, Alberto G. Berruezo, Géraldine Laumond, Christiane Moog, Francisco Conejero-Lara
139 [GO] 2022―Dec―07 SARS-CoV-2 Spike Protein Induces Hemagglutination: Implications for COVID-19 Morbidities and Therapeutics and for Vaccine Adverse Effects Celine Boschi, David E. Scheim, Audrey Bancod, Muriel Militello, Marion Le Bideau, Philippe Colson, et al. (+2)
140 [GO] 2022―Dec―07 Longitudinal Analysis of Urinary Cytokines and Biomarkers in COVID-19 Patients with Subclinical Acute Kidney Injury Gustavo Casas-Aparicio, Claudia Alvarado-de la Barrera, David Escamilla-Illescas, Isabel León-Rodríguez, Perla Mariana Del Río-Estrada, Mauricio González-Navarro, et al. (+11)
141 [GO] 2022―Dec―07 Pharmacological Mechanism of NRICM101 for COVID-19 Treatments by Combined Network Pharmacology and Pharmacodynamics Sher Singh, Ying-Fei Yang
142 [GO] 2022―Dec―07 COVID-19 Vaccines, Effectiveness, and Immune Responses Haneen Imad Abufares, Leen Oyoun Alsoud, Mohammad A. Y. Alqudah, Mohd Shara, Nelson C. Soares, Karem H. Alzoubi, et al. (+4)
143 [GO] 2022―Dec―05 Dyslipidemia and Inflammation as Hallmarks of Oxidative Stress in COVID-19: A Follow-Up Study Álvaro Aparisi, Marta Martín-Fernández, Cristina Ybarra-Falcón, José Francisco Gil, Manuel Carrasco-Moraleja, Pedro Martínez-Paz, et al. (+9)
144 [GO] 2022―Dec―05 SARS-CoV-2 Altered Hemorheological and Hematological Parameters during One-Month Observation Period in Critically Ill COVID-19 Patients Daniel Alexander Bizjak, Lucas John, Lynn Matits, Alisa Uhl, Sebastian Victor Waldemar Schulz, Jana Schellenberg, et al. (+7)
145 [GO] 2022―Dec―05 Association between 25-OH Vitamin D Deficiency and COVID-19 Severity in Pregnant Women Johana Vásquez-Procopio, Johnatan Torres-Torres, Hector Borboa-Olivares, Salvador Espino Y Sosa, Raigam Jafet Martínez-Portilla, Mario Solis-Paredes, et al. (+6)
146 [GO] 2022―Dec―05 Real-Time Reverse Transcription Recombinase-Aided Amplification Assay for Rapid Amplification of the N Gene of SARS-CoV-2 Huan Cui, Fei Tu, Cheng Zhang, Chunmao Zhang, Kui Zhao, Juxiang Liu, et al. (+4)
147 [GO] 2022―Dec―05 Nucleoside Analogs and Perylene Derivatives Modulate Phase Separation of SARS-CoV-2 N Protein and Genomic RNA In Vitro Julia Svetlova, Ekaterina Knizhnik, Valentin Manuvera, Vyacheslav Severov, Dmitriy Shirokov, Ekaterina Grafskaia, et al. (+11)
148 [GO] 2022―Dec―05 Genetic and Structural Data on the SARS-CoV-2 Omicron BQ.1 Variant Reveal Its Low Potential for Epidemiological Expansion Fabio Scarpa, Daria Sanna, Domenico Benvenuto, Alessandra Borsetti, Ilenia Azzena, Marco Casu, et al. (+10)
149 [GO] 2022―Dec―05 Platelet Reactivity and Inflammatory Phenotype Induced by Full-Length Spike SARS-CoV-2 Protein and Its RBD Domain Alan Cano-Mendez, Nallely García-Larragoiti, Maria Damian-Vazquez, Patricia Guzman-Cancino, Sandra Lopez-Castaneda, Alejandra Ochoa-Zarzosa, Martha Eva Viveros-Sandoval
150 [GO] 2022―Dec―05 Detection of SARS-CoV-2 Virus by Triplex Enhanced Nucleic Acid Detection Assay (TENADA) Anna Aviñó, Carlos Cuestas-Ayllón, Manuel Gutiérrez-Capitán, Lluisa Vilaplana, Valeria Grazu, Véronique Noé, et al. (+12)
151 [GO] 2022―Dec―05 Tolerogenic Dendritic Cells Induce Apoptosis-Independent T Cell Hyporesponsiveness of SARS-CoV-2-Specific T Cells in an Antigen-Specific Manner Mats Van Delen, Ibo Janssens, Amber Dams, Laurence Roosens, Benson Ogunjimi, Zwi N. Berneman, et al. (+2)
152 [GO] 2022―Dec―05 Weak Point of SARS-CoV-2: Human and Viral Ion Channels under External Physical Fields Andrzej Fuliński
153 [GO] 2022―Dec―02 A Pleomorphic Puzzle: Heterogeneous Pulmonary Vascular Occlusions in Patients with COVID-19 Jeeshan Singh, Irmgard Herrmann, Aparna Mahajan, Christine Schauer, Xiaomei Shan, Arndt Hartmann, et al. (+10)
154 [GO] 2022―Dec―02 The Significance of COVID-19 Diseases in Lipid Metabolism Pregnancy Women and Newborns Miljana Z. Jovandaric, Milan Dokic, Ivana R. Babovic, Srboljub Milicevic, Jelena Dotlic, Branislav Milosevic, et al. (+8)
155 [GO] 2022―Dec―02 Focus on Marine Animal Safety and Marine Bioresources in Response to the SARS-CoV-2 Crisis Yao Yang, Jiacheng Li, Fang Han
156 [GO] 2022―Dec―02 Antigen-Specific T Cells and SARS-CoV-2 Infection: Current Approaches and Future Possibilities Zuzana Nova, Tomas Zemanek, Norbert Botek
157 [GO] 2022―Dec―01 The Interplay of Lung Cancer, COVID-19, and Vaccines Dragan Trivanović, Željka Peršurić, Andrea Agaj, Marko Jakopović, Miroslav Samaržija, Lela Bitar, Krešimir Pavelić
158 [GO] 2022―Nov―30 Immune Responses to COVID-19 Vaccines in Patients with Chronic Kidney Disease and Lead Exposure Ju-Shao Yen, Yao-Cheng Wu, Ju-Ching Yen, I-Kuan Wang, Jen-Fen Fu, Chao-Min Cheng, Tzung-Hai Yen
159 [GO] 2022―Nov―30 Electrostatic Interactions Are the Primary Determinant of the Binding Affinity of SARS-CoV-2 Spike RBD to ACE2: A Computational Case Study of Omicron Variants Peng Sang, Yong-Qin Chen, Meng-Ting Liu, Yu-Ting Wang, Ting Yue, Yi Li, et al. (+2)
160 [GO] 2022―Nov―30 Long-Term Effectiveness of BNT162b2 Pfizer-BioNTech mRNA-Based Vaccine on B Cell Compartment: Efficient Recall of SARS-CoV-2-Specific Memory B Cells Rosalia Busà, Monica Miele, Maria Concetta Sorrentino, Giandomenico Amico, Francesca Timoneri, Vitale Miceli, et al. (+7)
161 [GO] 2022―Nov―30 Quality of T-Cell Response to SARS-CoV-2 mRNA Vaccine in ART-Treated PLWH Eeva Tortellini, Maria Antonella Zingaropoli, Giulia Mancarella, Raffaella Marocco, Anna Carraro, Meriem Jamhour, et al. (+16)
162 [GO] 2022―Nov―28 Tryptophan Metabolism ‘Hub’ Gene Expression Associates with Increased Inflammation and Severe Disease Outcomes in COVID-19 Infection and Inflammatory Bowel Disease Sonia Bustamante, Yunki Yau, Victoria Boys, Jeff Chang, Sudarshan Paramsothy, Aviv Pudipeddi, et al. (+2)
163 [GO] 2022―Nov―28 The Connection between Gut and Lung Microbiota, Mast Cells, Platelets and SARS-CoV-2 in the Elderly Patient Giovanna Traina
164 [GO] 2022―Nov―28 Schizophyllum commune Reduces Expression of the SARS-CoV-2 Receptors ACE2 and TMPRSS2 Te-Kai Sun, Wen-Chin Huang, Yu-Wen Sun, Jeng-Shyan Deng, Liang-Hsuan Chien, Ya-Ni Chou, et al. (+3)
165 [GO] 2022―Nov―25 Computational Study of Helicase from SARS-CoV-2 in RNA-Free and Engaged Form Francesca Di Matteo, Giorgia Frumenzio, Balasubramanian Chandramouli, Alessandro Grottesi, Andrew Emerson, Francesco Musiani
166 [GO] 2022―Nov―25 Prediction of Recurrent Mutations in SARS-CoV-2 Using Artificial Neural Networks Bryan Saldivar-Espinoza, Guillem Macip, Pol Garcia-Segura, Júlia Mestres-Truyol, Pere Puigbò, Adrià Cereto-Massagué, et al. (+2)
167 [GO] 2022―Nov―24 Dynamics of SARS-CoV-2 Major Genetic Lineages in Moscow in the Context of Vaccine Prophylaxis Vladimir A. Gushchin, Andrei A. Pochtovyi, Daria D. Kustova, Darya A. Ogarkova, Ivan Y. Tarnovetskii, Elizaveta D. Belyaeva, et al. (+12)
168 [GO] 2022―Nov―22 Therapeutic Efficacy and Outcomes of Remdesivir versus Remdesivir with Tocilizumab in Severe SARS-CoV-2 Infection Damiana-Maria Vulturar, Maria Adriana Neag, Ștefan Cristian Vesa, Anca-Diana Maierean, Diana Gherman, Anca Dana Buzoianu, et al. (+2)
169 [GO] 2022―Nov―22 N-acetylcysteine Reduces Inflammasome Activation Induced by SARS-CoV-2 Proteins In Vitro Javier Milara, Fernando Martínez-Expósito, Paula Montero, Inés Roger, Maria Amparo Bayarri, Pilar Ribera, et al. (+4)
170 [GO] 2022―Nov―22 IL-33 and the Cytokine Storm in COVID-19: From a Potential Immunological Relationship towards Precision Medicine Fabiana Furci, Giuseppe Murdaca, Alessandro Allegra, Luca Gammeri, Gianenrico Senna, Sebastiano Gangemi
171 [GO] 2022―Nov―21 Durable CD8 T Cell Memory against SARS-CoV-2 by Prime/Boost and Multi-Dose Vaccination: Considerations on Inter-Dose Time Intervals Ambra Natalini, Sonia Simonetti, Carmel Sher, Ugo D’Oro, Adrian C. Hayday, Francesca Di Rosa
172 [GO] 2022―Nov―21 Evaluation of Various Alternative Economical and High Throughput SARS-CoV-2 Testing Methods within Resource-Limited Settings Zamathombeni Duma, Veron Ramsuran, Anil A. Chuturgoon, Vinodh A. Edward, Pragalathan Naidoo, Zilungile L. Mkhize-Kwitshana
173 [GO] 2022―Nov―21 Targeting the Complement-Sphingolipid System in COVID-19 and Gaucher Diseases: Evidence for a New Treatment Strategy Vyoma Snehal Trivedi, Albert Frank Magnusen, Reena Rani, Luca Marsili, Anne Michele Slavotinek, Daniel Ray Prows, et al. (+3)
174 [GO] 2022―Nov―18 Elevated Serum Amyloid A Levels Contribute to Increased Platelet Adhesion in COVID-19 Patients Ronen Siman-Tov, Rulla Shalabi, Amir Shlomai, Elad Goldberg, Wesam Essa, Eden Shusterman, et al. (+4)
175 [GO] 2022―Nov―18 Vitamin D Deficiency and COVID-19: A Biological Database Study on Pathways and Gene-Disease Associations Ángela Alcalá-Santiago, Miguel Rodríguez-Barranco, Marta Rava, María Ángeles Jiménez-Sousa, Ángel Gil, María José Sánchez, Esther Molina-Montes
176 [GO] 2022―Nov―18 Molecular Advances in SARS-CoV-2: A Brief Update on Transmission, Infection, and Pathology Aspects João R. Mesquita
177 [GO] 2022―Nov―17 Recent Progress in Research on COVID-19 Pathophysiology: Biomarkers, Repurposed Drugs, Viral Invasiveness, SARS-CoV-2 Genetic Diversity, the Crystal Structure of Viral Proteins, and the Molecular and Cellular Outcomes of COVID-19 Jacek Z. Kubiak, Malgorzata Kloc
178 [GO] 2022―Nov―17 Pathogenesis and Preventive Tactics of Immune-Mediated Non-Pulmonary COVID-19 in Children and Beyond Hsin Chi, Lung Chang, Yen-Chun Chao, Dar-Shong Lin, Horng-Woei Yang, Li-Chih Fang, et al. (+3)
179 [GO] 2022―Nov―17 Subclinical Acute Kidney Injury in COVID-19: Possible Mechanisms and Future Perspectives Rodrigo P. Silva-Aguiar, Douglas E. Teixeira, Rodrigo A. S. Peres, Diogo B. Peruchetti, Carlos P. Gomes, Alvin H. Schmaier, et al. (+3)
180 [GO] 2022―Nov―17 Molecular Mechanisms of Pathogenesis, Prevention, and Therapy of COVID-19: Summarizing the Results of 2021 Evgenii Gusev
181 [GO] 2022―Nov―17 Cytokine Profiling in Different SARS-CoV-2 Genetic Variants Zoia R. Korobova, Natalia A. Arsentieva, Natalia E. Liubimova, Oleg K. Batsunov, Vladimir G. Dedkov, Anna S. Gladkikh, et al. (+10)
182 [GO] 2022―Nov―16 Alterations in the Kynurenine-Tryptophan Pathway and Lipid Dysregulation Are Preserved Features of COVID-19 in Hemodialysis Max Schuller, Monika Oberhuber, Barbara Prietl, Elmar Zügner, Eva-Maria Prugger, Christoph Magnes, et al. (+7)
183 [GO] 2022―Nov―16 The Future of Point-of-Care Nucleic Acid Amplification Diagnostics after COVID-19: Time to Walk the Walk Juan García-Bernalt Diego, Pedro Fernández-Soto, Antonio Muro
184 [GO] 2022―Nov―15 The SARS-CoV-2 Delta-Omicron Recombinant Lineage (XD) Exhibits Immune-Escape Properties Similar to the Omicron (BA.1) Variant Prerna Arora, Lu Zhang, Cheila Rocha, Luise Graichen, Inga Nehlmeier, Amy Kempf, et al. (+10)
185 [GO] 2022―Nov―14 The Renin-Angiotensin-Aldosterone System, Nitric Oxide, and Hydrogen Sulfide at the Crossroads of Hypertension and COVID-19: Racial Disparities and Outcomes Tara Ranjbar, Palak P. Oza, Khosrow Kashfi
186 [GO] 2022―Nov―14 Computational Analysis of SAM Analogs as Methyltransferase Inhibitors of nsp16/nsp10 Complex from SARS-CoV-2 Alessandra M. Balieiro, Eduarda L. S. Anunciação, Clauber H. S. Costa, Wesam S. Qayed, José Rogério A. Silva
187 [GO] 2022―Nov―14 Adaptive Immunity to Viruses: What Did We Learn from SARS-CoV-2 Infection? István Vályi-Nagy, Ferenc Uher, Éva Rákóczi, Zoltán Szekanecz
188 [GO] 2022―Nov―11 Long Chain N3-PUFA Decreases ACE2 Protein Levels and Prevents SARS-CoV-2 Cell Entry Shiqi Huang, Carla G. Taylor, Peter Zahradka
189 [GO] 2022―Nov―09 Vascular Endothelial Growth Factor Receptor 2: Molecular Mechanism and Therapeutic Potential in Preeclampsia Comorbidity with Human Immunodeficiency Virus and Severe Acute Respiratory Syndrome Coronavirus 2 Infections Tashlen Abel, Jagidesa Moodley, Olive P. Khaliq, Thajasvarie Naicker
190 [GO] 2022―Nov―09 Immune Response Gaps Linked to SARS-CoV-2 Infection: Cellular Exhaustion, Senescence, or Both? Leonardo Vinicius Barbosa, Daniele Margarita Marani Prá, Seigo Nagashima, Marcos Roberto Curcio Pereira, Rebecca Benicio Stocco, Francys de Luca Fernandes da Silva, et al. (+15)
191 [GO] 2022―Nov―08 Emerging Effects of IL-33 on COVID-19 Yuan Gao, Luwei Cai, Lili Li, Yidan Zhang, Jing Li, Chengliang Luo, et al. (+2)
192 [GO] 2022―Nov―08 Antiviral Potential of Plants against COVID-19 during Outbreaks-An Update Qazi Mohammad Sajid Jamal
193 [GO] 2022―Nov―08 Buffy Coat Transcriptomic Analysis Reveals Alterations in Host Cell Protein Synthesis and Cell Cycle in Severe COVID-19 Patients Liliane Tavares de Faria Cavalcante, Guilherme Cordenonsi da Fonseca, Luciane Almeida Amado Leon, Andreza Lemos Salvio, Otávio José Brustolini, Alexandra Lehmkuhl Gerber, et al. (+9)
194 [GO] 2022―Nov―08 Antiviral and Anti-Inflammatory Activities of Fluoxetine in a SARS-CoV-2 Infection Mouse Model David Péricat, Stephen Adonai Leon-Icaza, Marina Sanchez Rico, Christiane Mühle, Iulia Zoicas, Fabian Schumacher, et al. (+16)
195 [GO] 2022―Nov―08 The Expression Levels of SARS-CoV-2 Infection-Mediating Molecules Promoted by Interferon-γ and Tumor Necrosis Factor-α Are Downregulated by Hydrogen Sulfide Xue Zhao, Yedi Cao, Enmin Zhao, Tiancheng Li, Tiechuan Cong, Ying Gao, Junqing Zhang
196 [GO] 2022―Nov―08 Natural IgG against S-Protein and RBD of SARS-CoV-2 Do Not Bind and Hydrolyze DNA and Are Not Autoimmune Anna M. Timofeeva, Sergey E. Sedykh, Evgeny A. Ermakov, Andrey L. Matveev, Eva I. Odegova, Tatiana A. Sedykh, et al. (+6)
197 [GO] 2022―Nov―08 A Vaccine of SARS-CoV-2 S Protein RBD Induces Protective Immunity Qiaoqiao Qu, Pengfei Hao, Wang Xu, Letian Li, Yuhang Jiang, Zhiqiang Xu, et al. (+5)
198 [GO] 2022―Nov―04 The Increased Amyloidogenicity of Spike RBD and pH-Dependent Binding to ACE2 May Contribute to the Transmissibility and Pathogenic Properties of SARS-CoV-2 Omicron as Suggested by In Silico Study Anna Y. Aksenova, Ilya V. Likhachev, Sergei Y. Grishin, Oxana V. Galzitskaya
199 [GO] 2022―Nov―02 COVID-19 Molecular Pathophysiology: Acetylation of Repurposing Drugs Jong Hoon Lee, Badar Kanwar, Asif Khattak, Jenny Balentine, Ngoc Huy Nguyen, Richard E. Kast, et al. (+8)
200 [GO] 2022―Nov―01 Oligomerization-Dependent Beta-Structure Formation in SARS-CoV-2 Envelope Protein Wahyu Surya, Jaume Torres
201 [GO] 2022―Oct―30 Development and Clinical Validation of RT-LAMP-Based Lateral-Flow Devices and Electrochemical Sensor for Detecting Multigene Targets in SARS-CoV-2 Apoorva Saxena, Pawankumar Rai, Srishti Mehrotra, Samiya Baby, Suman Singh, Vikas Srivastava, et al. (+2)
202 [GO] 2022―Oct―30 The Spike Mutants Website: A Worldwide Used Resource against SARS-CoV-2 Isabella Romeo, Ingrid Guarnetti Prandi, Emanuela Giombini, Cesare Ernesto Maria Gruber, Daniele Pietrucci, Stefano Borocci, et al. (+5)
203 [GO] 2022―Oct―30 Microarray Profiling of Vaccination-Induced Antibody Responses to SARS-CoV-2 Variants of Interest and Concern Julia Svetlova, Dmitry Gustin, Valentin Manuvera, Dmitriy Shirokov, Varvara Shokina, Kirill Prusakov, et al. (+7)
204 [GO] 2022―Oct―30 Sensitive Detection of SARS-CoV-2 Variants Using an Electrochemical Impedance Spectroscopy Based Aptasensor Assem Kurmangali, Kanat Dukenbayev, Damira Kanayeva
205 [GO] 2022―Oct―28 Lung Inflammasome Activation in SARS-CoV-2 Post-Mortem Biopsies Lucas Baena Carstens, Raissa Campos D’amico, Karen Fernandes de Moura, Eduardo Morais de Castro, Flávia Centenaro, Giovanna Silva Barbosa, et al. (+14)
206 [GO] 2022―Oct―26 A Timeframe for SARS-CoV-2 Genomes: A Proof of Concept for Postmortem Interval Estimations Jacobo Pardo-Seco, Xabier Bello, Alberto Gómez-Carballa, Federico Martinón-Torres, José Ignacio Muñoz-Barús, Antonio Salas
207 [GO] 2022―Oct―26 Pediatric Multisystem Syndrome Associated with SARS-CoV-2 (MIS-C): The Interplay of Oxidative Stress and Inflammation Serafina Perrone, Laura Cannavò, Sara Manti, Immacolata Rullo, Giuseppe Buonocore, Susanna Maria Roberta Esposito, Eloisa Gitto
208 [GO] 2022―Oct―26 SARS-CoV-2 RNA Testing Using Different Assays-Impact on Testing Strategies in a Clinical Setting Gerald M. Eibinger, Harald H. Kessler, Evelyn Stelzl, Klaus Vander, Anita Weber-Lassacher, Wilfried Renner, Markus Herrmann
209 [GO] 2022―Oct―26 Endometriosis and COVID-19: A Systematic Review and Meta-Analysis Ziyaana Kabani, Maria E. Ramos-Nino, Prakash V. A. K. Ramdass
210 [GO] 2022―Oct―20 Update on Innate Immunity in Acute Kidney Injury-Lessons Taken from COVID-19 Kinga Musiał
211 [GO] 2022―Oct―20 Mulberry Component Kuwanon C Exerts Potent Therapeutic Efficacy In Vitro against COVID-19 by Blocking the SARS-CoV-2 Spike S1 RBD:ACE2 Receptor Interaction Young Soo Kim, Eun-Bin Kwon, Buyun Kim, Hwan-Suck Chung, Garam Choi, Yeoun-Hee Kim, Jang-Gi Choi
212 [GO] 2022―Oct―20 Antifungal Effect of Nanoparticles against COVID-19 Linked Black Fungus: A Perspective on Biomedical Applications Sangiliyandi Gurunathan, Ah Reum Lee, Jin Hoi Kim
213 [GO] 2022―Oct―20 Bergamottin and PAP-1 Induced ACE2 Degradation to Alleviate Infection of SARS-CoV-2 Mengjia Li, Yongzheng Zhang, Amir Zeb, Yang Wu, Lufeng Cheng
214 [GO] 2022―Oct―20 Reactive Centre Loop Mutagenesis of SerpinB3 to Target TMPRSS2 and Furin: Inhibition of SARS-CoV-2 Cell Entry and Replication Saravjeet Singh, Sophie O’Reilly, Hossam Gewaid, Andrew G. Bowie, Virginie Gautier, D. Margaret Worrall
215 [GO] 2022―Oct―19 Antithrombin as Therapeutic Intervention against Sepsis-Induced Coagulopathy and Disseminated Intravascular Coagulation: Lessons Learned from COVID-19-Associated Coagulopathy Christian J. Wiedermann
216 [GO] 2022―Oct―19 Two Ligand-Binding Sites on SARS-CoV-2 Non-Structural Protein 1 Revealed by Fragment-Based X-ray Screening Shumeng Ma, Shymaa Damfo, Jiaqi Lou, Nikos Pinotsis, Matthew W. Bowler, Shozeb Haider, Frank Kozielski
217 [GO] 2022―Oct―18 The Effects of Vitamin D Supplementation in COVID-19 Patients: A Systematic Review Ángela Feiner Solís, Ana Avedillo Salas, María José Luesma Bartolomé, Sonia Santander Ballestín
218 [GO] 2022―Oct―17 Reconstructed Genome-Scale Metabolic Model Characterizes Adaptive Metabolic Flux Changes in Peripheral Blood Mononuclear Cells in Severe COVID-19 Patients Hao Tang, Yanguang Liu, Yao Ruan, Lingqiao Ge, Qingye Zhang
219 [GO] 2022―Oct―17 A Review: Highlighting the Links between Epigenetics, COVID-19 Infection, and Vitamin D Ashmika Foolchand, Siyanda Mazaleni, Terisha Ghazi, Anil A. Chuturgoon
220 [GO] 2022―Oct―17 The Challenge of Long COVID-19 Management: From Disease Molecular Hallmarks to the Proposal of Exercise as Therapy Raffaele Scurati, Nadia Papini, Paola Giussani, Giampietro Alberti, Cristina Tringali
221 [GO] 2022―Oct―17 Role of Micronutrients and Gut Microbiota-Derived Metabolites in COVID-19 Recovery Teresita de Jesús Hernández-Flores, Eliza Julia Pedraza-Brindis, Jhonathan Cárdenas-Bedoya, José Daniel Ruíz-Carrillo, Anibal Samael Méndez-Clemente, Marco Alonso Martínez-Guzmán, Liliana Iñiguez-Gutiérrez
222 [GO] 2022―Oct―17 Inflammation Causes Exacerbation of COVID-19: How about Skin Inflammation? Mayumi Komine, Tuba Mussarat Ansary, Md Razib Hossain, Koji Kamiya, Mamitaro Ohtsuki
223 [GO] 2022―Oct―17 SARS-CoV-2 Spike Protein (RBD) Subunit Adsorption at Abiotic Surfaces and Corona Formation at Polymer Particles Paulina Żeliszewska, Monika Wasilewska, Piotr Batys, Katarzyna Pogoda, Piotr Deptuła, Robert Bucki, Zbigniew Adamczyk
224 [GO] 2022―Oct―17 Coenzyme Q10 Attenuates Human Platelet Aggregation Induced by SARS-CoV-2 Spike Protein via Reducing Oxidative Stress In Vitro Ruijie Wang, Yiting Chen, Zezhong Tian, Meiyan Zhu, Bingying Zhang, Sijin Du, et al. (+4)
225 [GO] 2022―Oct―17 Neutralizing Ability of a Single Domain VNAR Antibody: In Vitro Neutralization of SARS-CoV-2 Variants of Concern Blanca J. Valdovino-Navarro, Salvador Dueñas, G. Isaí Flores-Acosta, Jahaziel Gasperin-Bulbarela, Johanna Bernaldez-Sarabia, Olivia Cabanillas-Bernal, et al. (+2)
226 [GO] 2022―Oct―14 Comparative Analysis of Antibody Titers against the Spike Protein of SARS-CoV-2 Variants in Infected Patient Cohorts and Diverse Vaccination Regimes Alexandru Odainic, Jasper Spitzer, Jennifer Barbara Szlapa, Simon Schade, Tim Jonas Krämer, Jakob Neuberger, et al. (+24)
227 [GO] 2022―Oct―14 Anticoagulants as Potential SARS-CoV-2 Mpro Inhibitors for COVID-19 Patients: In Vitro, Molecular Docking, Molecular Dynamics, DFT, and SAR Studies Ayman Abo Elmaaty, Wagdy M. Eldehna, Muhammad Khattab, Omnia Kutkat, Radwan Alnajjar, Ahmed N. El-Taweel, et al. (+6)
228 [GO] 2022―Oct―12 Multi-Omics Reveals Mechanisms of Partial Modulation of COVID-19 Dysregulation by Glucocorticoid Treatment Matt Spick, Amy Campbell, Ivona Baricevic-Jones, Johanna von Gerichten, Holly-May Lewis, Cecile F. Frampas, et al. (+7)
229 [GO] 2022―Oct―09 Systematic Down-Selection of Repurposed Drug Candidates for COVID-19 Christopher A. MacRaild, Muzaffar-Ur-Rehman Mohammed, Sankaranarayanan Murugesan, Ian K. Styles, Amanda L. Peterson, Carl M. J. Kirkpatrick, et al. (+10)
230 [GO] 2022―Oct―09 Diversified Effects of COVID-19 as a Consequence of the Differential Metabolism of Phospholipids and Lipid Peroxidation Evaluated in the Plasma of Survivors and Deceased Patients upon Admission to the Hospital Neven Žarković, Wojciech Łuczaj, Iwona Jarocka-Karpowicz, Biserka Orehovec, Bruno Baršić, Marko Tarle, et al. (+4)
231 [GO] 2022―Oct―09 Direct Interaction of Coronavirus Nonstructural Protein 3 with Melanoma Differentiation-Associated Gene 5 Modulates Type I Interferon Response during Coronavirus Infection Xinxin Sun, Li Quan, Ruiai Chen, Dingxiang Liu
232 [GO] 2022―Oct―09 Design, Synthesis and In Vitro Evaluation of Spirooxindole-Based Phenylsulfonyl Moiety as a Candidate Anti-SAR-CoV-2 and MERS-CoV-2 with the Implementation of Combination Studies Assem Barakat, Ahmed Mostafa, M. Ali, Abdullah Mohammed Al-Majid, Luis R. Domingo, Omnia Kutkat, et al. (+4)
233 [GO] 2022―Oct―09 Exscalate4CoV: Innovative High Performing Computing (HPC) Strategies to Tackle Pandemic Crisis Andrea R. Beccari, Giulio Vistoli
234 [GO] 2022―Oct―09 Dynamic Evaluation of Natural Killer Cells Subpopulations in COVID-19 Patients Adina Huțanu, Doina Manu, Manuela Rozalia Gabor, Anca Meda Văsieșiu, Akos Vince Andrejkovits, Minodora Dobreanu
235 [GO] 2022―Oct―09 Evaluation of Free Light Chains (FLCs) Synthesis in Response to Exposure to SARS-CoV-2 Monika Gudowska-Sawczuk, Anna Moniuszko-Malinowska, Sara Pączek, Katarzyna Guziejko, Monika Chorąży, Barbara Mroczko
236 [GO] 2022―Sep―30 Complementary Sets of Autoantibodies Induced by SARS-CoV-2, Adenovirus and Bacterial Antigens Cross-React with Human Blood Protein Antigens in COVID-19 Coagulopathies Robert Root-Bernstein, Jack Huber, Alison Ziehl
237 [GO] 2022―Sep―30 SARS-CoV-2 Spatiotemporal Genomic and Molecular Analysis of the First Wave of the COVID-19 Pandemic in Macaé, the Brazilian Capital of Oil Bruno da-Costa-Rodrigues, Caio Cheohen, Felipe Sciammarella, Allan Pierre-Bonetti-Pozzobon, Lupis Ribeiro, José Luciano Nepomuceno-Silva, et al. (+7)
238 [GO] 2022―Sep―30 Probing Mechanisms of Binding and Allostery in the SARS-CoV-2 Spike Omicron Variant Complexes with the Host Receptor: Revealing Functional Roles of the Binding Hotspots in Mediating Epistatic Effects and Communication with Allosteric Pockets Gennady Verkhivker, Steve Agajanian, Ryan Kassab, Keerthi Krishnan
239 [GO] 2022―Sep―28 Theoretical Explanation for the Rarity of Antibody-Dependent Enhancement of Infection (ADE) in COVID-19 Anna E. Boldova, Julia D. Korobkin, Yury D. Nechipurenko, Anastasia N. Sveshnikova
240 [GO] 2022―Sep―28 CXCL8, CCL2, and CMV Seropositivity as New Prognostic Factors for a Severe COVID-19 Course Ewa Pius-Sadowska, Anna Niedźwiedź, Piotr Kulig, Bartłomiej Baumert, Anna Sobuś, Dorota Rogińska, et al. (+10)
241 [GO] 2022―Sep―28 The Receptor Binding Domain of SARS-CoV-2 Lambda Variant Has a Better Chance Than the Delta Variant in Evading BNT162b2 COVID-19 mRNA Vaccine-Induced Humoral Immunity Haolin Liu, Pengcheng Wei, Katja Aviszus, Qianqian Zhang, Jared Linderberger, John Yang, et al. (+9)
242 [GO] 2022―Sep―28 Comparison of Homologous and Heterologous Booster SARS-CoV-2 Vaccination in Autoimmune Rheumatic and Musculoskeletal Patients Dániel Honfi, Nikolett Gémes, Enikő Szabó, Patrícia Neuperger, József Á. Balog, Lajos I. Nagy, et al. (+4)
243 [GO] 2022―Sep―26 Role of Demyelination in the Persistence of Neurological and Mental Impairments after COVID-19 Marina Y. Khodanovich, Daria A. Kamaeva, Anna V. Naumova
244 [GO] 2022―Sep―26 Antiviral Drugs Screening for Swine Acute Diarrhea Syndrome Coronavirus Yangzhen Chen, Yecheng You, Shuqi Wang, Lin Jiang, Lili Tian, Shaozhou Zhu, et al. (+4)
245 [GO] 2022―Sep―26 Coronavirus Disease 2019-Associated Thrombotic Microangiopathy: Literature Review Marija Malgaj Vrečko, Andreja Aleš Rigler, Željka Večerić-Haler
246 [GO] 2022―Sep―26 Discovery of the Cryptic Sites of SARS-CoV-2 Papain-like Protease and Analysis of Its Druggability Yue Qiu, Qing Liu, Gao Tu, Xiao-Jun Yao
247 [GO] 2022―Sep―26 Update on Extracellular Vesicle-Based Vaccines and Therapeutics to Combat COVID-19 Tamanna Mustajab, Moriasi Sheba Kwamboka, Da Ae Choi, Dae Wook Kang, Junho Kim, Kyu Ri Han, et al. (+4)
248 [GO] 2022―Sep―22 Altered Surface Expression of Insulin-Degrading Enzyme on Monocytes and Lymphocytes from COVID-19 Patients Both at Diagnosis and after Hospital Discharge Carlos M. González-Casimiro, Elisa Arribas-Rodríguez, Aida Fiz-López, Javier Casas, Sara Gutiérrez, Pablo Tellería, et al. (+7)
249 [GO] 2022―Sep―22 Transcriptomics and RNA-Based Therapeutics as Potential Approaches to Manage SARS-CoV-2 Infection Cristian Arriaga-Canon, Laura Contreras-Espinosa, Rosa Rebollar-Vega, Rogelio Montiel-Manríquez, Alberto Cedro-Tanda, José Antonio García-Gordillo, et al. (+4)
250 [GO] 2022―Sep―22 Variant-Specific Analysis Reveals a Novel Long-Range RNA-RNA Interaction in SARS-CoV-2 Orf1a Matthew Dukeshire, David Schaeper, Pravina Venkatesan, Amirhossein Manzourolajdad
251 [GO] 2022―Sep―22 Molecular Docking and In-Silico Analysis of Natural Biomolecules against Dengue, Ebola, Zika, SARS-CoV-2 Variants of Concern and Monkeypox Virus Mackingsley Kushan Dassanayake, Teng-Jin Khoo, Chien Hwa Chong, Patrick Di Martino
252 [GO] 2022―Sep―21 Target-Specific Machine Learning Scoring Function Improved Structure-Based Virtual Screening Performance for SARS-CoV-2 Drugs Development Muhammad Tahir ul Qamar, Xi-Tong Zhu, Ling-Ling Chen, Laila Alhussain, Maha A. Alshiekheid, Abdulrahman Theyab, Mohammad Algahtani
253 [GO] 2022―Sep―21 Virtual Screening and Quantum Chemistry Analysis for SARS-CoV-2 RNA-Dependent RNA Polymerase Using the ChEMBL Database: Reproduction of the Remdesivir-RTP and Favipiravir-RTP Binding Modes Obtained from Cryo-EM Experiments with High Binding Affinity Motonori Tsuji
254 [GO] 2022―Sep―20 Correlation between Type I Interferon Associated Factors and COVID-19 Severity Dóra Bencze, Tünde Fekete, Kitti Pázmándi
255 [GO] 2022―Sep―19 Understanding the Pharmacology of COVID-19 mRNA Vaccines: Playing Dice with the Spike? Marco Cosentino, Franca Marino
256 [GO] 2022―Sep―19 COVID-19, Vaccination, and Female Fertility in the Czech Republic Lucie Kolatorova, Karolina Adamcova, Jana Vitku, Lenka Horackova, Marketa Simkova, Marketa Hornova, et al. (+4)
257 [GO] 2022―Sep―19 Screening and Characterization of Shark-Derived VNARs against SARS-CoV-2 Spike RBD Protein Yu-Lei Chen, Jin-Jin Lin, Huan Ma, Ning Zhong, Xin-Xin Xie, Yunru Yang, et al. (+4)
258 [GO] 2022―Sep―19 Fluorine Atoms on C6H5-Corrole Affect the Interaction with Mpro and PLpro Proteases of SARS-CoV-2: Molecular Docking and 2D-QSAR Approaches Otávio Augusto Chaves, Cláudio Eduardo Rodrigues-Santos, Áurea Echevarria, Carolina Q. Sacramento, Natalia Fintelman-Rodrigues, Jairo R. Temerozo, et al. (+2)
259 [GO] 2022―Sep―15 The Perspective of Vitamin D on suPAR-Related AKI in COVID-19 Tzu-Hsien Liao, Hsien-Chang Wu, Min-Tser Liao, Wan-Chung Hu, Kuo-Wang Tsai, Ching-Chieh Lin, Kuo-Cheng Lu
260 [GO] 2022―Sep―15 Act Early and at the Right Location: SARS-CoV-2 T Cell Kinetics and Tissue Localization Antonio Bertoletti, Nina Le Bert, Anthony T. Tan
261 [GO] 2022―Sep―15 Toll-Like Receptor Mediation in SARS-CoV-2: A Therapeutic Approach Abdul Manan, Rameez Hassan Pirzada, Muhammad Haseeb, Sangdun Choi
262 [GO] 2022―Sep―14 In Silico Evaluation of Hexamethylene Amiloride Derivatives as Potential Luminal Inhibitors of SARS-CoV-2 E Protein Pouria H. Jalily, Horia Jalily Hasani, David Fedida
263 [GO] 2022―Sep―14 Metabolic and Proteomic Profiles Associated with Immune Responses Induced by Different Inactivated SARS-CoV-2 Vaccine Candidates Shouzhi Yu, Yao He, Wenheng Ji, Rong Yang, Yuxiu Zhao, Yan Li, et al. (+5)
264 [GO] 2022―Sep―13 Vitamin D as a Possible COVID-19 Prevention Strategy Marie Bičíková, Ludmila Máčová, Martin Hill
265 [GO] 2022―Sep―13 Proteomic Analysis Identifies Molecular Players and Biological Processes Specific to SARS-CoV-2 Exposure in Endothelial Cells Thatiana Corrêa de Melo, Dilza Trevisan-Silva, Miryam P. Alvarez-Flores, Renata Nascimento Gomes, Marcelo Medina de Souza, Hellen Paula Valerio, et al. (+7)
266 [GO] 2022―Sep―13 Singularity and Commonality in Response to SARS-CoV-2 in Lung and Colon Cell Models Anastasia Meshcheryakova, Philip Zimmermann, Martina Salzmann, Peter Pietschmann, Diana Mechtcheriakova
267 [GO] 2022―Sep―09 SARS-CoV-2 Spike Proteins and Cell-Cell Communication Inhibits TFPI and Induces Thrombogenic Factors in Human Lung Microvascular Endothelial Cells and Neutrophils: Implications for COVID-19 Coagulopathy Pathogenesis Biju Bhargavan, Georgette D. Kanmogne
268 [GO] 2022―Sep―09 Inflammatory Biomarkers Associated with In-Hospital Mortality in Critical COVID-19 Patients Krisztina Pál, Anca Alexandra Molnar, Adina Huțanu, János Szederjesi, Ionuț Branea, Ágota Timár, Minodora Dobreanu
269 [GO] 2022―Sep―08 The Entero-Mammary Pathway and Perinatal Transmission of Gut Microbiota and SARS-CoV-2 Carmen Josefina Juárez-Castelán, Juan Manuel Vélez-Ixta, Karina Corona-Cervantes, Alberto Piña-Escobedo, Yair Cruz-Narváez, Alejandro Hinojosa-Velasco, et al. (+6)
270 [GO] 2022―Sep―08 Venous Thromboembolic Disease in COVID-19, Pathophysiology, Therapy and Prophylaxis Małgorzata Dybowska, Dorota Wyrostkiewicz, Lucyna Opoka, Katarzyna Lewandowska, Małgorzata Sobiecka, Witold Tomkowski, Monika Szturmowicz
271 [GO] 2022―Sep―08 Role of Innate and Adaptive Cytokines in the Survival of COVID-19 Patients Jorge Monserrat, Ana Gómez-Lahoz, Miguel A. Ortega, José Sanz, Benjamin Muñoz, Juan Arévalo-Serrano, et al. (+11)
272 [GO] 2022―Sep―08 State-of-the-Art Molecular Dynamics Simulation Studies of RNA-Dependent RNA Polymerase of SARS-CoV-2 Shoichi Tanimoto, Satoru G. Itoh, Hisashi Okumura
273 [GO] 2022―Sep―08 Hesperetin from Root Extract of Clerodendrum petasites S. Moore Inhibits SARS-CoV-2 Spike Protein S1 Subunit-Induced NLRP3 Inflammasome in A549 Lung Cells via Modulation of the Akt/MAPK/AP-1 Pathway Punnida Arjsri, Kamonwan Srisawad, Sariya Mapoung, Warathit Semmarath, Pilaiporn Thippraphan, Sonthaya Umsumarng, et al. (+2)
274 [GO] 2022―Sep―07 miR-142 Targets TIM-1 in Human Endothelial Cells: Potential Implications for Stroke, COVID-19, Zika, Ebola, Dengue, and Other Viral Infections Urna Kansakar, Jessica Gambardella, Fahimeh Varzideh, Roberta Avvisato, Stanislovas S. Jankauskas, Pasquale Mone, et al. (+2)
275 [GO] 2022―Sep―06 Oxidative Stress Markers and Sperm DNA Fragmentation in Men Recovered from COVID-19 Anastasiia D. Shcherbitskaia, Evgeniia M. Komarova, Yulia P. Milyutina, Mariia A. Ishchuk, Yanina M. Sagurova, Galina K. Safaryan, et al. (+4)
276 [GO] 2022―Sep―06 Study of Albumin Oxidation in COVID-19 Pneumonia Patients: Possible Mechanisms and Consequences Tomasz Wybranowski, Marta Napiórkowska, Maciej Bosek, Jerzy Pyskir, Blanka Ziomkowska, Michał Cyrankiewicz, et al. (+5)
277 [GO] 2022―Sep―06 Effect of Delta and Omicron Mutations on the RBD-SD1 Domain of the Spike Protein in SARS-CoV-2 and the Omicron Mutations on RBD-ACE2 Interface Complex Wai-Yim Ching, Puja Adhikari, Bahaa Jawad, Rudolf Podgornik
278 [GO] 2022―Sep―06 Targeting the SARS-CoV-2 HR1 with Small Molecules as Inhibitors of the Fusion Process Davide Gentile, Alessandro Coco, Vincenzo Patamia, Chiara Zagni, Giuseppe Floresta, Antonio Rescifina
279 [GO] 2022―Sep―06 Circulating Endothelial Cells: A New Possible Marker of Endothelial Damage in Kawasaki Disease, Multisystem Inflammatory Syndrome in Children and Acute SARS-CoV-2 Infection Marianna Fabi, Biljana Petrovic, Laura Andreozzi, Elena Corinaldesi, Emanuele Filice, Carlotta Biagi, et al. (+4)
280 [GO] 2022―Sep―06 3D Lung Tissue Models for Studies on SARS-CoV-2 Pathophysiology and Therapeutics Roberto Plebani, Haiqing Bai, Longlong Si, Jing Li, Chunhe Zhang, Mario Romano
281 [GO] 2022―Sep―06 Antiviral Activity of N1,N3-Disubstituted Uracil Derivatives against SARS-CoV-2 Variants of Concern Andrei E. Siniavin, Mikhail S. Novikov, Vladimir A. Gushchin, Alexander A. Terechov, Igor A. Ivanov, Maria P. Paramonova, et al. (+10)
282 [GO] 2022―Sep―01 In Silico Study of piRNA Interactions with the SARS-CoV-2 Genome Aigul Akimniyazova, Oxana Yurikova, Anna Pyrkova, Aizhan Rakhmetullina, Togzhan Niyazova, Alma-Gul Ryskulova, Anatoliy Ivashchenko
283 [GO] 2022―Aug―29 The Severity of COVID-19 Affects the Plasma Soluble Levels of the Immune Checkpoint HLA-G Molecule Jéssica F. C. Cordeiro, Talita M. Fernandes, Diana M. Toro, Pedro V. da Silva-Neto, Vinícius E. Pimentel, Malena M. Pérez, et al. (+16)
284 [GO] 2022―Aug―29 Ultrastructural Characterization of Human Bronchial Epithelial Cells during SARS-CoV-2 Infection: Morphological Comparison of Wild-Type and CFTR-Modified Cells Flavia Merigo, Virginia Lotti, Paolo Bernardi, Anita Conti, Andrea Di Clemente, Marco Ligozzi, et al. (+4)
285 [GO] 2022―Aug―26 Effects of Varying Glucose Concentrations on ACE2′s Hypothalamic Expression and Its Potential Relation to COVID-19-Associated Neurological Dysfunction Ankita Srivastava, Bashair M. Mussa
286 [GO] 2022―Aug―26 Computational Pipeline for Reference-Free Comparative Analysis of RNA 3D Structures Applied to SARS-CoV-2 UTR Models Julita Gumna, Maciej Antczak, Ryszard W. Adamiak, Janusz M. Bujnicki, Shi-Jie Chen, Feng Ding, et al. (+16)
287 [GO] 2022―Aug―26 Quinolizidines as Novel SARS-CoV-2 Entry Inhibitors Li Huang, Lei Zhu, Hua Xie, Jeffery Shawn Goodwin, Tanu Rana, Lan Xie, Chin-Ho Chen
288 [GO] 2022―Aug―25 Dissecting Physiopathology of COVID-19 Jacek Z. Kubiak, Malgorzata Kloc
289 [GO] 2022―Aug―25 Comments about the IJMS Special Issue: Molecular Interactions and Mechanisms of COVID-19 Inhibition Francesco Caruso, Miriam Rossi
290 [GO] 2022―Aug―23 Nicotine in Combination with SARS-CoV-2 Affects Cells Viability, Inflammatory Response and Ultrastructural Integrity Luigi Sansone, Antonio de Iure, Mario Cristina, Manuel Belli, Laura Vitiello, Federica Marcolongo, et al. (+8)
291 [GO] 2022―Aug―22 Angioimmunoblastic T-Cell Lymphoma with Exuberant CD30-Positive Follicular Dendritic Cell Proliferation in a SARS-CoV-2 Patient: The Role of Mutational Analysis to Exclude an Associated Follicular Dendritic Cell Sarcoma Evelina Rogges, Sabrina Pelliccia, Gianluca Lopez, Sabina Barresi, Agostino Tafuri, Rita Alaggio, Arianna Di Napoli
292 [GO] 2022―Aug―22 Differentiation of SARS-CoV-2 Variants Using RT-qPCRs by Targeting Recurrent Mutation Sites: A Diagnostic Laboratory Experience from Multi-Center Regional Study, August 2020-December 2021, Poland Karolina Wegrzynska, Magdalena Komiazyk, Jaroslaw Walory, Aleksandra Kozinska, Izabela Wasko, Anna Baraniak
293 [GO] 2022―Aug―19 Recent Developments in the Understanding of Immunity, Pathogenesis and Management of COVID-19 Aram Yegiazaryan, Arbi Abnousian, Logan J. Alexander, Ali Badaoui, Brandon Flaig, Nisar Sheren, et al. (+7)
294 [GO] 2022―Aug―18 Gene Network Analysis of the Transcriptome Impact of SARS-CoV-2 Interacting MicroRNAs in COVID-19 Disease Alexandra Ioana Moatar, Aimee Rodica Chis, Catalin Marian, Ioan-Ovidiu Sirbu
295 [GO] 2022―Aug―17 A Uniquely Stable Trimeric Model of SARS-CoV-2 Spike Transmembrane Domain Elena T. Aliper, Nikolay A. Krylov, Dmitry E. Nolde, Anton A. Polyansky, Roman G. Efremov
296 [GO] 2022―Aug―16 Combining Deep Phenotyping of Serum Proteomics and Clinical Data via Machine Learning for COVID-19 Biomarker Discovery Antonio Paolo Beltrami, Maria De Martino, Emiliano Dalla, Matilde Clarissa Malfatti, Federica Caponnetto, Marta Codrich, et al. (+13)
297 [GO] 2022―Aug―16 Plasma Microbiome in COVID-19 Subjects: An Indicator of Gut Barrier Defects and Dysbiosis Ram Prasad, Michael John Patton, Jason Levi. Floyd, Seth Fortmann, Mariana DuPont, Angela Harbour, et al. (+5)
298 [GO] 2022―Aug―16 Allelic Variations in the Human Genes TMPRSS2 and CCR5, and the Resistance to Viral Infection by SARS-CoV-2 Girolamo Aurelio Vitello, Concetta Federico, Francesca Bruno, Mirella Vinci, Antonino Musumeci, Alda Ragalmuto, et al. (+4)
299 [GO] 2022―Aug―16 Nutrition as Personalized Medicine against SARS-CoV-2 Infections: Clinical and Oncological Options with a Specific Female Groups Overview Miriam Dellino, Eliano Cascardi, Marina Vinciguerra, Bruno Lamanna, Antonio Malvasi, Salvatore Scacco, et al. (+12)
300 [GO] 2022―Aug―15 A Comparative Study of the Plasma Chemokine Profile in COVID-19 Patients Infected with Different SARS-CoV-2 Variants Zoia R. Korobova, Natalia A. Arsentieva, Natalia E. Liubimova, Vladimir G. Dedkov, Anna S. Gladkikh, Alena A. Sharova, et al. (+8)
301 [GO] 2022―Aug―15 Hair Loss and Telogen Effluvium Related to COVID-19: The Potential Implication of Adipose-Derived Mesenchymal Stem Cells and Platelet-Rich Plasma as Regenerative Strategies Pietro Gentile
302 [GO] 2022―Aug―15 Role of the Pangolin in Origin of SARS-CoV-2: An Evolutionary Perspective Shishir K. Gupta, Rashmi Minocha, Prithivi Jung Thapa, Mugdha Srivastava, Thomas Dandekar
303 [GO] 2022―Aug―12 SARS-CoV-2 and Immunity: Natural Infection Compared with Vaccination Simone Vespa, Pasquale Simeone, Giulia Catitti, Davide Buca, Domenico De Bellis, Laura Pierdomenico, et al. (+9)
304 [GO] 2022―Aug―10 Cytokine Storm Signature in Patients with Moderate and Severe COVID-19 Olga Kalinina, Alexey Golovkin, Ekaterina Zaikova, Arthur Aquino, Vadim Bezrukikh, Olesya Melnik, et al. (+4)
305 [GO] 2022―Aug―10 Monitoring Anti-PEG Antibodies Level upon Repeated Lipid Nanoparticle-Based COVID-19 Vaccine Administration Giuditta Guerrini, Sabrina Gioria, Aisha V. Sauer, Simone Lucchesi, Francesca Montagnani, Gabiria Pastore, et al. (+3)
306 [GO] 2022―Aug―09 Computational Analysis of Short Linear Motifs in the Spike Protein of SARS-CoV-2 Variants Provides Possible Clues into the Immune Hijack and Evasion Mechanisms of Omicron Variant Anjana Soorajkumar, Ebrahim Alakraf, Mohammed Uddin, Stefan S. Du Plessis, Alawi Alsheikh-Ali, Richard K. Kandasamy
307 [GO] 2022―Aug―05 Angiotensin II Exaggerates SARS-CoV-2 Specific T-Cell Response in Convalescent Individuals following COVID-19 Moudhi Almutlaq, Fatmah A. Mansour, Jahad Alghamdi, Yassen Alhendi, Abir Abdullah Alamro, Amani Ahmed Alghamdi, et al. (+3)
308 [GO] 2022―Aug―05 Gene Variants Related to Cardiovascular and Pulmonary Diseases May Correlate with Severe Outcome of COVID-19 Mateusz Sypniewski, Zbigniew J. Król, Joanna Szyda, Elżbieta Kaja, Magdalena Mroczek, Tomasz Suchocki, et al. (+13)
309 [GO] 2022―Aug―04 COVID-19 and the Immune Response: A Multi-Phasic Approach to the Treatment of COVID-19 Tzuriel Sapir, Zaelig Averch, Brian Lerman, Abraham Bodzin, Yeshaya Fishman, Radhashree Maitra
310 [GO] 2022―Aug―01 A Multistage In Silico Study of Natural Potential Inhibitors Targeting SARS-CoV-2 Main Protease Eslam B. Elkaeed, Ibrahim H. Eissa, Hazem Elkady, Ahmed Abdelalim, Ahmad M. Alqaisi, Aisha A. Alsfouk, et al. (+2)
311 [GO] 2022―Aug―01 Effectiveness of SARS-CoV-2 Vaccines for Short- and Long-Term Immunity: A General Overview for the Pandemic Contrast Alessio Danilo Inchingolo, Giuseppina Malcangi, Sabino Ceci, Assunta Patano, Alberto Corriero, Luigi Vimercati, et al. (+32)
312 [GO] 2022―Aug―01 New Imaging Modality of COVID-19 Pneumonia Developed on the Basis of Alzheimer’s Disease Research Przemysław Koźmiński, Dorota Niedziałek, Grzegorz Wieczorek, Paweł K. Halik, Kamila Czarnecka, Aleksandra Rogut, et al. (+4)
313 [GO] 2022―Jul―28 Associations of Dynapenic Obesity and Sarcopenic Obesity with the Risk of Complications in COVID-19 Laura Pérez-Campos Mayoral, Carlos Alberto Matias-Cervantes, Eduardo Pérez-Campos, Carlos Romero Díaz, Luis Ángel Laguna Barrios, María del Socorro Pina Canseco, et al. (+6)
314 [GO] 2022―Jul―28 Roles of RNA Sensors in Host Innate Response to Influenza Virus and Coronavirus Infections Wei Li, Hongnuan Wang, Shijun J. Zheng
315 [GO] 2022―Jul―28 A Systematic Study on the Optimal Nucleotide Analogue Concentration and Rate Limiting Nucleotide of the SARS-CoV-2 RNA-Dependent RNA Polymerase Hasan Vatandaslar
316 [GO] 2022―Jul―27 Rhabdomyolysis-Induced AKI (RIAKI) Including the Role of COVID-19 Ewelina Młynarska, Julia Krzemińska, Magdalena Wronka, Beata Franczyk, Jacek Rysz
317 [GO] 2022―Jul―27 Usefulness of Vaccine Adverse Event Reporting System for Machine-Learning Based Vaccine Research: A Case Study for COVID-19 Vaccines James Flora, Wasiq Khan, Jennifer Jin, Daniel Jin, Abir Hussain, Khalil Dajani, Bilal Khan
318 [GO] 2022―Jul―27 Prognostic Role of sST2 in Acute Heart Failure and COVID-19 Infection-A Narrative Review on Pathophysiology and Clinical Prospective Luca Marino, Antonio Concistrè, Marianna Suppa, Gioacchino Galardo, Antonello Rosa, Giuliano Bertazzoni, et al. (+3)
319 [GO] 2022―Jul―27 Short-Term Effect of SARS-CoV-2 Spike Protein Receptor-Binding Domain-Specific Antibody Induction on Neutrophil-Mediated Immune Response in Mice Elena L. Bolkhovitina, Julia D. Vavilova, Andrey O. Bogorodskiy, Yuliya A. Zagryadskaya, Ivan S. Okhrimenko, Alexander M. Sapozhnikov, et al. (+2)
320 [GO] 2022―Jul―26 Immunomodulation of Mesenchymal Stem Cells in Acute Lung Injury: From Preclinical Animal Models to Treatment of Severe COVID-19 Ju-Pi Li, Kang-Hsi Wu, Wan-Ru Chao, Yi-Ju Lee, Shun-Fa Yang, Yu-Hua Chao
321 [GO] 2022―Jul―26 Characterization of SARS-CoV-2 Escape Mutants to a Pair of Neutralizing Antibodies Targeting the RBD and the NTD Antonia Sophia Peter, Eva Grüner, Eileen Socher, Kirsten Fraedrich, Elie Richel, Sandra Mueller-Schmucker, et al. (+4)
322 [GO] 2022―Jul―25 Melatonin: Regulation of Viral Phase Separation and Epitranscriptomics in Post-Acute Sequelae of COVID-19 Doris Loh, Russel J. Reiter
323 [GO] 2022―Jul―20 Patients Recovering from Severe COVID-19 Develop a Polyfunctional Antigen-Specific CD4+ T Cell Response Annamaria Paolini, Rebecca Borella, Anita Neroni, Domenico Lo Tartaro, Marco Mattioli, Lucia Fidanza, et al. (+12)
324 [GO] 2022―Jul―20 Developing New Treatments for COVID-19 through Dual-Action Antiviral/Anti-Inflammatory Small Molecules and Physiologically Based Pharmacokinetic Modeling Panagiotis Zagaliotis, Anthi Petrou, George A. Mystridis, Athina Geronikaki, Ioannis S. Vizirianakis, Thomas J. Walsh
325 [GO] 2022―Jul―19 Comprehensive Cytokine Profiling of Patients with COVID-19 Receiving Tocilizumab Therapy Anna Lebedeva, Ivan Molodtsov, Alexandra Anisimova, Anastasia Berestovskaya, Oleg Dukhin, Antonina Elizarova, et al. (+17)
326 [GO] 2022―Jul―18 Genetically Encoded Fluorescent Sensors for SARS-CoV-2 Papain-like Protease PLpro Elena L. Sokolinskaya, Lidia V. Putlyaeva, Vasilisa S. Polinovskaya, Konstantin A. Lukyanov
327 [GO] 2022―Jul―14 Celiac Disease and Targeting the Molecular Mechanisms of Autoimmunity in COVID Pandemic Laura Marinela Ailioaie, Constantin Ailioaie, Gerhard Litscher, Dragos Andrei Chiran
328 [GO] 2022―Jul―13 Potential COVID-19 Therapies from Computational Repurposing of Drugs and Natural Products against the SARS-CoV-2 Helicase Sakshi Piplani, Puneet Singh, David A. Winkler, Nikolai Petrovsky
329 [GO] 2022―Jul―13 Current Therapeutics for COVID-19, What We Know about the Molecular Mechanism and Efficacy of Treatments for This Novel Virus Divya Narayanan, Tanyalak Parimon
330 [GO] 2022―Jul―12 Pre-Omicron Vaccine Breakthrough Infection Induces Superior Cross-Neutralization against SARS-CoV-2 Omicron BA.1 Compared to Infection Alone Eveline Santos da Silva, Michel Kohnen, Georges Gilson, Therese Staub, Victor Arendt, Christiane Hilger, et al. (+7)
331 [GO] 2022―Jul―11 Biodistribution and Cellular Internalization of Inactivated SARS-CoV-2 in Wild-Type Mice Anett Hudák, Gareth Morgan, Jaromir Bacovsky, Roland Patai, Tamás F. Polgár, Annamária Letoha, et al. (+4)
332 [GO] 2022―Jul―04 Comparison of Cell Fusions Induced by Influenza Virus and SARS-CoV-2 Chuyuan Zhang, Xinjie Meng, Hanjun Zhao
333 [GO] 2022―Jul―04 The Role of Vitamin D in SARS-CoV-2 Infection and Acute Kidney Injury Ming-Chun Hsieh, Po-Jen Hsiao, Min-Tser Liao, Yi-Chou Hou, Ya-Chieh Chang, Wen-Fang Chiang, et al. (+3)
334 [GO] 2022―Jul―01 The Relationship between COVID-19 and Hypothalamic-Pituitary-Adrenal Axis: A Large Spectrum from Glucocorticoid Insufficiency to Excess-The CAPISCO International Expert Panel Mojca Jensterle, Rok Herman, Andrej Janež, Wael Al Mahmeed, Khalid Al-Rasadi, Kamila Al-Alawi, et al. (+18)
335 [GO] 2022―Jul―01 Gal-3BP in Viral Infections: An Emerging Role in Severe Acute Respiratory Syndrome Coronavirus 2 Valentina Gallo, Alyexandra Arienzo, Stefano Iacobelli, Valentina Iacobelli, Giovanni Antonini
336 [GO] 2022―Jul―01 Development of a Mortality Prediction Model in Hospitalised SARS-CoV-2 Positive Patients Based on Routine Kidney Biomarkers Anna N. Boss, Abhirup Banerjee, Michail Mamalakis, Surajit Ray, Andrew J. Swift, Craig Wilkie, et al. (+5)
337 [GO] 2022―Jul―01 Electrostatic Map of the SARS-CoV-2 Virion Specifies Binding Sites of the Antiviral Cationic Photosensitizer Vladimir Fedorov, Ekaterina Kholina, Sergei Khruschev, Ilya Kovalenko, Andrew Rubin, Marina Strakhovskaya
338 [GO] 2022―Jun―30 Gene Networks of Hyperglycemia, Diabetic Complications, and Human Proteins Targeted by SARS-CoV-2: What Is the Molecular Basis for Comorbidity? Olga V. Saik, Vadim V. Klimontov
339 [GO] 2022―Jun―30 T Cells in Multisystem Inflammatory Syndrome in Children (MIS-C) Have a Predominant CD4+ T Helper Response to SARS-CoV-2 Peptides and Numerous Virus-Specific CD4- CD8- Double-Negative T Cells Li-En Hsieh, Jaeyoon Song, Alba Grifoni, Chisato Shimizu, Adriana H. Tremoulet, Kirsten B. Dummer, et al. (+3)
340 [GO] 2022―Jun―29 Early and Polyantigenic CD4 T Cell Responses Correlate with Mild Disease in Acute COVID-19 Donors Alison Tarke, Marina Potesta, Stefania Varchetta, Daniela Fenoglio, Marco Iannetta, Loredana Sarmati, et al. (+8)
341 [GO] 2022―Jun―24 Major Histocompatibility Complex Class I Chain-Related α (MICA) STR Polymorphisms in COVID-19 Patients Juan Francisco Gutiérrez-Bautista, Alba Martinez-Chamorro, Antonio Rodriguez-Nicolas, Antonio Rosales-Castillo, Pilar Jiménez, Per Anderson, et al. (+3)
342 [GO] 2022―Jun―23 Intramyocardial Inflammation after COVID-19 Vaccination: An Endomyocardial Biopsy-Proven Case Series Christian Baumeier, Ganna Aleshcheva, Dominik Harms, Ulrich Gross, Christian Hamm, Birgit Assmus, et al. (+14)
343 [GO] 2022―Jun―22 In Silico Molecular Dynamics of Griseofulvin and Its Derivatives Revealed Potential Therapeutic Applications for COVID-19 Parisa Aris, Masoud Mohamadzadeh, Yulong Wei, Xuhua Xia
344 [GO] 2022―Jun―22 D,L-Lysine-Acetylsalicylate + Glycine (LASAG) Reduces SARS-CoV-2 Replication and Shows an Additive Effect with Remdesivir Johannes Jungwirth, Clio Häring, Sarah König, Liane Giebeler, Heena Doshi, Christian Brandt, et al. (+3)
345 [GO] 2022―Jun―22 Multi-Step In Silico Discovery of Natural Drugs against COVID-19 Targeting Main Protease Eslam B. Elkaeed, Fadia S. Youssef, Ibrahim H. Eissa, Hazem Elkady, Aisha A. Alsfouk, Mohamed L. Ashour, et al. (+3)
346 [GO] 2022―Jun―20 Synergistic Antiviral Activity of Pamapimod and Pioglitazone against SARS-CoV-2 and Its Variants of Concern Christian Setz, Maximilian Große, Janina Auth, Maria Fröba, Pia Rauch, Alexander Bausch, et al. (+2)
347 [GO] 2022―Jun―17 Deferiprone: A Forty-Year-Old Multi-Targeting Drug with Possible Activity against COVID-19 and Diseases of Similar Symptomatology George J. Kontoghiorghes
348 [GO] 2022―Jun―17 Electrochemical Determination of Interaction between SARS-CoV-2 Spike Protein and Specific Antibodies Maryia Drobysh, Viktorija Liustrovaite, Ausra Baradoke, Alma Rucinskiene, Almira Ramanaviciene, Vilma Ratautaite, et al. (+10)
349 [GO] 2022―Jun―15 Pharmacotherapy Based on ACE2 Targeting and COVID-19 Infection Antonio Vitiello, Francesco Ferrara
350 [GO] 2022―Jun―15 Cationic Surfactants as Disinfectants against SARS-CoV-2 Eduard V. Karamov, Viktor F. Larichev, Galina V. Kornilaeva, Irina T. Fedyakina, Ali S. Turgiev, Andrey V. Shibaev, et al. (+3)
351 [GO] 2022―Jun―14 Human Superantibodies to 3CLpro Inhibit Replication of SARS-CoV-2 across Variants Kittirat Glab-ampai, Kanasap Kaewchim, Thanatsaran Saenlom, Watayagorn Thepsawat, Kodchakorn Mahasongkram, Nitat Sookrung, et al. (+2)
352 [GO] 2022―Jun―13 Effective Natural Killer Cell Degranulation Is an Essential Key in COVID-19 Evolution Sara Garcinuño, Francisco Javier Gil-Etayo, Esther Mancebo, Marta López-Nevado, Antonio Lalueza, Raquel Díaz-Simón, et al. (+6)
353 [GO] 2022―Jun―10 Development of Metal Complexes for Treatment of Coronaviruses Hany M. Abd Abd El-Lateef, Tarek El-Dabea, Mai M. Khalaf, Ahmed M. Abu-Dief
354 [GO] 2022―Jun―10 Evolution of SARS-CoV-2 in Spain during the First Two Years of the Pandemic: Circulating Variants, Amino Acid Conservation, and Genetic Variability in Structural, Non-Structural, and Accessory Proteins Paloma Troyano-Hernáez, Roberto Reinosa, África Holguín
355 [GO] 2022―Jun―10 How to Restore Oxidative Balance That Was Disrupted by SARS-CoV-2 Infection Kajetan Kiełbowski, Mariola Herian, Andrzej Pawlik
356 [GO] 2022―Jun―10 RAGE against the Machine: Can Increasing Our Understanding of RAGE Help Us to Battle SARS-CoV-2 Infection in Pregnancy? Courtney K. Kurashima, Po’okela K. Ng, Claire E. Kendal-Wright
357 [GO] 2022―Jun―10 A Study of Drug Repurposing to Identify SARS-CoV-2 Main Protease (3CLpro) Inhibitors Seri Jo, Luca Signorile, Suwon Kim, Mi-Sun Kim, Oscar Huertas, Raúl Insa, et al. (+2)
358 [GO] 2022―Jun―05 Smaller, Stronger, More Stable: Peptide Variants of a SARS-CoV-2 Neutralizing Miniprotein Lucas Weißenborn, Elie Richel, Helena Hüseman, Julia Welzer, Silvan Beck, Simon Schäfer, et al. (+3)
359 [GO] 2022―Jun―03 Beyond GWAS-Could Genetic Differentiation within the Allograft Rejection Pathway Shape Natural Immunity to COVID-19? Joanna Szyda, Paula Dobosz, Joanna Stojak, Mateusz Sypniewski, Tomasz Suchocki, Krzysztof Kotlarz, et al. (+7)
360 [GO] 2022―Jun―02 SARS-CoV-2 Continuous Genetic Divergence and Changes in Multiplex RT-PCR Detection Pattern on Positive Retesting Median 150 Days after Initial Infection Dakai Liu, George D. Rodriguez, Hang-Yu Zhou, Ye-Xiao Cheng, Xiaofeng Li, Wenwen Tang, et al. (+10)
361 [GO] 2022―Jun―02 A Universal Fluorescent Immunochromatography Assay Based on Quantum Dot Nanoparticles for the Rapid Detection of Specific Antibodies against SARS-CoV-2 Nucleocapsid Protein Zehui Li, Aiping Wang, Jingming Zhou, Yumei Chen, Hongliang Liu, Yankai Liu, et al. (+7)
362 [GO] 2022―Jun―01 The Endothelium and COVID-19: An Increasingly Clear Link Brief Title: Endotheliopathy in COVID-19 Isabelle Six, Nicolas Guillaume, Valentine Jacob, Romuald Mentaverri, Said Kamel, Agnès Boullier, Michel Slama
363 [GO] 2022―Jun―01 A Possible Way to Relate the Effects of SARS-CoV-2-Induced Changes in Transferrin to Severe COVID-19-Associated Diseases Elek Telek, Zoltán Ujfalusi, Gábor Kemenesi, Brigitta Zana, Ferenc Jakab, Gabriella Hild, et al. (+2)
364 [GO] 2022―Jun―01 Potential Antiviral Strategy Exploiting Dependence of SARS-CoV-2 Replication on Lysosome-Based Pathway Yungang Lan, Wenqi He, Gaili Wang, Zhenzhen Wang, Yuzhu Chen, Feng Gao, Deguang Song
365 [GO] 2022―May―30 A Multivalent Vaccine Based on Ferritin Nanocage Elicits Potent Protective Immune Responses against SARS-CoV-2 Mutations Seong A. Kim, Seohyun Kim, Gi Beom Kim, Jiyoung Goo, Nayeon Kim, Yeram Lee, et al. (+7)
366 [GO] 2022―May―29 The Role of Antibodies in the Treatment of SARS-CoV-2 Virus Infection, and Evaluating Their Contribution to Antibody-Dependent Enhancement of Infection Mohammed A. H. Farouq, Reinaldo Acevedo, Valerie A. Ferro, Paul A. Mulheran, Mohammed M. Al Qaraghuli
367 [GO] 2022―May―29 Newly Emerged Antiviral Strategies for SARS-CoV-2: From Deciphering Viral Protein Structural Function to the Development of Vaccines, Antibodies, and Small Molecules Chunye Zhang, Ming Yang
368 [GO] 2022―May―28 Determination of IgG1 and IgG3 SARS-CoV-2 Spike Protein and Nucleocapsid Binding-Who Is Binding Who and Why? Jason K. Iles, Raminta Zmuidinaite, Christoph Sadee, Anna Gardiner, Jonathan Lacey, Stephen Harding, et al. (+6)
369 [GO] 2022―May―24 Atomistic-Level Description of the Covalent Inhibition of SARS-CoV-2 Papain-like Protease Cécilia Hognon, Marco Marazzi, Cristina García-Iriepa
370 [GO] 2022―May―22 In-Silico Selection of Aptamer Targeting SARS-CoV-2 Spike Protein Yu-Chao Lin, Wen-Yih Chen, En-Te Hwu, Wen-Pin Hu
371 [GO] 2022―May―19 Binding Properties of RNA Quadruplex of SARS-CoV-2 to Berberine Compared to Telomeric DNA Quadruplex Rosario Oliva, Sanjib Mukherjee, Magiliny Manisegaran, Marco Campanile, Pompea Del Vecchio, Luigi Petraccone, Roland Winter
372 [GO] 2022―May―18 Effects of Drugs Formerly Suggested for COVID-19 Repurposing on Pannexin1 Channels Anne Caufriez, Andrés Tabernilla, Raf Van Campenhout, Axelle Cooreman, Kaat Leroy, Julen Sanz Serrano, et al. (+5)
373 [GO] 2022―May―18 A Structural Comparison of SARS-CoV-2 Main Protease and Animal Coronaviral Main Protease Reveals Species-Specific Ligand Binding and Dimerization Mechanism Chien-Yi Ho, Jia-Xin Yu, Yu-Chuan Wang, Yu-Chuan Lin, Yi-Fang Chiu, Jing-Yan Gao, et al. (+5)
374 [GO] 2022―May―17 Structure-Based Development of SARS-CoV-2 Spike Interactors Flavia Squeglia, Maria Romano, Luciana Esposito, Giovanni Barra, Pietro Campiglia, Marina Sala, et al. (+3)
375 [GO] 2022―May―16 A Novel Human Neutralizing mAb Recognizes Delta, Gamma and Omicron Variants of SARS-CoV-2 and Can Be Used in Combination with Sotrovimab Margherita Passariello, Veronica Ferrucci, Emanuele Sasso, Lorenzo Manna, Rosa Rapuano Lembo, Stefano Pascarella, et al. (+4)
376 [GO] 2022―May―11 Antiviral Characterization of Advanced Materials: Use of Bacteriophage Phi 6 as Surrogate of Enveloped Viruses Such as SARS-CoV-2 Ángel Serrano-Aroca
377 [GO] 2022―May―10 The Role of Nuclear Factor Kappa B (NF-κB) in Development and Treatment of COVID-19: Review Monika Gudowska-Sawczuk, Barbara Mroczko
378 [GO] 2022―May―10 Dimerization Tendency of 3CLpros of Human Coronaviruses Based on the X-ray Crystal Structure of the Catalytic Domain of SARS-CoV-2 3CLpro Seri Jo, Hwa Young Kim, Dong Hae Shin, Mi-Sun Kim
379 [GO] 2022―May―08 Rationale for 1068 nm Photobiomodulation Therapy (PBMT) as a Novel, Non-Invasive Treatment for COVID-19 and Other Coronaviruses: Roles of NO and Hsp70 Lydia C. Kitchen, Marvin Berman, James Halper, Paul Chazot
380 [GO] 2022―May―06 Collective Knowledge Used to Unveil Cardiovascular Injury Emerged during COVID-19 Atsushi Tanaka, Koichi Node
381 [GO] 2022―May―05 Shared Inflammatory Pathology of Stroke and COVID-19 Kathryn E. Sánchez, Gary A. Rosenberg
382 [GO] 2022―May―04 SARS-CoV-2 Infection Dysregulates Cilia and Basal Cell Homeostasis in the Respiratory Epithelium of Hamsters Tom Schreiner, Lisa Allnoch, Georg Beythien, Katarzyna Marek, Kathrin Becker, Dirk Schaudien, et al. (+9)
383 [GO] 2022―May―04 Angiotensin II Promotes SARS-CoV-2 Infection via Upregulation of ACE2 in Human Bronchial Cells Ilaria Caputo, Brasilina Caroccia, Ilaria Frasson, Elena Poggio, Stefania Zamberlan, Margherita Morpurgo, et al. (+5)
384 [GO] 2022―May―01 Effects of Drugs Formerly Proposed for COVID-19 Treatment on Connexin43 Hemichannels Axelle Cooreman, Anne Caufriez, Andrés Tabernilla, Raf Van Campenhout, Kaat Leroy, Prashant Kadam, et al. (+4)
385 [GO] 2022―Apr―30 Antigens and Antibodies of the Antiphospholipid Syndrome as New Allies in the Pathogenesis of COVID-19 Coagulopathy Manuel Serrano, Gerard Espinosa, Antonio Serrano, Ricard Cervera
386 [GO] 2022―Apr―30 Molecular Dynamics Studies on the Structural Stability Prediction of SARS-CoV-2 Variants Including Multiple Mutants Kwang-Eun Choi, Jeong-Min Kim, Jee Eun Rhee, Ae Kyung Park, Eun-Jin Kim, Cheon Kwon Yoo, Nam Sook Kang
387 [GO] 2022―Apr―28 Liver Injury in COVID-19 Patients with Drugs as Causatives: A Systematic Review of 996 DILI Cases Published 2020/2021 Based on RUCAM as Causality Assessment Method Rolf Teschke, Nahum Méndez-Sánchez, Axel Eickhoff
388 [GO] 2022―Apr―28 Calprotectin and Imbalances between Acute-Phase Mediators Are Associated with Critical Illness in COVID-19 Georgios Kassianidis, Athanasios Siampanos, Garyphalia Poulakou, George Adamis, Aggeliki Rapti, Haralampos Milionis, et al. (+8)
389 [GO] 2022―Apr―28 Low-Dose SARS-CoV-2 S-Trimer with an Emulsion Adjuvant Induced Th1-Biased Protective Immunity Hung-Chun Liao, Wan-Ling Wu, Chen-Yi Chiang, Min-Syuan Huang, Kuan-Yin Shen, Yu-Ling Huang, et al. (+4)
390 [GO] 2022―Apr―28 Cytokines from Bench to Bedside: A Retrospective Study Identifies a Definite Panel of Biomarkers to Early Assess the Risk of Negative Outcome in COVID-19 Patients Martina Fabris, Fabio Del Ben, Emanuela Sozio, Antonio Paolo Beltrami, Adriana Cifé, Giacomo Bertolino, et al. (+4)
391 [GO] 2022―Apr―27 Anti-Inflammatory Effects and Decreased Formation of Neutrophil Extracellular Traps by Enoxaparin in COVID-19 Patients Supichcha Saithong, Wilasinee Saisorn, Punyot Tovichayathamrong, Grace Filbertine, Pattama Torvorapanit, Helen L. Wright, et al. (+4)
392 [GO] 2022―Apr―27 Can Selenium Reduce the Susceptibility and Severity of SARS-CoV-2?-A Comprehensive Review Muhammed Majeed, Kalyanam Nagabhushanam, Priji Prakasan, Lakshmi Mundkur
393 [GO] 2022―Apr―21 Immune Signature of COVID-19: In-Depth Reasons and Consequences of the Cytokine Storm Paulina Niedźwiedzka-Rystwej, Adam Majchrzak, Sara Kurkowska, Paulina Małkowska, Olga Sierawska, Rafał Hrynkiewicz, Miłosz Parczewski
394 [GO] 2022―Apr―21 The Endolysosomal System: The Acid Test for SARS-CoV-2 Daniella Cesar-Silva, Filipe S. Pereira-Dutra, Ana Lucia Moraes Moraes Giannini, Cecília Jacques G. Jacques G. de Almeida
395 [GO] 2022―Apr―18 Computer Simulations and Network-Based Profiling of Binding and Allosteric Interactions of SARS-CoV-2 Spike Variant Complexes and the Host Receptor: Dissecting the Mechanistic Effects of the Delta and Omicron Mutations Gennady Verkhivker, Steve Agajanian, Ryan Kassab, Keerthi Krishnan
396 [GO] 2022―Apr―15 Nucleic Acids as Biotools at the Interface between Chemistry and Nanomedicine in the COVID-19 Era Nicola Borbone, Ilaria Piccialli, Andrea Patrizia Falanga, Vincenzo Piccialli, Giovanni N. Roviello, Giorgia Oliviero
397 [GO] 2022―Apr―15 Identification of B-Cell Epitopes for Eliciting Neutralizing Antibodies against the SARS-CoV-2 Spike Protein through Bioinformatics and Monoclonal Antibody Targeting Hui Xuan Lim, Malihe Masomian, Kanwal Khalid, Asqwin Uthaya Kumar, Paul A. MacAry, Chit Laa Poh
398 [GO] 2022―Apr―14 COVID-19: Are We Facing Secondary Pellagra Which Cannot Simply Be Cured by Vitamin B3? Renata Novak Kujundžić
399 [GO] 2022―Apr―13 Implications of SARS-CoV-2 Infection in Systemic Juvenile Idiopathic Arthritis Laura Marinela Ailioaie, Constantin Ailioaie, Gerhard Litscher
400 [GO] 2022―Apr―11 COVID-19 and One-Carbon Metabolism Joanna Perła-Kaján, Hieronim Jakubowski
401 [GO] 2022―Apr―11 Effects of SARS-CoV-2 Inflammation on Selected Organ Systems of the Human Body Marta Kopańska, Edyta Barnaś, Joanna Błajda, Barbara Kuduk, Anna Łagowska, Agnieszka Banaś-Ząbczyk
402 [GO] 2022―Apr―10 Theophylline: Old Drug in a New Light, Application in COVID-19 through Computational Studies Luis Montaño, Bettina Sommer, Juan Gomez-Verjan, Genaro Morales-Paoli, Gema Ramírez-Salinas, Héctor Solís-Chagoyán, et al. (+7)
403 [GO] 2022―Apr―10 Anti-Inflammatory and Antiviral Effects of Cannabinoids in Inhibiting and Preventing SARS-CoV-2 Infection Marcin Janecki, Michał Graczyk, Agata Anna Lewandowska, Łukasz Pawlak
404 [GO] 2022―Apr―09 SARS-CoV-2 Pandemic Tracing in Italy Highlights Lineages with Mutational Burden in Growing Subsets Angelo Boccia, Rossella Tufano, Veronica Ferrucci, Leandra Sepe, Martina Bianchi, Stefano Pascarella, et al. (+2)
405 [GO] 2022―Apr―08 SARS-CoV-2 Spike Protein Binding of Glycated Serum Albumin-Its Potential Role in the Pathogenesis of the COVID-19 Clinical Syndromes and Bias towards Individuals with Pre-Diabetes/Type 2 Diabetes and Metabolic Diseases Jason Iles, Raminta Zmuidinaite, Christoph Sadee, Anna Gardiner, Jonathan Lacey, Stephen Harding, et al. (+5)
406 [GO] 2022―Apr―06 Identification of Entry Inhibitors against Delta and Omicron Variants of SARS-CoV-2 Richard Kuan-Lin Lee, Tian-Neng Li, Sui-Yuan Chang, Tai-Ling Chao, Chun-Hsien Kuo, Max Yu-Chen Pan, et al. (+8)
407 [GO] 2022―Apr―06 Drug-Free Nasal Spray as a Barrier against SARS-CoV-2 and Its Delta Variant: In Vitro Study of Safety and Efficacy in Human Nasal Airway Epithelia Fabio Fais, Reda Juskeviciene, Veronica Francardo, Stéphanie Mateos, Manuela Guyard, Cécile Viollet, et al. (+3)
408 [GO] 2022―Apr―06 In Vitro SARS-CoV-2 Infection of Microvascular Endothelial Cells: Effect on Pro-Inflammatory Cytokine and Chemokine Release Maria Dolci, Lucia Signorini, Sarah D’Alessandro, Federica Perego, Silvia Parapini, Michele Sommariva, et al. (+4)
409 [GO] 2022―Apr―03 Swine Enteric Coronavirus: Diverse Pathogen-Host Interactions Quanhui Yan, Xiaodi Liu, Yawei Sun, Weijun Zeng, Yuwan Li, Feifan Zhao, et al. (+5)
410 [GO] 2022―Apr―03 In Silico Drug Repositioning to Target the SARS-CoV-2 Main Protease as Covalent Inhibitors Employing a Combined Structure-Based Virtual Screening Strategy of Pharmacophore Models and Covalent Docking Luis Heriberto Vázquez-Mendoza, Humberto L. Mendoza-Figueroa, Juan Benjamín García-Vázquez, José Correa-Basurto, Jazmín García-Machorro
411 [GO] 2022―Mar―31 Potential Role of the Antidepressants Fluoxetine and Fluvoxamine in the Treatment of COVID-19 Mohamed Mahdi, Levente Hermán, János M. Réthelyi, Bálint László Bálint
412 [GO] 2022―Mar―30 Host and Viral Zinc-Finger Proteins in COVID-19 Sabrina Esposito, Gianluca D’Abrosca, Anna Antolak, Paolo Vincenzo Pedone, Carla Isernia, Gaetano Malgieri
413 [GO] 2022―Mar―30 SARS-CoV-2 Morbidity in the CNS and the Aged Brain Specific Vulnerability Tiziana Casoli
414 [GO] 2022―Mar―28 Repurposing Multiple-Molecule Drugs for COVID-19-Associated Acute Respiratory Distress Syndrome and Non-Viral Acute Respiratory Distress Syndrome via a Systems Biology Approach and a DNN-DTI Model Based on Five Drug Design Specifications Ching-Tse Ting, Bor-Sen Chen
415 [GO] 2022―Mar―28 What Is Currently Known about the Role of CXCL10 in SARS-CoV-2 Infection? Monika Gudowska-Sawczuk, Barbara Mroczko
416 [GO] 2022―Mar―28 The Role of Vitamin D in Supporting Health in the COVID-19 Era Alice Albergamo, Giulia Apprato, Francesca Silvagno
417 [GO] 2022―Mar―23 Potential Resistance of SARS-CoV-2 Main Protease (Mpro) against Protease Inhibitors: Lessons Learned from HIV-1 Protease János András Mótyán, Mohamed Mahdi, Gyula Hoffka, József Tőzsér
418 [GO] 2022―Mar―22 The Path to Therapeutic Furin Inhibitors: From Yeast Pheromones to SARS-CoV-2 Gary Thomas, Frédéric Couture, Anna Kwiatkowska
419 [GO] 2022―Mar―22 Diagnostic and Therapeutic Potential for HNP-1, HBD-1 and HBD-4 in Pregnant Women with COVID-19 Mariarita Brancaccio, Cristina Mennitti, Mariella Calvanese, Alessandro Gentile, Roberta Musto, Giulia Gaudiello, et al. (+7)
420 [GO] 2022―Mar―21 Artificial Intelligence Technologies for COVID-19 De Novo Drug Design Giuseppe Floresta, Chiara Zagni, Davide Gentile, Vincenzo Patamia, Antonio Rescifina
421 [GO] 2022―Mar―21 Coagulopathy and Fibrinolytic Pathophysiology in COVID-19 and SARS-CoV-2 Vaccination Shinya Yamada, Hidesaku Asakura
422 [GO] 2022―Mar―21 SARS-CoV-2 Associated Immune Dysregulation and COVID-Associated Pulmonary Aspergilliosis (CAPA): A Cautionary Tale Dominic Adam Worku
423 [GO] 2022―Mar―21 High-Integrity Sequencing of Spike Gene for SARS-CoV-2 Variant Determination Yu-Chieh Liao, Feng-Jui Chen, Min-Chieh Chuang, Han-Chieh Wu, Wan-Chen Ji, Guann-Yi Yu, Tsi-Shu Huang
424 [GO] 2022―Mar―21 SARS-CoV-2 Spike Protein and Mouse Coronavirus Inhibit Biofilm Formation by Streptococcus pneumoniae and Staphylococcus aureus Mun Fai Loke, Indresh Yadav, Teck Kwang Lim, Johan R. C. van der Maarel, Lok-To Sham, Vincent T. Chow
425 [GO] 2022―Mar―21 SARS-CoV-2 Proteins Interact with Alpha Synuclein and Induce Lewy Body-like Pathology In Vitro Zhengcun Wu, Xiuao Zhang, Zhangqiong Huang, Kaili Ma
426 [GO] 2022―Mar―16 An Upgrade on the Surveillance System of SARS-CoV-2: Deployment of New Methods for Genetic Inspection José Francisco Muñoz-Valle, Alberto Antony Venancio-Landeros, Rocío Sánchez-Sánchez, Karen Reyes-Díaz, Byron Galindo-Ornelas, Wendy Susana Hérnandez-Monjaraz, et al. (+8)
427 [GO] 2022―Mar―14 Neuroinflammation and COVID-19 Ischemic Stroke Recovery-Evolving Evidence for the Mediating Roles of the ACE2/Angiotensin-(1-7)/Mas Receptor Axis and NLRP3 Inflammasome Che Mohd Nasril Che Mohd Nassir, Mohd K. I. Zolkefley, Muhammad Danial Ramli, Haziq Hazman Norman, Hafizah Abdul Hamid, Muzaimi Mustapha
428 [GO] 2022―Mar―11 On the Efficacy of ZnO Nanostructures against SARS-CoV-2 Maria Chiara Sportelli, Margherita Izzi, Daniela Loconsole, Anna Sallustio, Rosaria Anna Picca, Roberto Felici, et al. (+2)
429 [GO] 2022―Mar―10 Cross-Recognition of SARS-CoV-2 B-Cell Epitopes with Other Betacoronavirus Nucleoproteins Ana Tajuelo, Mireia López-Siles, Vicente Más, Pilar Pérez-Romero, José María Aguado, Verónica Briz, et al. (+3)
430 [GO] 2022―Mar―10 SARS-CoV-2 Membrane Protein: From Genomic Data to Structural New Insights Catarina Marques-Pereira, Manuel N. Pires, Raquel P. Gouveia, Nádia N. Pereira, Ana B. Caniceiro, Nícia Rosário-Ferreira, Irina S. Moreira
431 [GO] 2022―Mar―08 Structural and Computational Studies of the SARS-CoV-2 Spike Protein Binding Mechanisms with Nanobodies: From Structure and Dynamics to Avidity-Driven Nanobody Engineering Gennady Verkhivker
432 [GO] 2022―Mar―07 Comment on Kopańska et al. Disorders of the Cholinergic System in COVID-19 Era-A Review of the Latest Research. Int. J. Mol. Sci. 2022, 23, 672 Concetta Cafiero, Alessandra Micera, Agnese Re, Beniamino Schiavone, Giulio Benincasa, Raffaele Palmirotta
433 [GO] 2022―Mar―07 Reply to Cafiero et al. Comment on “Kopańska et al. Disorders of the Cholinergic System in COVID-19 Era-A Review of the Latest Research. Int. J. Mol. Sci. 2022, 23, 672” Marta Kopańska, Jacek Szczygielski, Paulina Bartman, Agnieszka Banaś-Ząbczyk
434 [GO] 2022―Mar―07 An Overview of Systematic Reviews of the Role of Vitamin D on Inflammation in Patients with Diabetes and the Potentiality of Its Application on Diabetic Patients with COVID-19 Christiano Argano, Raffaella Mallaci Bocchio, Marika Lo Monaco, Salvatore Scibetta, Giuseppe Natoli, Attilio Cavezzi, et al. (+2)
435 [GO] 2022―Mar―01 COVID-19 Pandemic: Escape of Pathogenic Variants and MHC Evolution Pierre Pontarotti, Julien Paganini
436 [GO] 2022―Mar―01 Malnutrition and Dietary Habits Alter the Immune System Which May Consequently Influence SARS-CoV-2 Virulence: A Review Ashmika Foolchand, Terisha Ghazi, Anil A. Chuturgoon
437 [GO] 2022―Feb―28 Molecular Interactions of Tannic Acid with Proteins Associated with SARS-CoV-2 Infectivity Mohamed Haddad, Roger Gaudreault, Gabriel Sasseville, Phuong Trang Nguyen, Hannah Wiebe, Theo Van De Ven, et al. (+3)
438 [GO] 2022―Feb―25 A Deadly Embrace: Hemagglutination Mediated by SARS-CoV-2 Spike Protein at Its 22 N-Glycosylation Sites, Red Blood Cell Surface Sialoglycoproteins, and Antibody David E. Scheim
439 [GO] 2022―Feb―23 COVIDomics: The Proteomic and Metabolomic Signatures of COVID-19 Michele Costanzo, Marianna Caterino, Roberta Fedele, Armando Cevenini, Mariarca Pontillo, Lucia Barra, Margherita Ruoppolo
440 [GO] 2022―Feb―23 Nanoparticle Delivery Platforms for RNAi Therapeutics Targeting COVID-19 Disease in the Respiratory Tract Yuan Zhang, Juhura G. Almazi, Hui Xin Ong, Matt D. Johansen, Scott Ledger, Daniela Traini, et al. (+3)
441 [GO] 2022―Feb―22 Immunomodulatory and Anti-Inflammatory Properties of Selenium-Containing Agents: Their Role in the Regulation of Defense Mechanisms against COVID-19 Valentina N. Mal’tseva, Michael V. Goltyaev, Egor A. Turovsky, Elena G. Varlamova
442 [GO] 2022―Feb―22 Discovery of SARS-CoV-2 3CLPro Peptidomimetic Inhibitors through the Catalytic Dyad Histidine-Specific Protein-Ligand Interactions Yaxin Wang, Binghong Xu, Sen Ma, Hao Wang, Luqing Shang, Cheng Zhu, Sheng Ye
443 [GO] 2022―Feb―18 Kidney Injury in COVID-19: Epidemiology, Molecular Mechanisms, and Potential Therapeutic Targets J. Pedro Teixeira, Sharon Barone, Kamyar Zahedi, Manoocher Soleimani
444 [GO] 2022―Feb―18 Molecular and Cellular Mechanisms of M. tuberculosis and SARS-CoV-2 Infections-Unexpected Similarities of Pathogenesis and What to Expect from Co-Infection Anna A. Starshinova, Igor Kudryavtsev, Anna Malkova, Ulia Zinchenko, Vadim Karev, Dmitry Kudlay, et al. (+6)
445 [GO] 2022―Feb―17 Implication of COVID-19 on Erythrocytes Functionality: Red Blood Cell Biochemical Implications and Morpho-Functional Aspects Annamaria Russo, Ester Tellone, Davide Barreca, Silvana Ficarra, Giuseppina Laganà
446 [GO] 2022―Feb―17 Self-Assembled Particles Combining SARS-CoV-2 RBD Protein and RBD DNA Vaccine Induce Synergistic Enhancement of the Humoral Response in Mice Mariya B. Borgoyakova, Larisa I. Karpenko, Andrey P. Rudometov, Ekaterina A. Volosnikova, Iuliia A. Merkuleva, Ekaterina V. Starostina, et al. (+15)
447 [GO] 2022―Feb―17 Allosteric Determinants of the SARS-CoV-2 Spike Protein Binding with Nanobodies: Examining Mechanisms of Mutational Escape and Sensitivity of the Omicron Variant Gennady Verkhivker
448 [GO] 2022―Feb―15 Exploring Mitochondrial Localization of SARS-CoV-2 RNA by Padlock Assay: A Pilot Study in Human Placenta Francesca Gabanella, Christian Barbato, Nicoletta Corbi, Marco Fiore, Carla Petrella, Marco de Vincentiis, et al. (+11)
449 [GO] 2022―Feb―14 Omicron Genetic and Clinical Peculiarities That May Overturn SARS-CoV-2 Pandemic: A Literature Review Giorgio Tiecco, Samuele Storti, Melania Degli Antoni, Emanuele Focà, Francesco Castelli, Eugenia Quiros-Roldan
450 [GO] 2022―Feb―14 Analysis of the Neutralizing Activity of Antibodies Targeting Open or Closed SARS-CoV-2 Spike Protein Conformations Gabriel Cia, Fabrizio Pucci, Marianne Rooman
451 [GO] 2022―Feb―10 Loss of Detection of sgN Precedes Viral Abridged Replication in COVID-19-Affected Patients-A Target for SARS-CoV-2 Propagation Veronica Ferrucci, Pasqualino de Antonellis, Fabrizio Quarantelli, Fatemeh Asadzadeh, Francesca Bibbò, Roberto Siciliano, et al. (+25)
452 [GO] 2022―Feb―09 AKR1B10, One of the Triggers of Cytokine Storm in SARS-CoV2 Severe Acute Respiratory Syndrome Clovis Chabert, Anne-Laure Vitte, Domenico Iuso, Florent Chuffart, Candice Trocme, Marlyse Buisson, et al. (+7)
453 [GO] 2022―Feb―07 Mechanism of Caspase-1 Inhibition by Four Anti-inflammatory Drugs Used in COVID-19 Treatment Francesco Caruso, Jens Z. Pedersen, Sandra Incerpi, Sarjit Kaur, Stuart Belli, Radu-Mihai Florea, Miriam Rossi
454 [GO] 2022―Feb―04 Identification of Potential Antiviral Inhibitors from Hydroxychloroquine and 1,2,4,5-Tetraoxanes Analogues and Investigation of the Mechanism of Action in SARS-CoV-2 Ryan S. Ramos, Rosivaldo S. Borges, João S. N. de Souza, Inana F. Araujo, Mariana H. Chaves, Cleydson B. R. Santos
455 [GO] 2022―Feb―04 Molecular Docking and Molecular Dynamics Simulations Discover Curcumin Analogue as a Plausible Dual Inhibitor for SARS-CoV-2 Shailima Rampogu, Gihwan Lee, Jun Sung Park, Keun Woo Lee, Myeong Ok Kim
456 [GO] 2022―Feb―03 Sars-Cov-2-Specific Immune Response and the Pathogenesis of COVID-19 Evgenii Gusev, Alexey Sarapultsev, Liliya Solomatina, Valeriy Chereshnev
457 [GO] 2022―Feb―03 COVID-19 and Lung Mast Cells: The Kallikrein-Kinin Activation Pathway Seigo Nagashima, Anderson Azevedo Dutra, Mayara Pezzini Arantes, Rafaela Chiuco Zeni, Carolline Konzen Klein, Flávia Centenaro de Oliveira, et al. (+11)
458 [GO] 2022―Feb―01 A Multi-Disulfide Receptor-Binding Domain (RBD) of the SARS-CoV-2 Spike Protein Expressed in E. coli Using a SEP-Tag Produces Antisera Interacting with the Mammalian Cell Expressed Spike (S1) Protein  Subbaian Brindha, Yutaka Kuroda
459 [GO] 2022―Jan―31 Conformational Flexibility and Local Frustration in the Functional States of the SARS-CoV-2 Spike B.1.1.7 and B.1.351 Variants: Mutation-Induced Allosteric Modulation Mechanism of Functional Dynamics and Protein Stability Gennady Verkhivker
460 [GO] 2022―Jan―30 Time-Dependent Molecular Motifs of Pulmonary Fibrogenesis in COVID-19 Jan C. Kamp, Lavinia Neubert, Maximilian Ackermann, Helge Stark, Christopher Werlein, Jan Fuge, et al. (+11)
461 [GO] 2022―Jan―30 The “Elastic Perspective” of SARS-CoV-2 Infection and the Role of Intrinsic and Extrinsic Factors Federica Boraldi, Francesco Demetrio Lofaro, Andrea Cossarizza, Daniela Quaglino
462 [GO] 2022―Jan―28 Oral Pathology in COVID-19 and SARS-CoV-2 Infection-Molecular Aspects Agnieszka Drozdzik, Marek Drozdzik
463 [GO] 2022―Jan―26 The Transmembrane Protease TMPRSS2 as a Therapeutic Target for COVID-19 Treatment Lukas Wettstein, Frank Kirchhoff, Jan Münch
464 [GO] 2022―Jan―26 Aptamers-Diagnostic and Therapeutic Solution in SARS-CoV-2 Tomasz Wandtke, Ewelina Wędrowska, Marcin Szczur, Grzegorz Przybylski, Marek Libura, Piotr Kopiński
465 [GO] 2022―Jan―26 RT-qPCR Detection of SARS-CoV-2: No Need for a Dedicated Reverse Transcription Step Stephen A. Bustin, Gregory L. Shipley, Sara Kirvell, Reinhold Mueller, Tania Nolan
466 [GO] 2022―Jan―24 Meta-Analysis of APP Expression Modulated by SARS-CoV-2 Infection via the ACE2 Receptor Alyssa Caradonna, Tanvi Patel, Matea Toleska, Sedra Alabed, Sulie L. Chang
467 [GO] 2022―Jan―19 Secondary Structures of the Transmembrane Domain of SARS-CoV-2 Spike Protein in Detergent Micelles Qingxin Li, Qiwei Huang, Congbao Kang
468 [GO] 2022―Jan―19 Ibuprofen, Flurbiprofen, Etoricoxib or Paracetamol Do Not Influence ACE2 Expression and Activity In Vitro or in Mice and Do Not Exacerbate In-Vitro SARS-CoV-2 Infection Natasja de Bruin, Ann-Kathrin Schneider, Philipp Reus, Sonja Talmon, Sandra Ciesek, Denisa Bojkova, et al. (+9)
469 [GO] 2022―Jan―17 Could Lower Testosterone in Older Men Explain Higher COVID-19 Morbidity and Mortalities? Luis M. Montaño, Bettina Sommer, Héctor Solís-Chagoyán, Bianca S. Romero-Martínez, Arnoldo Aquino-Gálvez, Juan C. Gomez-Verjan, et al. (+3)
470 [GO] 2022―Jan―14 Consequences of COVID-19 for the Pancreas Urszula Abramczyk, Maciej Nowaczyński, Adam Słomczyński, Piotr Wojnicz, Piotr Zatyka, Aleksandra Kuzan
471 [GO] 2022―Jan―13 Computational Design of Miniproteins as SARS-CoV-2 Therapeutic Inhibitors Bahaa Jawad, Puja Adhikari, Kun Cheng, Rudolf Podgornik, Wai-Yim Ching
472 [GO] 2022―Jan―13 Air-Liquid-Interface Differentiated Human Nose Epithelium: A Robust Primary Tissue Culture Model of SARS-CoV-2 Infection Bang M. Tran, Samantha L. Grimley, Julie L. McAuley, Abderrahman Hachani, Linda Earnest, Sharon L. Wong, et al. (+11)
473 [GO] 2022―Jan―12 Syndecan-4 Is a Key Facilitator of the SARS-CoV-2 Delta Variant’s Superior Transmission Anett Hudák, Gábor Veres, Annamária Letoha, László Szilák, Tamás Letoha
474 [GO] 2022―Jan―10 Disorders of the Cholinergic System in COVID-19 Era-A Review of the Latest Research Marta Kopańska, Marta Batoryna, Paulina Bartman, Jacek Szczygielski, Agnieszka Banaś-Ząbczyk
475 [GO] 2022―Jan―10 Biosensors for the Determination of SARS-CoV-2 Virus and Diagnosis of COVID-19 Infection Maryia Drobysh, Almira Ramanaviciene, Roman Viter, Chien-Fu Chen, Urte Samukaite-Bubniene, Vilma Ratautaite, Arunas Ramanavicius
476 [GO] 2022―Jan―10 COVID-19 in Joint Ageing and Osteoarthritis: Current Status and Perspectives Marianne Lauwers, Manting Au, Shuofeng Yuan, Chunyi Wen
477 [GO] 2022―Jan―07 Synthesis of Nucleoside-like Molecules from a Pyrolysis Product of Cellulose and Their Computational Prediction as Potential SARS-CoV-2 RNA-Dependent RNA Polymerase Inhibitors Andrea Defant, Federico Dosi, Nicole Innocenti, Ines Mancini
478 [GO] 2022―Jan―07 Glycosylation of Receptor Binding Domain of SARS-CoV-2 S-Protein Influences on Binding to Immobilized DNA Aptamers Fedor Grabovenko, Liudmila Nikiforova, Bogdan Yanenko, Andrey Ulitin, Eugene Loktyushov, Timofei Zatsepin, et al. (+2)
479 [GO] 2021―Dec―31 Commercial SARS-CoV-2 Targeted, Protease Inhibitor Focused and Protein-Protein Interaction Inhibitor Focused Molecular Libraries for Virtual Screening and Drug Design Sebastjan Kralj, Marko Jukič, Urban Bren
480 [GO] 2021―Dec―28 Role of Selenium in Viral Infections with a Major Focus on SARS-CoV-2 Sabrina Sales Martinez, Yongjun Huang, Leonardo Acuna, Eduardo Laverde, David Trujillo, Manuel A. Barbieri, et al. (+3)
481 [GO] 2021―Dec―28 A Review of the Current Landscape of SARS-CoV-2 Main Protease Inhibitors: Have We Hit the Bullseye Yet? Guillem Macip, Pol Garcia-Segura, Júlia Mestres-Truyol, Bryan Saldivar-Espinoza, Gerard Pujadas, Santiago Garcia-Vallvé
482 [GO] 2021―Dec―28 Exploring the Catalytic Mechanism of the RNA Cap Modification by nsp16-nsp10 Complex of SARS-CoV-2 through a QM/MM Approach José Rogério A. Silva, Jaime Urban, Edson Araújo, Jerônimo Lameira, Vicent Moliner, Cláudio Nahum Alves
483 [GO] 2021―Dec―24 COVID-19: Immunohistochemical Analysis of TGF-β Signaling Pathways in Pulmonary Fibrosis Caroline Busatta Vaz de Vaz de Paula, Seigo Nagashima, Vanessa Liberalesso, Mariana Collete, Felipe Paes Gomes da da Silva, Alessandro Gonçalves Gomes Oricil, et al. (+5)
484 [GO] 2021―Dec―22 Molecular Networking for Drug Toxicities Studies: The Case of Hydroxychloroquine in COVID-19 Patients Pierre-Jean Ferron, Brendan Le Daré, Julie Bronsard, Clara Steichen, Elodie Babina, Romain Pelletier, et al. (+7)
485 [GO] 2021―Dec―22 Protective Effects of Meldonium in Experimental Models of Cardiovascular Complications with a Potential Application in COVID-19 Reinis Vilskersts, Dana Kigitovica, Stanislava Korzh, Melita Videja, Karlis Vilks, Helena Cirule, et al. (+4)
486 [GO] 2021―Dec―21 Analysis of Immune Escape Variants from Antibody-Based Therapeutics against COVID-19: A Systematic Review Daniele Focosi, Fabrizio Maggi, Massimo Franchini, Scott McConnell, Arturo Casadevall
487 [GO] 2021―Dec―20 Mechanism of Blood-Heart-Barrier Leakage: Implications for COVID-19 Induced Cardiovascular Injury Rubens P. Homme, Akash K. George, Mahavir Singh, Irina Smolenkova, Yuting Zheng, Sathnur Pushpakumar, Suresh C. Tyagi
488 [GO] 2021―Dec―20 SARS-CoV-2 Exacerbates Beta-Amyloid Neurotoxicity, Inflammation and Oxidative Stress in Alzheimer’s Disease Patients Luigi Chiricosta, Agnese Gugliandolo, Emanuela Mazzon
489 [GO] 2021―Dec―20 Entrectinib-A SARS-CoV-2 Inhibitor in Human Lung Tissue (HLT) Cells Alejandro Peralta-Garcia, Mariona Torrens-Fontanals, Tomasz Maciej Stepniewski, Judith Grau-Expósito, David Perea, Vikram Ayinampudi, et al. (+5)
490 [GO] 2021―Dec―20 Prothrombotic Phenotype in COVID-19: Focus on Platelets Cristina Barale, Elena Melchionda, Alessandro Morotti, Isabella Russo
491 [GO] 2021―Dec―15 Protein-Based Nanoparticle Vaccines for SARS-CoV-2 Hyo-Dong Sung, Nayeon Kim, Yeram Lee, Eun Jung Lee
492 [GO] 2021―Dec―10 Iota-Carrageenan Inhibits Replication of SARS-CoV-2 and the Respective Variants of Concern Alpha, Beta, Gamma and Delta Maria Fröba, Maximilian Große, Christian Setz, Pia Rauch, Janina Auth, Lucas Spanaus, et al. (+8)
493 [GO] 2021―Dec―07 MicroRNA-Mediated Regulation of the Virus Cycle and Pathogenesis in the SARS-CoV-2 Disease Rosalia Battaglia, Ruben Alonzo, Chiara Pennisi, Angela Caponnetto, Carmen Ferrara, Michele Stella, et al. (+5)
494 [GO] 2021―Dec―01 Involvement of the ACE2/Ang-(1-7)/MasR Axis in Pulmonary Fibrosis: Implications for COVID-19 Taylor Morganstein, Zahraa Haidar, Joshua Trivlidis, Ilan Azuelos, Megan Jiaxin Huang, David H. Eidelman, Carolyn J. Baglole
495 [GO] 2021―Dec―01 Alternative RAS in Various Hypoxic Conditions: From Myocardial Infarction to COVID-19 Tomas Rajtik, Peter Galis, Linda Bartosova, Ludovit Paulis, Eva Goncalvesova, Jan Klimas
496 [GO] 2021―Nov―30 Natural Bioactive Molecules: An Alternative Approach to the Treatment and Control of COVID-19 Fahadul Islam, Shabana Bibi, Atkia Farzana Khan Meem, Md. Mohaimenul Islam, Md. Saidur Rahaman, Sristy Bepary, et al. (+9)
497 [GO] 2021―Nov―30 Non-Woven Infection Prevention Fabrics Coated with Biobased Cranberry Extracts Inactivate Enveloped Viruses Such as SARS-CoV-2 and Multidrug-Resistant Bacteria Kazuo Takayama, Alberto Tuñón-Molina, Alba Cano-Vicent, Yukiko Muramoto, Takeshi Noda, José Luis Aparicio-Collado, et al. (+3)
498 [GO] 2021―Nov―22 How Immunosenescence and Inflammaging May Contribute to Hyperinflammatory Syndrome in COVID-19 Ludmila Müller, Svetlana Di Benedetto
499 [GO] 2021―Nov―19 Chemical Exposures Affect Innate Immune Response to SARS-CoV-2 Olatunbosun Arowolo, Leonid Pobezinsky, Alexander Suvorov
500 [GO] 2021―Nov―18 Monoclonal Antibodies against Nucleocapsid Protein of SARS-CoV-2 Variants for Detection of COVID-19 Ruei-Min Lu, Shih-Han Ko, Wan-Yu Chen, Yu-Ling Chang, Hsiu-Ting Lin, Han-Chung Wu
501 [GO] 2021―Nov―17 Molecular Mechanisms of Possible Action of Phenolic Compounds in COVID-19 Protection and Prevention Nikola Gligorijevic, Mirjana Radomirovic, Olgica Nedic, Marija Stojadinovic, Urmila Khulal, Dragana Stanic-Vucinic, Tanja Cirkovic Velickovic
502 [GO] 2021―Nov―15 Cardiometabolic Alterations in the Interplay of COVID-19 and Diabetes: Current Knowledge and Future Avenues Ali A. Rizvi, Andrej Janez, Manfredi Rizzo
503 [GO] 2021―Nov―12 SARS-CoV-2, Cardiovascular Diseases, and Noncoding RNAs: A Connected Triad Lucia Natarelli, Fabio Virgili, Christian Weber
504 [GO] 2021―Nov―10 Xanthohumol Is a Potent Pan-Inhibitor of Coronaviruses Targeting Main Protease Yuxi Lin, Ruochen Zang, Yanlong Ma, Zhuoya Wang, Li Li, Siyuan Ding, et al. (+4)
505 [GO] 2021―Nov―09 SARS-CoV-2 Variants, RBD Mutations, Binding Affinity, and Antibody Escape Lin Yang, Jiacheng Li, Shuai Guo, Chengyu Hou, Chenchen Liao, Liping Shi, et al. (+6)
506 [GO] 2021―Nov―08 An Insight into the Role of Postmortem Immunohistochemistry in the Comprehension of the Inflammatory Pathophysiology of COVID-19 Disease and Vaccine-Related Thrombotic Adverse Events: A Narrative Review Chiara Stassi, Cristina Mondello, Gennaro Baldino, Luigi Cardia, Alessio Asmundo, Elvira Ventura Spagnolo
507 [GO] 2021―Nov―08 Pathogenic Basis of Thromboinflammation and Endothelial Injury in COVID-19: Current Findings and Therapeutic Implications Yasutomi Higashikuni, Wenhao Liu, Takumi Obana, Masataka Sata
508 [GO] 2021―Nov―04 A Patent Review on the Therapeutic Application of Monoclonal Antibodies in COVID-19 Syed Mohammed Basheeruddin Asdaq, Syed Imam Rabbani, Meshary Alkahtani, Meshal Meshary Aldohyan, Abdullah Mohammad Alabdulsalam, Majed Sadun Alshammari, et al. (+7)
509 [GO] 2021―Nov―03 The Role of Endothelium in COVID-19 Mihaela Ionescu, Anca Pantea Stoian, Manfredi Rizzo, Dragos Serban, Domenico Nuzzo, Laura Mazilu, et al. (+3)
510 [GO] 2021―Nov―02 A Review on the Role of Stem Cells against SARS-CoV-2 in Children and Pregnant Women Fatemeh Sanie-Jahromi, Yaser NejatyJahromy, Rahim Raoofi Jahromi
511 [GO] 2021―Nov―02 Natural Products-Based Drug Design against SARS-CoV-2 Mpro 3CLpro Rai C. Silva, Humberto F. Freitas, Joaquín M. Campos, Njogu M. Kimani, Carlos H. T. P. Silva, Rosivaldo S. Borges, et al. (+2)
512 [GO] 2021―Nov―02 25-Hydroxycholesterol-Conjugated EK1 Peptide with Potent and Broad-Spectrum Inhibitory Activity against SARS-CoV-2, Its Variants of Concern, and Other Human Coronaviruses Qiaoshuai Lan, Chao Wang, Jie Zhou, Lijue Wang, Fanke Jiao, Yanbo Zhang, et al. (+4)
513 [GO] 2021―Nov―02 SARS-CoV-2 Exposed Mesenchymal Stromal Cell from Congenital Pulmonary Airway Malformations: Transcriptomic Analysis and the Expression of Immunomodulatory Genes Andrea Valeri, Luigi Chiricosta, Agnese Gugliandolo, Mara Biasin, Maria Antonietta Avanzini, Valeria Calcaterra, et al. (+6)
514 [GO] 2021―Nov―02 Structural and Biochemical Analysis of the Dual Inhibition of MG-132 against SARS-CoV-2 Main Protease (Mpro/3CLpro) and Human Cathepsin-L Elisa Costanzi, Maria Kuzikov, Francesca Esposito, Simone Albani, Nicola Demitri, Barbara Giabbai, et al. (+5)
515 [GO] 2021―Oct―29 Whey-Derived Peptides at the Heart of the COVID-19 Pandemic Yara Chamata, Kim G. Jackson, Kimberly A. Watson, Paula Jauregi
516 [GO] 2021―Oct―29 Establishment of a Rapid Detection System for ISG20-Dependent SARS-CoV-2 Subreplicon RNA Degradation Induced by Interferon-α Yutaka Furutani, Mariko Toguchi, Shoko Higuchi, Kaori Yanaka, Luc Gailhouste, Xian-Yang Qin, et al. (+3)
517 [GO] 2021―Oct―28 A Collection of Designed Peptides to Target SARS-CoV-2 Spike RBD-ACE2 Interaction Narcis Fernandez-Fuentes, Ruben Molina, Baldo Oliva
518 [GO] 2021―Oct―28 Infection of Brain Pericytes Underlying Neuropathology of COVID-19 Patients Matteo Bocci, Clara Oudenaarden, Xavier Sàenz-Sardà, Joel Simrén, Arvid Edén, Jonas Sjölund, et al. (+5)
519 [GO] 2021―Oct―27 Structural and Functional Analysis of Female Sex Hormones against SARS-CoV-2 Cell Entry Jorge Alberto Aguilar-Pineda, Mazen Albaghdadi, Wanlin Jiang, Karin J. Vera-Lopez, Rita Nieto-Montesinos, Karla Lucia F. Alvarez, et al. (+5)
520 [GO] 2021―Oct―26 Metabolic Reprogramming in COVID-19 Tao Shen, Tingting Wang
521 [GO] 2021―Oct―26 Pituitary-Adrenal Responses and Glucocorticoid Receptor Expression in Critically Ill Patients with COVID-19 Dimitra A. Vassiliadi, Alice G. Vassiliou, Ioannis Ilias, Stylianos Tsagarakis, Anastasia Kotanidou, Ioanna Dimopoulou
522 [GO] 2021―Oct―26 ACE2 and Innate Immunity in the Regulation of SARS-CoV-2-Induced Acute Lung Injury: A Review Lihua Qu, Chao Chen, Tong Yin, Qian Fang, Zizhan Hong, Rui Zhou, et al. (+2)
523 [GO] 2021―Oct―20 Alveolar Regeneration in COVID-19 Patients: A Network Perspective Shishir K. Gupta, Mugdha Srivastava, Rashmi Minocha, Aman Akash, Seema Dangwal, Thomas Dandekar
524 [GO] 2021―Oct―18 Inflammatory Mediators of Platelet Activation: Focus on Atherosclerosis and COVID-19 Panagiotis Theofilis, Marios Sagris, Alexios S. Antonopoulos, Evangelos Oikonomou, Costas Tsioufis, Dimitris Tousoulis
525 [GO] 2021―Oct―18 Potential Novel Thioether-Amide or Guanidine-Linker Class of SARS-CoV-2 Virus RNA-Dependent RNA Polymerase Inhibitors Identified by High-Throughput Virtual Screening Coupled to Free-Energy Calculations Marko Jukič, Dušanka Janežič, Urban Bren
526 [GO] 2021―Oct―14 Molecular Insights on the Possible Role of Annexin A2 in COVID-19 Pathogenesis and Post-Infection Complications Prakash Patil, Praveenkumar Shetty, Nithin Kuriakose, Pavan Gollapalli, Sukanya Shetty, Roopa Bhandary, et al. (+2)
527 [GO] 2021―Oct―14 Promising Antiviral Activities of Natural Flavonoids against SARS-CoV-2 Targets: Systematic Review Ridhima Kaul, Pradipta Paul, Sanjay Kumar, Dietrich Büsselberg, Vivek Dhar Dwivedi, Ali Chaari
528 [GO] 2021―Oct―11 Successful Treatment of Persistent SARS-CoV-2 Infection in a B-Cell Depleted Patient with Activated Cytotoxic T and NK Cells: A Case Report Jacek Jassem, Natalia Maria Marek-Trzonkowska, Tomasz Smiatacz, Łukasz Arcimowicz, Ines Papak, Ewa Jassem, Jan Maciej Zaucha
529 [GO] 2021―Oct―11 Receptor-Loaded Virion Endangers GPCR Signaling: Mechanistic Exploration of SARS-CoV-2 Infections and Pharmacological Implications Qiangmin Zhang, Peter A. Friedman
530 [GO] 2021―Oct―09 SARS-CoV-2 Virus-Host Interaction: Currently Available Structures and Implications of Variant Emergence on Infectivity and Immune Response Luís Queirós-Reis, Priscilla Gomes da Silva, José Gonçalves, Andrea Brancale, Marcella Bassetto, João R. Mesquita
531 [GO] 2021―Oct―07 Establishment of Intestinal Organoid from Rousettus leschenaultii and the Susceptibility to Bat-Associated Viruses, SARS-CoV-2 and Pteropine Orthoreovirus Mohamed Elbadawy, Yuki Kato, Nagisa Saito, Kimika Hayashi, Amira Abugomaa, Mio Kobayashi, et al. (+10)
532 [GO] 2021―Oct―07 Coagulopathies after Vaccination against SARS-CoV-2 May Be Derived from a Combined Effect of SARS-CoV-2 Spike Protein and Adenovirus Vector-Triggered Signaling Pathways Ralf Kircheis
533 [GO] 2021―Oct―04 Tomatidine and Patchouli Alcohol as Inhibitors of SARS-CoV-2 Enzymes (3CLpro, PLpro and NSP15) by Molecular Docking and Molecular Dynamics Simulations Rafat Zrieq, Iqrar Ahmad, Mejdi Snoussi, Emira Noumi, Marcello Iriti, Fahad D. Algahtani, et al. (+6)
534 [GO] 2021―Oct―01 The Upper Respiratory Tract of Felids Is Highly Susceptible to SARS-CoV-2 Infection Nadine Krüger, Cheila Rocha, Sandra Runft, Johannes Krüger, Iris Färber, Federico Armando, et al. (+6)
535 [GO] 2021―Sep―30 Vitamin D and COVID-19: An Overview of Recent Evidence Drishti Ghelani, Simon Alesi, Aya Mousa
536 [GO] 2021―Sep―29 Untargeted Metabolic Profiling of Extracellular Vesicles of SARS-CoV-2-Infected Patients Shows Presence of Potent Anti-Inflammatory Metabolites Faisal A. Alzahrani, Mohammed Razeeth Shait Mohammed, Saleh Alkarim, Esam I. Azhar, Mohammed A. El-Magd, Yousef Hawsawi, et al. (+10)
537 [GO] 2021―Sep―29 Molecular Insights into SARS-CoV2-Induced Alterations of the Gut/Brain Axis Serge Nataf, Laurent Pays
538 [GO] 2021―Sep―29 The Crosstalk between SARS-CoV-2 Infection and the RAA System in Essential Hypertension-Analyses Using Systems Approach Dorota Formanowicz, Kaja Gutowska, Bartłomiej Szawulak, Piotr Formanowicz
539 [GO] 2021―Sep―27 The MiR-320 Family Is Strongly Downregulated in Patients with COVID-19 Induced Severe Respiratory Failure Ruth P. Duecker, Elisabeth H. Adam, Sarah Wirtz, Lucia Gronau, Yascha Khodamoradi, Fabian J. Eberhardt, et al. (+8)
540 [GO] 2021―Sep―27 Good Cholesterol Gone Bad? HDL and COVID-19 George E. G. Kluck, Jeong-Ah Yoo, Emmanuel H. Sakarya, Bernardo L. Trigatti
541 [GO] 2021―Sep―27 Cloning of a Passage-Free SARS-CoV-2 Genome and Mutagenesis Using Red Recombination Alexandra Herrmann, Doris Jungnickl, Arne Cordsmeier, Antonia Sophia Peter, Klaus Überla, Armin Ensser
542 [GO] 2021―Sep―25 Severity of COVID-19 Patients Predicted by Serum Sphingolipids Signature Enrica Torretta, Micaela Garziano, Mariacristina Poliseno, Daniele Capitanio, Mara Biasin, Teresa Antonia Santantonio, et al. (+4)
543 [GO] 2021―Sep―23 Lectin from Triticum vulgaris (WGA) Inhibits Infection with SARS-CoV-2 and Its Variants of Concern Alpha and Beta Janina Auth, Maria Fröba, Maximilian Große, Pia Rauch, Natalia Ruetalo, Michael Schindler, et al. (+6)
544 [GO] 2021―Sep―17 Increased Autotaxin Levels in Severe COVID-19, Correlating with IL-6 Levels, Endothelial Dysfunction Biomarkers, and Impaired Functions of Dendritic Cells Ioanna Nikitopoulou, Dionysios Fanidis, Konstantinos Ntatsoulis, Panagiotis Moulos, George Mpekoulis, Maria Evangelidou, et al. (+12)
545 [GO] 2021―Sep―17 Vitamin D and Platelets: A Menacing Duo in COVID-19 and Potential Relation to Bone Remodeling Francesca Salamanna, Melania Maglio, Maria Sartori, Maria Paola Landini, Milena Fini
546 [GO] 2021―Sep―14 Tumor Necrosis Factor-Alpha Exacerbates Viral Entry in SARS-CoV2-Infected iPSC-Derived Cardiomyocytes Chiu-Yang Lee, Chih-Heng Huang, Elham Rastegari, Vimalan Rengganaten, Ping-Cheng Liu, Ping-Hsing Tsai, et al. (+12)
547 [GO] 2021―Sep―13 Virtual Alanine Scan of the Main Protease Active Site in Severe Acute Respiratory Syndrome Coronavirus 2 Tomoki Nakayoshi, Koichi Kato, Eiji Kurimoto, Akifumi Oda
548 [GO] 2021―Sep―10 The Se-S Bond Formation in the Covalent Inhibition Mechanism of SARS-CoV-2 Main Protease by Ebselen-like Inhibitors: A Computational Study Angela Parise, Isabella Romeo, Nino Russo, Tiziana Marino
549 [GO] 2021―Sep―09 Cardiac and Renal SARS-CoV-2 Viral Entry Protein Regulation by Androgens and Diet: Implications for Polycystic Ovary Syndrome and COVID-19 Samar Rezq, Alexandra M. Huffman, Jelina Basnet, Licy L. Yanes Cardozo, Damian G. Romero
550 [GO] 2021―Sep―07 Computational Methods to Study Human Transcript Variants in COVID-19 Infected Lung Cancer Cells Jiao Sun, Naima Ahmed Fahmi, Heba Nassereddeen, Sze Cheng, Irene Martinez, Deliang Fan, et al. (+2)
551 [GO] 2021―Sep―06 Pharmacokinetic Drug-Drug Interactions among Antiepileptic Drugs, Including CBD, Drugs Used to Treat COVID-19 and Nutrients Marta Karaźniewicz-Łada, Anna K. Główka, Aniceta A. Mikulska, Franciszek K. Główka
552 [GO] 2021―Sep―02 The Serum Metabolome of Moderate and Severe COVID-19 Patients Reflects Possible Liver Alterations Involving Carbon and Nitrogen Metabolism Marianna Caterino, Michele Costanzo, Roberta Fedele, Armando Cevenini, Monica Gelzo, Alessandro Di Minno, et al. (+14)
553 [GO] 2021―Sep―02 Antimicrobial Face Shield: Next Generation of Facial Protective Equipment against SARS-CoV-2 and Multidrug-Resistant Bacteria Alberto Tuñón-Molina, Miguel Martí, Yukiko Muramoto, Takeshi Noda, Kazuo Takayama, Ángel Serrano-Aroca
554 [GO] 2021―Aug―31 Development of Effective Therapeutic Molecule from Natural Sources against Coronavirus Protease Adewale Oluwaseun Fadaka, Nicole Remaliah Samantha Sibuyi, Darius Riziki Martin, Ashwil Klein, Abram Madiehe, Mervin Meyer
555 [GO] 2021―Aug―31 Peptide Derivatives of the Zonulin Inhibitor Larazotide (AT1001) as Potential Anti SARS-CoV-2: Molecular Modelling, Synthesis and Bioactivity Evaluation Simone Di Micco, Simona Musella, Marina Sala, Maria C. Scala, Graciela Andrei, Robert Snoeck, et al. (+3)
556 [GO] 2021―Aug―27 Epigenetic Clocks Are Not Accelerated in COVID-19 Patients Julia Franzen, Selina Nüchtern, Vithurithra Tharmapalan, Margherita Vieri, Miloš Nikolić, Yang Han, et al. (+7)
557 [GO] 2021―Aug―26 SARS-CoV-2 Impairs Dendritic Cells and Regulates DC-SIGN Gene Expression in Tissues Guoshuai Cai, Mulong Du, Yohan Bossé, Helmut Albrecht, Fei Qin, Xizhi Luo, et al. (+8)
558 [GO] 2021―Aug―26 Phosphorylation of SARS-CoV-2 Orf9b Regulates Its Targeting to Two Binding Sites in TOM70 and Recruitment of Hsp90 Lukas Brandherm, Antonio Mario Kobaš, Mara Klöhn, Yannick Brüggemann, Stephanie Pfaender, Joachim Rassow, Sebastian Kreimendahl
559 [GO] 2021―Aug―26 The Role of the PFNA Operon of Bifidobacteria in the Recognition of Host’s Immune Signals: Prospects for the Use of the FN3 Protein in the Treatment of COVID-19 Venera Z. Nezametdinova, Roman A. Yunes, Marina S. Dukhinova, Maria G. Alekseeva, Valery N. Danilenko
560 [GO] 2021―Aug―25 Possible Link between Higher Transmissibility of Alpha, Kappa and Delta Variants of SARS-CoV-2 and Increased Structural Stability of Its Spike Protein and hACE2 Affinity Vipul Kumar, Jasdeep Singh, Seyed E. Hasnain, Durai Sundar
561 [GO] 2021―Aug―25 Exploring the Binding Mechanism of PF-07321332 SARS-CoV-2 Protease Inhibitor through Molecular Dynamics and Binding Free Energy Simulations Bilal Ahmad, Maria Batool, Qurat ul Ain, Moon Suk Kim, Sangdun Choi
562 [GO] 2021―Aug―23 Putative Role of Vitamin D for COVID-19 Vaccination Sheng-Kang Chiu, Kuo-Wang Tsai, Chia-Chao Wu, Cai-Mei Zheng, Chung-Hsiang Yang, Wan-Chung Hu, et al. (+3)
563 [GO] 2021―Aug―23 SARS-CoV-2 Proteins Bind to Hemoglobin and Its Metabolites Guilherme C. Lechuga, Franklin Souza-Silva, Carolina Q. Sacramento, Monique R. O. Trugilho, Richard H. Valente, Paloma Napoleão-Pêgo, et al. (+9)
564 [GO] 2021―Aug―23 Cell-Free Hemoglobin Does Not Attenuate the Effects of SARS-CoV-2 Spike Protein S1 Subunit in Pulmonary Endothelial Cells Sirsendu Jana, Michael R. Heaven, Abdu I. Alayash
565 [GO] 2021―Aug―23 Small Structural Proteins E and M Render the SARS-CoV-2 Pseudovirus More Infectious and Reveal the Phenotype of Natural Viral Variants Hsin-I Wang, Zih-Shiuan Chuang, Yu-Ting Kao, Yi-Ling Lin, Jian-Jong Liang, Chun-Che Liao, et al. (+3)
566 [GO] 2021―Aug―20 Adaptive Immunity and the Risk of Autoreactivity in COVID-19 Rhiane Moody, Kirsty Wilson, Katie L. Flanagan, Anthony Jaworowski, Magdalena Plebanski
567 [GO] 2021―Aug―20 “Molecular Masks” for ACE2 to Effectively and Safely Block SARS-CoV-2 Virus Entry Satya Prakash Shukla, Kwang Bog Cho, Vineeta Rustagi, Xiang Gao, Xinping Fu, Shaun Xiaoliu Zhang, et al. (+2)
568 [GO] 2021―Aug―18 Neutrophil Extracellular Traps (NETs) in Severe SARS-CoV-2 Lung Disease Monika Szturmowicz, Urszula Demkow
569 [GO] 2021―Aug―18 Oxidative Inactivation of SARS-CoV-2 on Photoactive AgNPs@TiO2 Ceramic Tiles Ridha Djellabi, Nicoletta Basilico, Serena Delbue, Sarah D’Alessandro, Silvia Parapini, Giuseppina Cerrato, et al. (+3)
570 [GO] 2021―Aug―18 Possible Use of Phytochemicals for Recovery from COVID-19-Induced Anosmia and Ageusia Sachiko Koyama, Kenji Kondo, Rumi Ueha, Hideki Kashiwadani, Thomas Heinbockel
571 [GO] 2021―Aug―18 Clearance of the SARS-CoV-2 Virus in an Immunocompromised Patient Mediated by Convalescent Plasma without B-Cell Recovery Maamoun Basheer, Elias Saad, Orly Laskar, Ofir Schuster, Hagai Rechnitzer, Simona Zisman-Rozen, et al. (+2)
572 [GO] 2021―Aug―13 Molecular Dynamics Studies on the Structural Characteristics for the Stability Prediction of SARS-CoV-2 Kwang-Eun Choi, Jeong-Min Kim, JeeEun Rhee, Ae Kyung Park, Eun-Jin Kim, Nam Sook Kang
573 [GO] 2021―Aug―13 RT-qPCR Diagnostics: The “Drosten” SARS-CoV-2 Assay Paradigm Stephen Bustin, Sara Kirvell, Jim F. Huggett, Tania Nolan
574 [GO] 2021―Aug―12 Anti-SARS-CoV-2 Strategies and the Potential Role of miRNA in the Assessment of COVID-19 Morbidity, Recurrence, and Therapy Maria Narożna, Błażej Rubiś
575 [GO] 2021―Aug―12 SARS-CoV-2: Understanding the Transcriptional Regulation of ACE2 and TMPRSS2 and the Role of Single Nucleotide Polymorphism (SNP) at Codon 72 of p53 in the Innate Immune Response against Virus Infection Niraj Lodhi, Rubi Singh, Satya Prakash Rajput, Quaiser Saquib
576 [GO] 2021―Aug―11 Melatonin as a Potential Adjuvant Treatment for COVID-19 beyond Sleep Disorders Adam Wichniak, Aleksander Kania, Mariusz Siemiński, Wiesław Jerzy Cubała
577 [GO] 2021―Aug―10 Geraniin Inhibits the Entry of SARS-CoV-2 by Blocking the Interaction between Spike Protein RBD and Human ACE2 Receptor Young Soo Kim, Hwan-Suck Chung, Sang Gyun Noh, Bonggi Lee, Hae Young Chung, Jang-Gi Choi
578 [GO] 2021―Aug―09 Selenium Deficiency Due to Diet, Pregnancy, Severe Illness, or COVID-19-A Preventable Trigger for Autoimmune Disease Lutz Schomburg
579 [GO] 2021―Aug―09 Novel Nested-Seq Approach for SARS-CoV-2 Real-Time Epidemiology and In-Depth Mutational Profiling in Wastewater Margaritis Avgeris, Panagiotis G. Adamopoulos, Aikaterini Galani, Marieta Xagorari, Dimitrios Gourgiotis, Ioannis P. Trougakos, et al. (+4)
580 [GO] 2021―Aug―09 Interactions of Spike-RBD of SARS-CoV-2 and Platelet Factor 4: New Insights in the Etiopathogenesis of Thrombosis Margherita Passariello, Cinzia Vetrei, Felice Amato, Claudia De Lorenzo
581 [GO] 2021―Aug―06 Severe COVID-19 Patients Show an Increase in Soluble TNFR1 and ADAM17, with a Relationship to Mortality Yadira Palacios, Andy Ruiz, Lucero Ramón-Luing, Ranferi Ocaña-Guzman, Omar Barreto-Rodriguez, Anahí Sánchez-Monciváis, et al. (+12)
582 [GO] 2021―Aug―02 Role of the Renin-Angiotensin-Aldosterone and Kinin-Kallikrein Systems in the Cardiovascular Complications of COVID-19 and Long COVID Samantha L. Cooper, Eleanor Boyle, Sophie R. Jefferson, Calum R. A. Heslop, Pirathini Mohan, Gearry G. J. Mohanraj, et al. (+4)
583 [GO] 2021―Jul―30 Mitochondrial Modulations, Autophagy Pathways Shifts in Viral Infections: Consequences of COVID-19 Shailendra Pratap Singh, Salomon Amar, Pinky Gehlot, Sanjib K. Patra, Navjot Kanwar, Abhinav Kanwal
584 [GO] 2021―Jul―30 The Effects of Aβ1-42 Binding to the SARS-CoV-2 Spike Protein S1 Subunit and Angiotensin-Converting Enzyme 2 John Tsu-An Hsu, Chih-Feng Tien, Guann-Yi Yu, Santai Shen, Yi-Hsuan Lee, Pei-Chien Hsu, et al. (+4)
585 [GO] 2021―Jul―28 Acute Kidney Injury in COVID-19 Marta Głowacka, Sara Lipka, Ewelina Młynarska, Beata Franczyk, Jacek Rysz
586 [GO] 2021―Jul―28 SARS-CoV-2 Infected Pediatric Cerebral Cortical Neurons: Transcriptomic Analysis and Potential Role of Toll-like Receptors in Pathogenesis Agnese Gugliandolo, Luigi Chiricosta, Valeria Calcaterra, Mara Biasin, Gioia Cappelletti, Stephana Carelli, et al. (+5)
587 [GO] 2021―Jul―27 The Good and Bad of Nrf2: An Update in Cancer and New Perspectives in COVID-19 Sonia Emanuele, Adriana Celesia, Antonella D’Anneo, Marianna Lauricella, Daniela Carlisi, Anna De Blasio, Michela Giuliano
588 [GO] 2021―Jul―27 Mechanics Insights of Alpha-Lipoic Acid against Cardiovascular Diseases during COVID-19 Infection Luc Rochette, Steliana Ghibu
589 [GO] 2021―Jul―27 An Overview of Adipose Tissue ACE2 Modulation by Diet and Obesity. Potential Implications in COVID-19 Infection and Severity Saioa Gómez-Zorita, Iñaki Milton-Laskibar, Laura García-Arellano, Marcela González, María P. Portillo
590 [GO] 2021―Jul―26 Inflammatory Response in COVID-19 Patients Resulting from the Interaction of the Inflammasome and SARS-CoV-2 So Yeong Cheon, Bon-Nyeo Koo
591 [GO] 2021―Jul―26 Perspective of the Relationship between the Susceptibility to Initial SARS-CoV-2 Infectivity and Optimal Nasal Conditioning of Inhaled Air Ranjan Ramasamy
592 [GO] 2021―Jul―26 The Role of P-Selectin in COVID-19 Coagulopathy: An Updated Review Chiara Agrati, Alessandra Sacchi, Eleonora Tartaglia, Alessandra Vergori, Roberta Gagliardini, Alessandra Scarabello, Michele Bibas
593 [GO] 2021―Jul―26 Boosted Pro-Inflammatory Activity in Human PBMCs by Lipopolysaccharide and SARS-CoV-2 Spike Protein Is Regulated by α-1 Antitrypsin Srinu Tumpara, Anna R. Gründing, Kokilavani Sivaraman, Sabine Wrenger, Beata Olejnicka, Tobias Welte, et al. (+5)
594 [GO] 2021―Jul―21 Diabetic Nephropathy and COVID-19: The Potential Role of Immune Actors Diane Mourad, Nadim S. Azar, Sami T. Azar
595 [GO] 2021―Jul―19 Cigarette Smoke Stimulates SARS-CoV-2 Internalization by Activating AhR and Increasing ACE2 Expression in Human Gingival Epithelial Cells Cassio Luiz Coutinho Almeida-da-Silva, Harmony Matshik Dakafay, Kaitlyn Liu, David M. Ojcius
596 [GO] 2021―Jul―19 Support Vector Machine as a Supervised Learning for the Prioritization of Novel Potential SARS-CoV-2 Main Protease Inhibitors Nedra Mekni, Claudia Coronnello, Thierry Langer, Maria De Rosa, Ugo Perricone
597 [GO] 2021―Jul―16 Therapy of Type 2 Diabetes in Patients with SARS-CoV-2 Infection Weronika Bielka, Agnieszka Przezak, Andrzej Pawlik
598 [GO] 2021―Jul―15 Problems of Pathogenesis and Pathogenetic Therapy of COVID-19 from the Perspective of the General Theory of Pathological Systems (General Pathological Processes) Evgenii Gusev, Alexey Sarapultsev, Desheng Hu, Valeriy Chereshnev
599 [GO] 2021―Jul―14 Extension of Collagen Deposition in COVID-19 Post Mortem Lung Samples and Computed Tomography Analysis Findings Lorenzo Ball, Emanuela Barisione, Luca Mastracci, Michela Campora, Delfina Costa, Chiara Robba, et al. (+8)
600 [GO] 2021―Jul―13 Oxidative Stress and Inflammatory Biomarkers for the Prediction of Severity and ICU Admission in Unselected Patients Hospitalized with COVID-19 Morgane Ducastel, Camille Chenevier-Gobeaux, Yassine Ballaa, Jean-François Meritet, Michel Brack, Nicolas Chapuis, et al. (+6)
601 [GO] 2021―Jul―13 COVID-19 in Children: Expressions of Type I/II/III Interferons, TRIM28, SETDB1, and Endogenous Retroviruses in Mild and Severe Cases Pier-Angelo Tovo, Silvia Garazzino, Valentina Daprà, Giulia Pruccoli, Cristina Calvi, Federica Mignone, et al. (+8)
602 [GO] 2021―Jul―13 Role of Extracellular Vimentin in Cancer-Cell Functionality and Its Influence on Cell Monolayer Permeability Changes Induced by SARS-CoV-2 Receptor Binding Domain Divyendu Goud Thalla, Philipp Jung, Markus Bischoff, Franziska Lautenschläger
603 [GO] 2021―Jul―12 Structural Evaluation of the Spike Glycoprotein Variants on SARS-CoV-2 Transmission and Immune Evasion Mohd Zulkifli Salleh, Jeremy P. Derrick, Zakuan Zainy Deris
604 [GO] 2021―Jul―05 Conventional and Unconventional Approaches for Innovative Drug Treatments in COVID-19: Looking Outside of Plato’s Cave George J. Kontoghiorghes, Annita Kolnagou, Stella Fetta, Christina N. Kontoghiorghe
605 [GO] 2021―Jul―01 Possible Link between SARS-CoV-2 Infection and Parkinson’s Disease: The Role of Toll-Like Receptor 4 Carmela Conte
606 [GO] 2021―Jul―01 Molecular Mechanisms of Palmitic Acid Augmentation in COVID-19 Pathologies Christie Joshi, Viren Jadeja, Heping Zhou
607 [GO] 2021―Jul―01 Albumin Infusion in Critically Ill COVID-19 Patients: Hemodilution and Anticoagulation Giuliano Ramadori
608 [GO] 2021―Jun―30 Structure-Based Virtual Screening Reveals Ibrutinib and Zanubrutinib as Potential Repurposed Drugs against COVID-19 Satyavani Kaliamurthi, Gur�an Selvaraj, Chandrabose Selvaraj, Sanjeev Kumar Singh, Dong-Qing Wei, Gilles H. Peslherbe
609 [GO] 2021―Jun―30 Identification of 13 Guanidinobenzoyl- or Aminidinobenzoyl-Containing Drugs to Potentially Inhibit TMPRSS2 for COVID-19 Treatment Xiaoqiang Huang, Robin Pearce, Gilbert S. Omenn, Yang Zhang
610 [GO] 2021―Jun―30 Pathophysiology and Clinical Manifestations of COVID-19-Related Acute Kidney Injury-The Current State of Knowledge and Future Perspectives Iwona Smarz-Widelska, Ewelina Grywalska, Izabela Morawska, Alicja Forma, Adam Michalski, Sebastian Mertowski, et al. (+5)
611 [GO] 2021―Jun―30 Seleno-Functionalization of Quercetin Improves the Non-Covalent Inhibition of Mpro and Its Antiviral Activity in Cells against SARS-CoV-2 Francesca Mangiavacchi, Pawel Botwina, Elena Menichetti, Luana Bagnoli, Ornelio Rosati, Francesca Marini, et al. (+16)
612 [GO] 2021―Jun―29 C9orf72 Intermediate Repeats Confer Genetic Risk for Severe COVID-19 Pneumonia Independently of Age Isabella Zanella, Eliana Zacchi, Simone Piva, Massimiliano Filosto, Giada Beligni, Diana Alaverdian, et al. (+8)
613 [GO] 2021―Jun―29 Innate Immune Response to SARS-CoV-2 Infection: From Cells to Soluble Mediators Daniela Ricci, Marilena Paola Etna, Fabiana Rizzo, Silvia Sandini, Martina Severa, Eliana Marina Coccia
614 [GO] 2021―Jun―29 Does the SARS-CoV-2 Spike Protein Receptor Binding Domain Interact Effectively with the DPP4 (CD26) Receptor? A Molecular Docking Study Kirsten Cameron, Lina Rozano, Marco Falasca, Ricardo L. Mancera
615 [GO] 2021―Jun―28 COVID-19 Lockdowns May Reduce Resistance Genes Diversity in the Human Microbiome and the Need for Antibiotics João S. Rebelo, Célia P. F. Domingues, Francisco Dionisio, Manuel C. Gomes, Ana Botelho, Teresa Nogueira
616 [GO] 2021―Jun―28 De novo ssRNA Aptamers against the SARS-CoV-2 Main Protease: In Silico Design and Molecular Dynamics Simulation Francesco Morena, Chiara Argentati, Ilaria Tortorella, Carla Emiliani, Sabata Martino
617 [GO] 2021―Jun―28 Imatinib (STI571) Inhibits the Expression of Angiotensin-Converting Enzyme 2 and Cell Entry of the SARS-CoV-2-Derived Pseudotyped Viral Particles You-Zhe Lin, Yi-Chun Shen, Wan-Rong Wu, Wei-Jan Wang, Yuan-Liang Wang, Chen-Yuan Lin, et al. (+2)
618 [GO] 2021―Jun―28 Brain Mechanisms of COVID-19-Sleep Disorders Oxana Semyachkina-Glushkovskaya, Aysel Mamedova, Valeria Vinnik, Maria Klimova, Elena Saranceva, Vasily Ageev, et al. (+4)
619 [GO] 2021―Jun―23 Do Changes in ACE-2 Expression Affect SARS-CoV-2 Virulence and Related Complications: A Closer Look into Membrane-Bound and Soluble Forms Huseyin C. Yalcin, Vijayakumar Sukumaran, Mahmoud Khatib A. A. Al-Ruweidi, Samar Shurbaji
620 [GO] 2021―Jun―23 Dexamethasone for Severe COVID-19: How Does It Work at Cellular and Molecular Levels? Tomoshige Kino, Irina Burd, James H. Segars
621 [GO] 2021―Jun―23 Comparative Anti-Inflammatory Effects of Salix Cortex Extracts and Acetylsalicylic Acid in SARS-CoV-2 Peptide and LPS-Activated Human In Vitro Systems Nguyen Phan Khoi Le, Corinna Herz, João Victor Dutra Gomes, Nadja Förster, Kyriaki Antoniadou, Verena Karolin Mittermeier-Kleßinger, et al. (+4)
622 [GO] 2021―Jun―21 Inflammatory Mechanisms in COVID-19 and Atherosclerosis: Current Pharmaceutical Perspectives Marios Sagris, Panagiotis Theofilis, Alexios S. Antonopoulos, Costas Tsioufis, Evangelos Oikonomou, Charalambos Antoniades, et al. (+3)
623 [GO] 2021―Jun―21 Heparan Sulfate Proteoglycans in Viral Infection and Treatment: A Special Focus on SARS-CoV-2 Valeria De Pasquale, Miriam Shasa Quiccione, Simona Tafuri, Luigi Avallone, Luigi Michele Pavone
624 [GO] 2021―Jun―18 SARS-CoV-2 Infection and Significance of Oral Health Management in the Era of “the New Normal with COVID-19” Kenichi Imai, Hajime Tanaka
625 [GO] 2021―Jun―18 Studying SARS-CoV-2 with Fluorescence Microscopy Lidia V. Putlyaeva, Konstantin A. Lukyanov
626 [GO] 2021―Jun―18 Estrogen Receptor Modulators in Viral Infections Such as SARS-CoV-2: Therapeutic Consequences Nikita Abramenko, Fréderic Vellieux, Petra Tesařová, Zdeněk Kejík, Robert Kaplánek, Lukáš Lacina, et al. (+6)
627 [GO] 2021―Jun―17 The Functional Consequences of the Novel Ribosomal Pausing Site in SARS-CoV-2 Spike Glycoprotein RNA Olga A. Postnikova, Sheetal Uppal, Weiliang Huang, Maureen A. Kane, Rafael Villasmil, Igor B. Rogozin, et al. (+2)
628 [GO] 2021―Jun―17 Antiviral Activity of Two Marine Carotenoids against SARS-CoV-2 Virus Entry In Silico and In Vitro Sung-Kun Yim, Inhee Kim, Boyd Warren, Jungwon Kim, Kyoojin Jung, Bosung Ku
629 [GO] 2021―Jun―17 More Is Always Better Than One: The N-Terminal Domain of the Spike Protein as Another Emerging Target for Hampering the SARS-CoV-2 Attachment to Host Cells Sonia Di Gaetano, Domenica Capasso, Pietro Delre, Luciano Pirone, Michele Saviano, Emilia Pedone, Giuseppe Felice Mangiatordi
630 [GO] 2021―Jun―07 Evidence for Biological Age Acceleration and Telomere Shortening in COVID-19 Survivors Alessia Mongelli, Veronica Barbi, Michela Gottardi Zamperla, Sandra Atlante, Luana Forleo, Marialisa Nesta, et al. (+11)
631 [GO] 2021―Jun―07 In Silico and In Vitro Analyses Validate Human MicroRNAs Targeting the SARS-CoV-2 3′-UTR María Asunción Barreda-Manso, Manuel Nieto-Díaz, Altea Soto, Teresa Muñoz-Galdeano, David Reigada, Rodrigo M. Maza
632 [GO] 2021―Jun―07 Nucleic Acid Testing of SARS-CoV-2 Hee Min Yoo, Il-Hwan Kim, Seil Kim
633 [GO] 2021―Jun―01 Extracellular Vesicles: Versatile Nanomediators, Potential Biomarkers and Therapeutic Agents in Atherosclerosis and COVID-19-Related Thrombosis Adriana Georgescu, Maya Simionescu
634 [GO] 2021―Jun―01 Multifaced Roles of HDL in Sepsis and SARS-CoV-2 Infection: Renal Implications Alessandra Stasi, Rossana Franzin, Marco Fiorentino, Enrico Squiccimarro, Giuseppe Castellano, Loreto Gesualdo
635 [GO] 2021―Jun―01 A Screening of the MMV Pandemic Response Box Reveals Epetraborole as A New Potent Inhibitor against Mycobacterium abscessus Taeho Kim, Bui-Thi-Bich Hanh, Boeun Heo, Nguyenthanh Quang, Yujin Park, Jihyeon Shin, et al. (+4)
636 [GO] 2021―Jun―01 Autophagy, Unfolded Protein Response, and Neuropilin-1 Cross-Talk in SARS-CoV-2 Infection: What Can Be Learned from Other Coronaviruses Morvarid Siri, Sanaz Dastghaib, Mozhdeh Zamani, Nasim Rahmani-Kukia, Kiarash Roustai Geraylow, Shima Fakher, et al. (+6)
637 [GO] 2021―May―31 The Significance of COVID-19 Immunological Status in Severe Neurological Complications and Multiple Sclerosis-A Literature Review Joanna Kulikowska, Agnieszka Kulczyńska-Przybik, Barbara Mroczko, Alina Kułakowska
638 [GO] 2021―May―28 The Immunological Role of the Placenta in SARS-CoV-2 Infection-Viral Transmission, Immune Regulation, and Lactoferrin Activity Iwona Bukowska-Ośko, Marta Popiel, Paweł Kowalczyk
639 [GO] 2021―May―28 Detection of SARS-CoV-2 RNA by a Multiplex Reverse-Transcription Loop-Mediated Isothermal Amplification Coupled with Melting Curves Analysis Igor P. Oscorbin, Georgiy Yu. Shevelev, Ksenia A. Pronyaeva, Andrey A. Stepanov, Darya V. Shamovskaya, Olga V. Mishukova, et al. (+2)
640 [GO] 2021―May―26 Induction of the Proinflammatory Chemokine Interleukin-8 Is Regulated by Integrated Stress Response and AP-1 Family Proteins Activated during Coronavirus Infection Qing Chun Zhu, Shumin Li, Li Xia Yuan, Rui Ai Chen, Ding Xiang Liu, To Sing Fung
641 [GO] 2021―May―26 Could Histamine H1 Receptor Antagonists Be Used for Treating COVID-19? Changbo Qu, Gwenny M. Fuhler, Yihang Pan
642 [GO] 2021―May―24 Possible Beneficial Actions of Caffeine in SARS-CoV-2 Bianca S. Romero-Martínez, Luis M. Montaño, Héctor Solís-Chagoyán, Bettina Sommer, Gemma Lizbeth Ramírez-Salinas, Gloria E. Pérez-Figueroa, Edgar Flores-Soto
643 [GO] 2021―May―21 Can the COVID-19 Pandemic Disrupt the Current Drug Development Practices? Jung-Hyun Won, Howard Lee
644 [GO] 2021―May―21 The Molecular Basis of COVID-19 Pathogenesis, Conventional and Nanomedicine Therapy Shirin Kouhpayeh, Laleh Shariati, Maryam Boshtam, Ilnaz Rahimmanesh, Mina Mirian, Yasaman Esmaeili, et al. (+7)
645 [GO] 2021―May―21 Existing Drugs Considered as Promising in COVID-19 Therapy Edyta Janik, Marcin Niemcewicz, Marcin Podogrocki, Joanna Saluk-Bijak, Michal Bijak
646 [GO] 2021―May―20 The Emerging Role of Neutrophils in the Pathogenesis of Thrombosis in COVID-19 Valeria Iliadi, Ina Konstantinidou, Konstantina Aftzoglou, Sergios Iliadis, Theocharis G. Konstantinidis, Christina Tsigalou
647 [GO] 2021―May―20 Regulatory Noncoding and Predicted Pathogenic Coding Variants of CCR5 Predispose to Severe COVID-19 Sueva Cantalupo, Vito Alessandro Lasorsa, Roberta Russo, Immacolata Andolfo, Giuseppe D’Alterio, Barbara Eleni Rosato, et al. (+15)
648 [GO] 2021―May―19 Contribution of Syndecans to the Cellular Entry of SARS-CoV-2 Anett Hudák, Annamária Letoha, László Szilák, Tamás Letoha
649 [GO] 2021―May―17 Immunological Aspects of SARS-CoV-2 Infection and the Putative Beneficial Role of Vitamin-D Ming-Yieh Peng, Wen-Chih Liu, Jing-Quan Zheng, Chien-Lin Lu, Yi-Chou Hou, Cai-Mei Zheng, et al. (+3)
650 [GO] 2021―May―13 Pathophysiological Association of Endothelial Dysfunction with Fatal Outcome in COVID-19 Tatsuya Maruhashi, Yukihito Higashi
651 [GO] 2021―May―10 Does Genetic Predisposition Contribute to the Exacerbation of COVID-19 Symptoms in Individuals with Comorbidities and Explain the Huge Mortality Disparity between the East and the West? Naoki Yamamoto, Rain Yamamoto, Yasuo Ariumi, Masashi Mizokami, Kunitada Shimotohno, Hiroshi Yoshikura
652 [GO] 2021―May―07 High Levels of the Cleaved Form of Galectin-9 and Osteopontin in the Plasma Are Associated with Inflammatory Markers That Reflect the Severity of COVID-19 Pneumonia Gaowa Bai, Daisuke Furushima, Toshiro Niki, Takashi Matsuba, Yosuke Maeda, Atsushi Takahashi, et al. (+2)
653 [GO] 2021―May―07 IgM and IgG Immunoreactivity of SARS-CoV-2 Recombinant M Protein Zorana Lopandić, Isidora Protić-Rosić, Aleksandra Todorović, Sofija Glamočlija, Marija Gnjatović, Danica Ćujic, Marija Gavrović-Jankulović
654 [GO] 2021―May―02 The Interference between SARS-CoV-2 and Tyrosine Kinase Receptor Signaling in Cancer Oana-Stefana Purcaru, Stefan-Alexandru Artene, Edmond Barcan, Cristian Adrian Silosi, Ilona Stanciu, Suzana Danoiu, et al. (+3)
655 [GO] 2021―Apr―30 Metabolic Signatures Associated with Severity in Hospitalized COVID-19 Patients Judith Marín-Corral, Jose Rodríguez-Morató, Alex Gomez-Gomez, Sergi Pascual-Guardia, Rosana Muñoz-Bermúdez, Anna Salazar-Degracia, et al. (+6)
656 [GO] 2021―Apr―29 ACE2 Is an Adjacent Element of Atherosclerosis and COVID-19 Pathogenesis Anastasia V. Poznyak, Evgeny E. Bezsonov, Ali H. Eid, Tatyana V. Popkova, Ludmila V. Nedosugova, Antonina V. Starodubova, Alexander N. Orekhov
657 [GO] 2021―Apr―27 Effects of SARS-CoV-2 on Cardiovascular System: The Dual Role of Angiotensin-Converting Enzyme 2 (ACE2) as the Virus Receptor and Homeostasis Regulator-Review Aneta Aleksova, Giulia Gagno, Gianfranco Sinagra, Antonio Paolo Beltrami, Milijana Janjusevic, Giuseppe Ippolito, et al. (+3)
658 [GO] 2021―Apr―27 Dysregulation of the Renin-Angiotensin-Aldosterone System (RAA) in Patients Infected with SARS-CoV-2-Possible Clinical Consequences Agnieszka Dettlaff-Pokora, Julian Swierczynski
659 [GO] 2021―Apr―27 PIMS-TS, the New Paediatric Systemic Inflammatory Disease Related to Previous Exposure to SARS-CoV-2 Infection-“Rheumatic Fever” of the 21st Century? Violetta Opoka-Winiarska, Ewelina Grywalska, Jacek Roliński
660 [GO] 2021―Apr―26 SARS-CoV-2 Viral Entry Proteins in Hyperandrogenemic Female Mice: Implications for Women with PCOS and COVID-19 Alexandra M. Huffman, Samar Rezq, Jelina Basnet, Licy L. Yanes Cardozo, Damian G. Romero
661 [GO] 2021―Apr―19 COVID-19: Direct and Indirect Mechanisms of Statins Agnieszka Pawlos, Mateusz Niedzielski, Paulina Gorzelak-Pabiś, Marlena Broncel, Ewelina Woźniak
662 [GO] 2021―Apr―15 Pharmacological Modulators of Autophagy as a Potential Strategy for the Treatment of COVID-19 Gustavo José da Silva Pereira, Anderson Henrique França Figueredo Leão, Adolfo Garcia Erustes, Ingrid Beatriz de Melo Morais, Talita Aparecida de Moraes Vrechi, Lucas dos Santos Zamarioli, et al. (+9)
663 [GO] 2021―Apr―15 Cardiovascular Outcomes in the Acute Phase of COVID-19 Hiroki Nakano, Kazuki Shiina, Hirofumi Tomiyama
664 [GO] 2021―Apr―15 Neurological Complications of COVID-19: Underlying Mechanisms and Management Ghaydaa A. Shehata, Kevin C. Lord, Michaela C. Grudzinski, Mohamed Elsayed, Ramy Abdelnaby, Hatem A. Elshabrawy
665 [GO] 2021―Apr―12 SARS-CoV-2 Papain-Like Protease Potential Inhibitors-In Silico Quantitative Assessment Adam Stasiulewicz, Alicja W. Maksymiuk, Mai Lan Nguyen, Barbara Bełza, Joanna I. Sulkowska
666 [GO] 2021―Apr―08 Influence of Previous COVID-19 and Mastitis Infections on the Secretion of Brain-Derived Neurotrophic Factor and Nerve Growth Factor in Human Milk Veronique Demers-Mathieu, Dustin J. Hines, Rochelle M. Hines, Sirima Lavangnananda, Shawn Fels, Elena Medo
667 [GO] 2021―Apr―06 Corticosteroids for COVID-19 Therapy: Potential Implications on Tuberculosis Radha Gopalaswamy, Selvakumar Subbian
668 [GO] 2021―Mar―26 Ribosome-Profiling Reveals Restricted Post Transcriptional Expression of Antiviral Cytokines and Transcription Factors during SARS-CoV-2 Infection Marina R. Alexander, Aaron M. Brice, Petrus Jansen van Vuren, Christina L. Rootes, Leon Tribolet, Christopher Cowled, et al. (+2)
669 [GO] 2021―Mar―22 Susceptibility and Severity of Viral Infections in Obesity: Lessons from Influenza to COVID-19. Does Leptin Play a Role? Valeria Guglielmi, Luca Colangeli, Monica D’Adamo, Paolo Sbraccia
670 [GO] 2021―Mar―22 Exosomes from COVID-19 Patients Carry Tenascin-C and Fibrinogen-β in Triggering Inflammatory Signals in Cells of Distant Organ Subhayan Sur, Mousumi Khatun, Robert Steele, T. Scott Isbell, Ranjit Ray, Ratna B. Ray
671 [GO] 2021―Mar―22 Identification of Anti-Severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Oxysterol Derivatives In Vitro Hirofumi Ohashi, Feng Wang, Frank Stappenbeck, Kana Tsuchimoto, Chisa Kobayashi, Wakana Saso, et al. (+10)
672 [GO] 2021―Mar―22 Renin-Angiotensin-Aldosterone System: Friend or Foe-The Matter of Balance. Insight on History, Therapeutic Implications and COVID-19 Interactions Fedor Simko, Jaroslav Hrenak, Michaela Adamcova, Ludovit Paulis
673 [GO] 2021―Mar―19 Dietary and Protective Factors to Halt or Mitigate Progression of Autoimmunity, COVID-19 and Its Associated Metabolic Diseases Camillo Ricordi, Francesca Pacifici, Giacomo Lanzoni, Anna Teresa Palamara, Enrico Garaci, David Della-Morte
674 [GO] 2021―Mar―17 Therapeutic Role of Tocilizumab in SARS-CoV-2-Induced Cytokine Storm: Rationale and Current Evidence Corrado Pelaia, Cecilia Calabrese, Eugenio Garofalo, Andrea Bruni, Alessandro Vatrella, Girolamo Pelaia
675 [GO] 2021―Mar―17 SARS-CoV-2 Entry Related Viral and Host Genetic Variations: Implications on COVID-19 Severity, Immune Escape, and Infectivity Szu-Wei Huang, Sheng-Fan Wang
676 [GO] 2021―Mar―16 Fecal Microbiota Transplantation during and Post-COVID-19 Pandemic Negin Kazemian, Dina Kao, Sepideh Pakpour
677 [GO] 2021―Mar―15 Do COVID-19 Infections Result in a Different Form of Secondary Hemophagocytic Lymphohistiocytosis Raymond Chu, Charmaine van Eeden, Sneha Suresh, Wendy I. Sligl, Mohammed Osman, Jan Willem Cohen Tervaert
678 [GO] 2021―Mar―15 Metal-Bound Methisazone; Novel Drugs Targeting Prophylaxis and Treatment of SARS-CoV-2, a Molecular Docking Study Ahmed Abdelaal Ahmed Mahmoud M. Alkhatip, Michail Georgakis, Lucio R. Montero Valenzuela, Mohamed Hamza, Ehab Farag, Jaqui Hodgkinson, et al. (+12)
679 [GO] 2021―Mar―10 A Novel Computational Approach for the Discovery of Drug Delivery System Candidates for COVID-19 Taeheum Cho, Hyo-Sang Han, Junhyuk Jeong, Eun-Mi Park, Kyu-Sik Shim
680 [GO] 2021―Mar―08 Interactions of SARS-CoV-2 with the Blood-Brain Barrier Michelle A. Erickson, Elizabeth M. Rhea, Rachel C. Knopp, William A. Banks
681 [GO] 2021―Mar―08 Towards Quantitative and Standardized Serological and Neutralization Assays for COVID-19 Linhua Tian, Elzafir B. Elsheikh, Paul N. Patrone, Anthony J. Kearsley, Adolfas K. Gaigalas, Sarah Inwood, et al. (+3)
682 [GO] 2021―Mar―05 The Role of Immunogenetics in COVID-19 Fanny Pojero, Giuseppina Candore, Calogero Caruso, Danilo Di Bona, David A. Groneberg, Mattia E. Ligotti, et al. (+2)
683 [GO] 2021―Mar―05 Population-Predicted MHC Class II Epitope Presentation of SARS-CoV-2 Structural Proteins Correlates to the Case Fatality Rates of COVID-19 in Different Countries Chunguang Liang, Elena Bencurova, Eric Psota, Priya Neurgaonkar, Martina Prelog, Carsten Scheller, Thomas Dandekar
684 [GO] 2021―Mar―05 CNBP Binds and Unfolds In Vitro G-Quadruplexes Formed in the SARS-CoV-2 Positive and Negative Genome Strands Georgina Bezzi, Ernesto J. Piga, Andrés Binolfi, Pablo Armas
685 [GO] 2021―Mar―01 Nutraceuticals in the Prevention of Viral Infections, Including COVID-19, among the Pediatric Population: A Review of the Literature Giuseppe Fabio Parisi, Giuseppe Carota, Carlo Castruccio Castracani, Mariarita Spampinato, Sara Manti, Maria Papale, et al. (+3)
686 [GO] 2021―Mar―01 COVID-19 and Diagnostic Testing for SARS-CoV-2 by RT-qPCR-Facts and Fallacies Stephen Bustin, Reinhold Mueller, Gregory Shipley, Tania Nolan
687 [GO] 2021―Feb―27 SARS-CoV-2 Infection and Disease Modelling Using Stem Cell Technology and Organoids Marta Trevisan, Silvia Riccetti, Alessandro Sinigaglia, Luisa Barzon
688 [GO] 2021―Feb―22 Innate Receptor Activation Patterns Involving TLR and NLR Synergisms in COVID-19, ALI/ARDS and Sepsis Cytokine Storms: A Review and Model Making Novel Predictions and Therapeutic Suggestions Robert Root-Bernstein
689 [GO] 2021―Feb―20 Computational Selectivity Assessment of Protease Inhibitors against SARS-CoV-2 André Fischer, Manuel Sellner, Karolina Mitusińska, Maria Bzówka, Markus A. Lill, Artur Góra, Martin Smieško
690 [GO] 2021―Feb―18 Opportunities, Challenges and Pitfalls of Using Cannabidiol as an Adjuvant Drug in COVID-19 Barbara Malinowska, Marta Baranowska-Kuczko, Aleksandra Kicman, Eberhard Schlicker
691 [GO] 2021―Feb―17 Adjunctive Nutraceutical Therapies for COVID-19 Lalita Subedi, Stephanie Tchen, Bhakta Prasad Gaire, Bingren Hu, Kurt Hu
692 [GO] 2021―Feb―15 Neutralizing Human Antibodies against Severe Acute Respiratory Syndrome Coronavirus 2 Isolated from a Human Synthetic Fab Phage Display Library Yu Jung Kim, Min Ho Lee, Se-Ra Lee, Hyo-Young Chung, Kwangmin Kim, Tae Gyu Lee, Dae Young Kim
693 [GO] 2021―Feb―14 Bioactive Alkaloids from Genus Aspergillus: Mechanistic Interpretation of Their Antimicrobial and Potential SARS-CoV-2 Inhibitory Activity Using Molecular Modelling Fadia S. Youssef, Elham Alshammari, Mohamed L. Ashour
694 [GO] 2021―Feb―13 Platelet Lysate Nebulization Protocol for the Treatment of COVID-19 and Its Sequels: Proof of Concept and Scientific Rationale Maider Beitia, Diego Delgado, Pello Sánchez, Ana Vallejo de la Cueva, José Ramón Cugat, Mikel Sánchez
695 [GO] 2021―Feb―12 Human Milk Antibodies Against S1 and S2 Subunits from SARS-CoV-2, HCoV-OC43, and HCoV-229E in Mothers with A Confirmed COVID-19 PCR, Viral SYMPTOMS, and Unexposed Mothers Veronique Demers-Mathieu, Ciera DaPra, Gabrielle Mathijssen, David A. A. Sela, Kirsi M. M. Jarvinen, Antti Seppo, et al. (+2)
696 [GO] 2021―Feb―12 Detection of Coronaviruses Using RNA Toehold Switch Sensors Soan Park, Jeong Wook Lee
697 [GO] 2021―Feb―12 Drugs, Metabolites, and Lung Accumulating Small Lysosomotropic Molecules: Multiple Targeting Impedes SARS-CoV-2 Infection and Progress to COVID-19 Markus Blaess, Lars Kaiser, Oliver Sommerfeld, René Csuk, Hans-Peter Deigner
698 [GO] 2021―Feb―12 The Impact of SARS-CoV-2 Infection on the Development of Neurodegeneration in Multiple Sclerosis Angela Dziedzic, Joanna Saluk-Bijak, Elzbieta Miller, Marcin Niemcewicz, Michal Bijak
699 [GO] 2021―Feb―10 Understanding Viral Infection Mechanisms and Patient Symptoms for the Development of COVID-19 Therapeutics Hyung Muk Choi, Soo Youn Moon, Hyung In Yang, Kyoung Soo Kim
700 [GO] 2021―Feb―10 ERAP1 and ERAP2 Enzymes: A Protective Shield for RAS against COVID-19? Silvia D’Amico, Patrizia Tempora, Valeria Lucarini, Ombretta Melaiu, Stefania Gaspari, Mattia Algeri, Doriana Fruci
701 [GO] 2021―Feb―10 In Silico Investigation of the New UK (B.1.1.7) and South African (501Y.V2) SARS-CoV-2 Variants with a Focus at the ACE2-Spike RBD Interface Bruno O. Villoutreix, Vincent Calvez, Anne-Geneviève Marcelin, Abdel-Majid Khatib
702 [GO] 2021―Feb―09 Viral Infection and Cardiovascular Disease: Implications for the Molecular Basis of COVID-19 Pathogenesis Sarah Seeherman, Yuichiro J. Suzuki
703 [GO] 2021―Feb―05 Tryptophan Metabolites and Aryl Hydrocarbon Receptor in Severe Acute Respiratory Syndrome, Coronavirus-2 (SARS-CoV-2) Pathophysiology George Anderson, Annalucia Carbone, Gianluigi Mazzoccoli
704 [GO] 2021―Feb―04 Comparison of Antiviral Activity of Gemcitabine with 2′-Fluoro-2′-Deoxycytidine and Combination Therapy with Remdesivir against SARS-CoV-2 Yejin Jang, Jin Soo Shin, Myoung Kyu Lee, Eunhye Jung, Timothy An, Uk-Il Kim, et al. (+2)
705 [GO] 2021―Feb―04 Predicting Potential SARS-COV-2 Drugs-In Depth Drug Database Screening Using Deep Neural Network Framework SSnet, Classical Virtual Screening and Docking Nischal Karki, Niraj Verma, Francesco Trozzi, Peng Tao, Elfi Kraka, Brian Zoltowski
706 [GO] 2021―Jan―30 Pseudo-Dipeptide Bearing α,α-Difluoromethyl Ketone Moiety as Electrophilic Warhead with Activity against Coronaviruses Andrea Citarella, Davide Gentile, Antonio Rescifina, Anna Piperno, Barbara Mognetti, Giorgio Gribaudo, et al. (+4)
707 [GO] 2021―Jan―30 Predicting Potential SARS-COV-2 Drugs-In Depth Drug Database Screening Using Deep Neural Network Framework SSnet, Classical Virtual Screening and Docking Nischal Karki, Niraj Verma, Francesco Trozzi, Peng Tao, Elfi Kraka, Brian Zoltowski
708 [GO] 2021―Jan―29 Expression of the SARS-CoV-2 Receptor ACE2 and Proinflammatory Cytokines Induced by the Periodontopathic Bacterium Fusobacterium nucleatum in Human Respiratory Epithelial Cells Yuwa Takahashi, Norihisa Watanabe, Noriaki Kamio, Sho Yokoe, Ryuta Suzuki, Shuichi Sato, et al. (+2)
709 [GO] 2021―Jan―28 Summary of the Available Molecular Methods for Detection of SARS-CoV-2 during the Ongoing Pandemic Fabio Arena, Simona Pollini, Gian Maria Rossolini, Maurizio Margaglione
710 [GO] 2021―Jan―28 The Central Role of Fibrinolytic Response in COVID-19-A Hematologist’s Perspective Hau C. Kwaan, Paul F. Lindholm
711 [GO] 2021―Jan―26 Mediterranean Diet for the Prevention of Gestational Diabetes in the Covid-19 Era: Implications of Il-6 In Diabesity Anna Lucia Fedullo, Antonio Schiattarella, Maddalena Morlando, Anna Raguzzini, Elisabetta Toti, Pasquale De Franciscis, Ilaria Peluso
712 [GO] 2021―Jan―25 A Missing Link: Engagements of Dendritic Cells in the Pathogenesis of SARS-CoV-2 Infections Abdulaziz Alamri, Derek Fisk, Deepak Upreti, Sam K. P. Kung
713 [GO] 2021―Jan―20 Can SARS-CoV-2 Virus Use Multiple Receptors to Enter Host Cells? Laura Kate Gadanec, Kristen Renee McSweeney, Tawar Qaradakhi, Benazir Ali, Anthony Zulli, Vasso Apostolopoulos
714 [GO] 2021―Jan―20 A Novel Approach to the Bioluminescent Detection of the SARS-CoV-2 ORF1ab Gene by Coupling Isothermal RNA Reverse Transcription Amplification with a Digital PCR Approach Zhongjie Fei, Rongbin Wei, Chu Cheng, Pengfeng Xiao
715 [GO] 2021―Jan―19 The Immunopathological and Histological Landscape of COVID-19-Mediated Lung Injury Giovanni Zarrilli, Valentina Angerilli, Gianluca Businello, Marta Sbaraglia, Giulia Traverso, Francesco Fortarezza, et al. (+6)
716 [GO] 2021―Jan―08 Mapping the SARS-CoV-2-Host Protein-Protein Interactome by Affinity Purification Mass Spectrometry and Proximity-Dependent Biotin Labeling: A Rational and Straightforward Route to Discover Host-Directed Anti-SARS-CoV-2 Therapeutics Rosa Terracciano, Mariaimmacolata Preianò, Annalisa Fregola, Corrado Pelaia, Tiziana Montalcini, Rocco Savino
717 [GO] 2021―Jan―01 Unpacking Pandora From Its Box: Deciphering the Molecular Basis of the SARS-CoV-2 Coronavirus Valerie Bríd O’Leary, Oliver James Dolly, Cyril Höschl, Marie Černa, Saak Victor Ovsepian
718 [GO] 2020―Dec―23 Multiple Recombination Events and Strong Purifying Selection at the Origin of SARS-CoV-2 Spike Glycoprotein Increased Correlated Dynamic Movements Massimiliano S. Tagliamonte, Nabil Abid, Stefano Borocci, Elisa Sangiovanni, David A. Ostrov, Sergei L. Kosakovsky Pond, et al. (+3)
719 [GO] 2020―Dec―22 The Current Status of Drug Repositioning and Vaccine Developments for the COVID-19 Pandemic Jung-Hyun Won, Howard Lee
720 [GO] 2020―Dec―21 Vascular Endothelial Glycocalyx Damage in COVID-19 Minako Yamaoka-Tojo
721 [GO] 2020―Dec―16 Antimicrobial and Amyloidogenic Activity of Peptides. Can Antimicrobial Peptides Be Used against SARS-CoV-2? Stanislav R. Kurpe, Sergei Yu. Grishin, Alexey K. Surin, Alexander V. Panfilov, Mikhail V. Slizen, Saikat D. Chowdhury, Oxana V. Galzitskaya
722 [GO] 2020―Dec―15 Identification of Host Cellular Protein Substrates of SARS-COV-2 Main Protease Márió Miczi, Mária Golda, Balázs Kunkli, Tibor Nagy, József Tőzsér, János András Mótyán
723 [GO] 2020―Dec―07 The Contribution of Endothelial Dysfunction in Systemic Injury Subsequent to SARS-Cov-2 Infection Jessica Maiuolo, Rocco Mollace, Micaela Gliozzi, Vincenzo Musolino, Cristina Carresi, Sara Paone, et al. (+9)
724 [GO] 2020―Dec―04 Interrelated Mechanism by Which the Methide Quinone Celastrol, Obtained from the Roots of Tripterygium wilfordii, Inhibits Main Protease 3CLpro of COVID-19 and Acts as Superoxide Radical Scavenger Francesco Caruso, Manrose Singh, Stuart Belli, Molly Berinato, Miriam Rossi
725 [GO] 2020―Dec―02 Establishment of Murine Hybridoma Cells Producing Antibodies against Spike Protein of SARS-CoV-2 Nadezhda V. Antipova, Tatyana D. Larionova, Andrei E. Siniavin, Maria A. Nikiforova, Vladimir A. Gushchin, Igor I. Babichenko, et al. (+3)
726 [GO] 2020―Nov―23 Immune-Modulating Drug MP1032 with SARS-CoV-2 Antiviral Activity In Vitro: A potential Multi-Target Approach for Prevention and Early Intervention Treatment of COVID-19 Sara Schumann, Astrid Kaiser, Ferdinando Nicoletti, Katia Mangano, Paolo Fagone, Eduard van Wijk, et al. (+9)
727 [GO] 2020―Nov―17 The Rationale for Angiotensin Receptor Neprilysin Inhibitors in a Multi-Targeted Therapeutic Approach to COVID-19 Alessandro Bellis, Ciro Mauro, Emanuele Barbato, Bruno Trimarco, Carmine Morisco
728 [GO] 2020―Nov―17 Large-Scale Plasma Analysis Revealed New Mechanisms and Molecules Associated with the Host Response to SARS-CoV-2 Elettra Barberis, Sara Timo, Elia Amede, Virginia V. Vanella, Chiara Puricelli, Giuseppe Cappellano, et al. (+19)
729 [GO] 2020―Nov―09 Cardiovascular Active Peptides of Marine Origin with ACE Inhibitory Activities: Potential Role as Anti-Hypertensive Drugs and in Prevention of SARS-CoV-2 Infection Marco Festa, Clementina Sansone, Christophe Brunet, Fabio Crocetta, Luisa Di Paola, Michele Lombardo, et al. (+3)
730 [GO] 2020―Nov―05 Coevolution, Dynamics and Allostery Conspire in Shaping Cooperative Binding and Signal Transmission of the SARS-CoV-2 Spike Protein with Human Angiotensin-Converting Enzyme 2 Gennady Verkhivker
731 [GO] 2020―Nov―03 Erythrocyte, Platelet, Serum Ferritin, and P-Selectin Pathophysiology Implicated in Severe Hypercoagulation and Vascular Complications in COVID-19 Chantelle Venter, Johannes Andries Bezuidenhout, Gert Jacobus Laubscher, Petrus Johannes Lourens, Janami Steenkamp, Douglas B. Kell, Etheresia Pretorius
732 [GO] 2020―Oct―31 Cardiovascular Disease and SARS-CoV-2: the Role of Host Immune Response Versus Direct Viral Injury Federico Biscetti, Maria Margherita Rando, Elisabetta Nardella, Andrea Leonardo Cecchini, Piergiorgio Bruno, Raffaele Landolfi, Andrea Flex
733 [GO] 2020―Oct―29 Emerging Mechanisms of Pulmonary Vasoconstriction in SARS-CoV-2-Induced Acute Respiratory Distress Syndrome (ARDS) and Potential Therapeutic Targets Harry Karmouty-Quintana, Rajarajan A. Thandavarayan, Steven P. Keller, Sandeep Sahay, Lavannya M. Pandit, Bindu Akkanti
734 [GO] 2020―Oct―26 Interleukin-6: Molecule in the Intersection of Cancer, Ageing and COVID-19 Jan Brábek, Milan Jakubek, Fréderic Vellieux, Jiří Novotný, Michal Kolář, Lukáš Lacina, et al. (+5)
735 [GO] 2020―Oct―26 SARS-CoV-2/Renin-Angiotensin System: Deciphering the Clues for a Couple with Potentially Harmful Effects on Skeletal Muscle Andrea Gonzalez, Josué Orozco-Aguilar, Oscar Achiardi, Felipe Simon, Claudio Cabello-Verrugio
736 [GO] 2020―Oct―06 Crystal Structure of Non-Structural Protein 10 from Severe Acute Respiratory Syndrome Coronavirus-2 Annika Rogstam, Maria Nyblom, Signe Christensen, Celeste Sele, Vladimir O. Talibov, Therese Lindvall, et al. (+5)
737 [GO] 2020―Sep―29 Targeting the SphK-S1P-SIPR Pathway as a Potential Therapeutic Approach for COVID-19 Eileen M McGowan, Nahal Haddadi, Najah T. Nassif, Yiguang Lin
738 [GO] 2020―Sep―28 Role of SARS-CoV-2 in Altering the RNA-Binding Protein and miRNA-Directed Post-Transcriptional Regulatory Networks in Humans Rajneesh Srivastava, Swapna Vidhur Daulatabad, Mansi Srivastava, Sarath Chandra Janga
739 [GO] 2020―Sep―22 Imaging Diagnostics and Pathology in SARS-CoV-2-Related Diseases Manuel Scimeca, Nicoletta Urbano, Rita Bonfiglio, Manuela Montanaro, Elena Bonanno, Orazio Schillaci, Alessandro Mauriello
740 [GO] 2020―Sep―18 Stem Cells Secretome from Oral Tissue Could Represent a Promising Therapeutic Approach in COVID-19-Disease? Francesca Diomede, Guya D. Marconi, Luigia Fonticoli, Jacopo Pizzicannella, Oriana Trubiani
741 [GO] 2020―Sep―16 Cardiovascular Complications Associated with COVID-19 and Potential Therapeutic Strategies Arun Samidurai, Anindita Das
742 [GO] 2020―Sep―15 SARS-CoV-2 Infection: A Role for S1P/S1P Receptor Signaling in the Nervous System? Elisabetta Meacci, Mercedes Garcia-Gil, Federica Pierucci
743 [GO] 2020―Sep―09 Smoking and COVID-19: Adding Fuel to the Flame Vivek K. Kashyap, Anupam Dhasmana, Andrew Massey, Sudhir Kotnala, Nadeem Zafar, Meena Jaggi, et al. (+2)
744 [GO] 2020―Sep―09 Improved Detection of Antibodies against SARS-CoV-2 by Microsphere-Based Antibody Assay Carol Ho-Yan Fong, Jian-Piao Cai, Thrimendra Kaushika Dissanayake, Lin-Lei Chen, Charlotte Yee-Ki Choi, Lok-Hin Wong, et al. (+11)
745 [GO] 2020―Sep―04 Cardiovascular Damage in COVID-19: Therapeutic Approaches Targeting the Renin-Angiotensin-Aldosterone System Jairo Lumpuy-Castillo, Ana Lorenzo-Almorós, Ana María Pello-Lázaro, Carlos Sánchez-Ferrer, Jesús Egido, José Tuñón, et al. (+2)
746 [GO] 2020―Sep―03 The HMOX1 Pathway as a Promising Target for the Treatment and Prevention of SARS-CoV-2 of 2019 (COVID-19) Neelu Batra, Cristabelle De Souza, Jyoti Batra, Alan G. Raetz, Ai-Ming Yu
747 [GO] 2020―Sep―01 Natural Killer Cell Dysfunction and Its Role in COVID-19 Charmaine van Eeden, Lamia Khan, Mohammed S. Osman, Jan Willem Cohen Tervaert
748 [GO] 2020―Aug―27 Using All-Atom Potentials to Refine RNA Structure Predictions of SARS-CoV-2 Stem Loops Christina Bergonzo, Andrea L. Szakal
749 [GO] 2020―Aug―20 Existence of SARS-CoV-2 Entry Molecules in the Oral Cavity Wakako Sakaguchi, Nobuhisa Kubota, Tomoko Shimizu, Juri Saruta, Shinya Fuchida, Akira Kawata, et al. (+4)
750 [GO] 2020―Aug―18 Deciphering SARS-CoV-2 Virologic and Immunologic Features Grégorie Lebeau, Damien Vagner, Étienne Frumence, Franck Ah-Pine, Xavier Guillot, Estelle Nobécourt, et al. (+2)
751 [GO] 2020―Aug―14 New Anti SARS-Cov-2 Targets for Quinoline Derivatives Chloroquine and Hydroxychloroquine Davide Gentile, Virginia Fuochi, Antonio Rescifina, Pio Maria Furneri
752 [GO] 2020―Aug―13 Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications Konstantinos Farsalinos, Elias Eliopoulos, Demetres D. Leonidas, Georgios E. Papadopoulos, Socrates Tzartos, Konstantinos Poulas
753 [GO] 2020―Aug―12 Obesity and COVID-19: Molecular Mechanisms Linking Both Pandemics Andreas Ritter, Nina-Naomi Kreis, Frank Louwen, Juping Yuan
754 [GO] 2020―Aug―10 SARS-CoV-2 Entry Inhibitors: Small Molecules and Peptides Targeting Virus or Host Cells Rolando Cannalire, Irina Stefanelli, Carmen Cerchia, Andrea R. Beccari, Sveva Pelliccia, Vincenzo Summa
755 [GO] 2020―Aug―07 Development and Evaluation of Novel and Highly Sensitive Single-Tube Nested Real-Time RT-PCR Assays for SARS-CoV-2 Detection Cyril Chik-Yan Yip, Siddharth Sridhar, Kit-Hang Leung, Anthony Chin-Ki Ng, Kwok-Hung Chan, Jasper Fuk-Woo Chan, et al. (+5)
756 [GO] 2020―Aug―04 COVID-19: The Immune Responses and Clinical Therapy Candidates Sareh Zhand, Marie Saghaeian Jazi, Saeed Mohammadi, Roozbeh Tarighati Rasekhi, Ghassem Rostamian, Mohammad Reza Kalani, et al. (+3)
757 [GO] 2020―Aug―04 Use of Whole Genome Sequencing Data for a First in Silico Specificity Evaluation of the RT-qPCR Assays Used for SARS-CoV-2 Detection Mathieu Gand, Kevin Vanneste, Isabelle Thomas, Steven Van Gucht, Arnaud Capron, Philippe Herman, et al. (+2)
758 [GO] 2020―Aug―03 SARS-CoV-2 and the Nervous System: From Clinical Features to Molecular Mechanisms Manuela Pennisi, Giuseppe Lanza, Luca Falzone, Francesco Fisicaro, Raffaele Ferri, Rita Bella
759 [GO] 2020―Jul―29 A Rapid, Simple, Inexpensive, and Mobile Colorimetric Assay COVID-19-LAMP for Mass On-Site Screening of COVID-19 Franklin Wang-Ngai Chow, Tony Tat-Yin Chan, Anthony Raymond Tam, Suhui Zhao, Weiming Yao, Joshua Fung, et al. (+21)
760 [GO] 2020―Jul―28 Phosphodiesterase Inhibitors: Could They Be Beneficial for the Treatment of COVID-19? Mauro Giorgi, Silvia Cardarelli, Federica Ragusa, Michele Saliola, Stefano Biagioni, Giancarlo Poiana, et al. (+2)
761 [GO] 2020―Jul―28 Computational Studies of SARS-CoV-2 3CLpro: Insights from MD Simulations Alessandro Grottesi, Neva Bešker, Andrew Emerson, Candida Manelfi, Andrea R. Beccari, Francesco Frigerio, et al. (+3)
762 [GO] 2020―Jul―22 Covid-19: The Rollercoaster of Fibrin(Ogen), D-Dimer, Von Willebrand Factor, P-Selectin and Their Interactions with Endothelial Cells, Platelets and Erythrocytes Corlia Grobler, Siphosethu C. Maphumulo, L. Mireille Grobbelaar, Jhade C. Bredenkamp, Gert J. Laubscher, Petrus J. Lourens, et al. (+3)
763 [GO] 2020―Jul―22 Protective Effect of Epigallocatechin-3-Gallate (EGCG) in Diseases with Uncontrolled Immune Activation: Could Such a Scenario Be Helpful to Counteract COVID-19? Marta Menegazzi, Rachele Campagnari, Mariarita Bertoldi, Rosalia Crupi, Rosanna Di Paola, Salvatore Cuzzocrea
764 [GO] 2020―Jul―22 A Comprehensive Mapping of the Druggable Cavities within the SARS-CoV-2 Therapeutically Relevant Proteins by Combining Pocket and Docking Searches as Implemented in Pockets 2.0 Silvia Gervasoni, Giulio Vistoli, Carmine Talarico, Candida Manelfi, Andrea R. Beccari, Gabriel Studer, et al. (+4)
765 [GO] 2020―Jul―21 COVID-19: A Review on Diagnosis, Treatment, and Prophylaxis Alessandra Fierabracci, Andrea Arena, Paolo Rossi
766 [GO] 2020―Jul―20 Point-of-Use Rapid Detection of SARS-CoV-2: Nanotechnology-Enabled Solutions for the COVID-19 Pandemic Navid Rabiee, Mojtaba Bagherzadeh, Amir Ghasemi, Hossein Zare, Sepideh Ahmadi, Yousef Fatahi, et al. (+5)
767 [GO] 2020―Jul―20 The COVID-19 Pandemic: Does Our Early Life Environment, Life Trajectory and Socioeconomic Status Determine Disease Susceptibility and Severity? Cyrielle Holuka, Myriam P. Merz, Sara B. Fernandes, Eleftheria G. Charalambous, Snehaa V. Seal, Nathalie Grova, Jonathan D. Turner
768 [GO] 2020―Jul―14 COVID-19/SARS-CoV-2 Infection: Lysosomes and Lysosomotropism Implicate New Treatment Strategies and Personal Risks Markus Blaess, Lars Kaiser, Martin Sauer, René Csuk, Hans-Peter Deigner
769 [GO] 2020―Jul―14 Lactoferrin as Protective Natural Barrier of Respiratory and Intestinal Mucosa against Coronavirus Infection and Inflammation Elena Campione, Terenzio Cosio, Luigi Rosa, Caterina Lanna, Stefano Di Girolamo, Roberta Gaziano, et al. (+2)
770 [GO] 2020―Jul―07 Implications of SARS-CoV-2 Mutations for Genomic RNA Structure and Host microRNA Targeting Ali Hosseini Rad SM, Alexander D. McLellan
771 [GO] 2020―Jul―06 Immunopathology of SARS-CoV-2 Infection: Immune Cells and Mediators, Prognostic Factors, and Immune-Therapeutic Implications Alessandro Allegra, Mario Di Gioacchino, Alessandro Tonacci, Caterina Musolino, Sebastiano Gangemi
772 [GO] 2020―Jun―30 Putative Roles for Peptidylarginine Deiminases in COVID-19 Elif Damla Arisan, Pinar Uysal-Onganer, Sigrun Lange
773 [GO] 2020―Jun―30 Body Composition Findings by Computed Tomography in SARS-CoV-2 Patients: Increased Risk of Muscle Wasting in Obesity Paola Gualtieri, Carmela Falcone, Lorenzo Romano, Sebastiano Macheda, Pierpaolo Correale, Pietro Arciello, et al. (+2)
774 [GO] 2020―Jun―30 Influence of Herbal Medicines on HMGB1 Release, SARS-CoV-2 Viral Attachment, Acute Respiratory Failure, and Sepsis. A Literature Review Marzena Wyganowska-Swiatkowska, Michal Nohawica, Katarzyna Grocholewicz, Gerard Nowak
775 [GO] 2020―Jun―26 Betacoronavirus Genomes: How Genomic Information has been Used to Deal with Past Outbreaks and the COVID-19 Pandemic Alejandro Llanes, Carlos M. Restrepo, Zuleima Caballero, Sreekumari Rajeev, Melissa A. Kennedy, Ricardo Lleonart
776 [GO] 2020―Jun―26 SARS-CoV-2 Evolutionary Adaptation toward Host Entry and Recognition of Receptor O-Acetyl Sialylation in Virus-Host Interaction Cheorl-Ho Kim
777 [GO] 2020―Jun―23 Optimized qRT-PCR Approach for the Detection of Intra- and Extra-Cellular SARS-CoV-2 RNAs Tuna Toptan, Sebastian Hoehl, Sandra Westhaus, Denisa Bojkova, Annemarie Berger, Björn Rotter, et al. (+4)
778 [GO] 2020―Jun―23 The Strategic Alliance between Clinical and Molecular Science in the War against SARS-CoV-2, with the Rapid-Diagnostics Test as an Indispensable Weapon for Front Line Doctors Antonio Vittorino Gaddi, Fabio Capello, Leonardo Aluigi, Pier Luigi Antignani, Annapaola Callegaro, Gavino Casu, et al. (+20)
779 [GO] 2020―Jun―02 Cerebrovascular and Neurological Dysfunction under the Threat of COVID-19: Is There a Comorbid Role for Smoking and Vaping? Sabrina Rahman Archie, Luca Cucullo
780 [GO] 2020―May―28 Pulmonary Delivery of Fenretinide: A Possible Adjuvant Treatment In COVID-19 Isabella Orienti, Giovanna Angela Gentilomi, Giovanna Farruggia
781 [GO] 2020―May―28 Broad-Spectrum Coronavirus Fusion Inhibitors to Combat COVID-19 and Other Emerging Coronavirus Diseases Xinling Wang, Shuai Xia, Qian Wang, Wei Xu, Weihua Li, Lu Lu, Shibo Jiang
782 [GO] 2020―May―28 Cannabinoid Receptor Type 2: A Possible Target in SARS-CoV-2 (CoV-19) Infection? Francesca Rossi, Chiara Tortora, Maura Argenziano, Alessandra Di Paola, Francesca Punzo
783 [GO] 2020―May―28 Prediction of Novel Inhibitors of the Main Protease (M-pro) of SARS-CoV-2 through Consensus Docking and Drug Reposition Aleix Gimeno, Júlia Mestres-Truyol, María José Ojeda-Montes, Guillem Macip, Bryan Saldivar-Espinoza, Adrià Cereto-Massagué, et al. (+2)
784 [GO] 2020―May―21 Potential Inhibitors for Novel Coronavirus Protease Identified by Virtual Screening of 606 Million Compounds André Fischer, Manuel Sellner, Santhosh Neranjan, Martin Smieško, Markus A. Lill
785 [GO] 2020―May―21 Proteasome Inhibitors as a Possible Therapy for SARS-CoV-2 Lucia Longhitano, Daniele Tibullo, Cesarina Giallongo, Giacomo Lazzarino, Nicola Tartaglia, Sara Galimberti, et al. (+3)
786 [GO] 2020―May―21 Smoking-Mediated Upregulation of the Androgen Pathway Leads to Increased SARS-CoV-2 Susceptibility Jaideep Chakladar, Neil Shende, Wei Tse Li, Mahadevan Rajasekaran, Eric Y. Chang, Weg M. Ongkeko
787 [GO] 2020―May―18 The Role of Lipid Metabolism in COVID-19 Virus Infection and as a Drug Target Mohamed Abu-Farha, Thangavel Alphonse Thanaraj, Mohammad G. Qaddoumi, Anwar Hashem, Jehad Abubaker, Fahd Al-Mulla
788 [GO] 2020―May―15 Deubiquitinating Enzymes in Coronaviruses and Possible Therapeutic Opportunities for COVID-19 Valentino Clemente, Padraig D’Arcy, Martina Bazzaro
789 [GO] 2020―May―14 COVID-19 and Individual Genetic Susceptibility/Receptivity: Role of ACE1/ACE2 Genes, Immunity, Inflammation and Coagulation. Might the Double X-chromosome in Females Be Protective against SARS-CoV-2 Compared to the Single X-Chromosome in Males? Donato Gemmati, Barbara Bramanti, Maria Luisa Serino, Paola Secchiero, Giorgio Zauli, Veronica Tisato
790 [GO] 2020―May―12 Essential Oils as Antiviral Agents. Potential of Essential Oils to Treat SARS-CoV-2 Infection: An In-Silico Investigation Joyce Kelly R. da Silva, Pablo Luis Baia Figueiredo, Kendall G. Byler, William N. Setzer
791 [GO] 2020―May―11 SARS-CoV-2 Inflammatory Syndrome. Clinical Features and Rationale for Immunological Treatment Marcella Prete, Elvira Favoino, Giacomo Catacchio, Vito Racanelli, Federico Perosa
792 [GO] 2020―May―08 Cytokine Release Syndrome in COVID-19 Patients, A New Scenario for an Old Concern: The Fragile Balance between Infections and Autoimmunity Andrea Picchianti Diamanti, Maria Manuela Rosado, Claudio Pioli, Giorgio Sesti, Bruno Laganà
793 [GO] 2020―May―07 Acute Kidney Injury in SARS-CoV-2 Infection: Direct Effect of Virus on Kidney Proximal Tubule Cells Manoocher Soleimani
794 [GO] 2020―May―04 Hybridization Chain Reactions Targeting the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Tzu-Heng Wu, Chia-Chen Chang, Ching-Hsu Yang, Wei-Yin Lin, Tan Joy Ee, Chii-Wann Lin
795 [GO] 2020―May―04 SARS Unique Domain (SUD) of Severe Acute Respiratory Syndrome Coronavirus Induces NLRP3 Inflammasome-Dependent CXCL10-Mediated Pulmonary Inflammation Young-Sheng Chang, Bo-Han Ko, Jyh-Cherng Ju, Hsin-Hou Chang, Su-Hua Huang, Cheng-Wen Lin
796 [GO] 2020―Apr―28 Functional Role of Dietary Intervention to Improve the Outcome of COVID-19: A Hypothesis of Work Giovanni Messina, Rita Polito, Vincenzo Monda, Luigi Cipolloni, Nunzio Di Nunno, Giulio Di Mizio, et al. (+9)
797 [GO] 2020―Apr―28 Structural and Evolutionary Analysis Indicate That the SARS-CoV-2 Mpro Is a Challenging Target for Small-Molecule Inhibitor Design Maria Bzówka, Karolina Mitusińska, Agata Raczyńska, Aleksandra Samol, Jack A. Tuszyński, Artur Góra
798 [GO] 2020―Apr―24 COVID-19 and RAS: Unravelling an Unclear Relationship Damiano D’Ardes, Andrea Boccatonda, Ilaria Rossi, Maria Teresa Guagnano, Francesca Santilli, Francesco Cipollone, Marco Bucci
799 [GO] 2020―Apr―24 RT-qPCR Testing of SARS-CoV-2: A Primer Stephen A. Bustin, Tania Nolan
800 [GO] 2020―Apr―23 Sex-Specific SARS-CoV-2 Mortality: Among Hormone-Modulated ACE2 Expression, Risk of Venous Thromboembolism and Hypovitaminosis D Sandro La Vignera, Rossella Cannarella, Rosita A. Condorelli, Francesco Torre, Antonio Aversa, Aldo E. Calogero
801 [GO] 2020―Apr―21 COVID-19 Drug Discovery Using Intensive Approaches Ayumu Asai, Masamitsu Konno, Miyuki Ozaki, Chihiro Otsuka, Andrea Vecchione, Takahiro Arai, et al. (+8)
802 [GO] 2020―Apr―21 A Novel Reverse Transcription Loop-Mediated Isothermal Amplification Method for Rapid Detection of SARS-CoV-2 Renfei Lu, Xiuming Wu, Zhenzhou Wan, Yingxue Li, Xia Jin, Chiyu Zhang
803 [GO] 2020―Apr―13 A Review of SARS-CoV-2 and the Ongoing Clinical Trials Yung-Fang Tu, Chian-Shiu Chien, Aliaksandr A. Yarmishyn, Yi-Ying Lin, Yung-Hung Luo, Yi-Tsung Lin, et al. (+6)
804 [GO] 2020―Apr―09 Development of a Novel, Genome Subtraction-Derived, SARS-CoV-2-Specific COVID-19-nsp2 Real-Time RT-PCR Assay and Its Evaluation Using Clinical Specimens Cyril Chik-Yan Yip, Chi-Chun Ho, Jasper Fuk-Woo Chan, Kelvin Kai-Wang To, Helen Shuk-Ying Chan, Sally Cheuk-Ying Wong, et al. (+12)
805 [GO] 2020―Mar―25 Could Intravenous Immunoglobulin Collected from Recovered Coronavirus Patients Protect against COVID-19 and Strengthen the Immune System of New Patients? Samir Jawhara
 [1] 

805 Results       Page 1


[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.363 sec